data_1vyx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vyx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG12 ' CA ' ' A' ' 17' ' ' GLY . 46.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.546 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' N ' HG11 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.592 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.546 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 67.2 m-20 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.586 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 41' ' ' TRP . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.732 0.301 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.514 ' O ' HD22 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.504 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CG ' ' CG ' ' A' ' 35' ' ' ARG . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.653 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' HD22 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 45' ' ' SER . 89.5 m-20 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.455 ' SG ' HG22 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.638 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 8.2 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.71 0.291 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE2' HD23 ' A' ' 30' ' ' LEU . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' N ' HG11 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 15.3 t30 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.578 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.541 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.5 m-80 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.556 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.513 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.501 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.511 ' N ' HD13 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.58 ' CD2' HD21 ' A' ' 42' ' ' LEU . 16.7 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 15' ' ' GLU . 54.8 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.481 ' O ' HD22 ' A' ' 16' ' ' LEU . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.575 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.575 HG12 ' CH2' ' A' ' 10' ' ' TRP . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.571 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 79.7 m-20 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 57' ' ' TYR . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.496 ' N ' HD13 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.409 ' C ' HG21 ' A' ' 48' ' ' THR . 44.4 m-20 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 56' ' ' VAL . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 56' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 48' ' ' THR . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 42' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG1' ' CA ' ' A' ' 17' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.584 ' CE2' HD23 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.582 ' CA ' ' CG1' ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.502 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' GLY . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.584 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.583 ' CE1' HD11 ' A' ' 16' ' ' LEU . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.445 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 54.9 m-20 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.513 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.565 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 20.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 15' ' ' GLU . 89.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.535 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.529 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.606 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 22.6 m-20 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.539 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.594 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 37' ' ' CYS . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.503 ' N ' HD11 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' C ' ' CG2' ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.527 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.43 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 52' ' ' ILE . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 12.1 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.564 ' CE2' HD23 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' C ' ' CG1' ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.607 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.564 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.508 ' N ' HD11 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 40' ' ' THR . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' HG11 ' A' ' 56' ' ' VAL . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' VAL . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.475 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.571 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CE2' HD23 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.445 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.552 ' N ' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 45.9 m-80 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 43' ' ' THR . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.485 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 43' ' ' THR . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.528 ' N ' HD11 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.467 ' O ' HG11 ' A' ' 56' ' ' VAL . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 48' ' ' THR . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HB ' ' OE2' ' A' ' 15' ' ' GLU . 86.1 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.59 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' HG11 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 2.4 m-80 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.484 ' N ' HG21 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.478 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 39' ' ' SER . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.501 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 7.4 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.537 ' CA ' HD22 ' A' ' 16' ' ' LEU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 10.1 t-20 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.545 ' OE1' ' CE1' ' A' ' 34' ' ' HIS . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD22 ' CA ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.534 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.535 ' N ' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 67.7 m-80 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 41' ' ' TRP . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.509 ' N ' HG21 ' A' ' 40' ' ' THR . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' HD23 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.492 ' CD1' HD11 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.515 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 70.6 m-80 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 41' ' ' TRP . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.523 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.516 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.523 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.506 ' N ' HD13 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 HD13 ' HB ' ' A' ' 43' ' ' THR . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' O ' ' OG1' ' A' ' 48' ' ' THR . 24.2 m-20 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.53 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.447 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.529 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.552 ' CZ ' ' C ' ' A' ' 49' ' ' ALA . 17.2 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.593 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.56 ' CE2' HD23 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.556 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' N ' HG11 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.543 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.54 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.593 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 66.9 m-80 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.527 ' N ' HD13 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 87.4 m-20 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.633 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 14.0 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' A' ' 15' ' ' GLU . 21.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.637 0.256 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.547 ' CA ' HD22 ' A' ' 16' ' ' LEU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' ASN . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.623 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' N ' HG11 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.433 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 33.1 m-80 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 40' ' ' THR . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 36' ' ' SER . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.558 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 52' ' ' ILE . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 55' ' ' VAL . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 48' ' ' THR . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' CD2' ' C ' ' A' ' 48' ' ' THR . 12.8 m-85 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 17' ' ' GLY . 67.5 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.558 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 28' ' ' GLY . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.535 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 40' ' ' THR . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD21 ' CG2' ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.469 ' O ' HD13 ' A' ' 44' ' ' ILE . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.5 ' N ' HD13 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 40' ' ' THR . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.522 ' C ' ' CG2' ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' CA ' HD22 ' A' ' 16' ' ' LEU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.589 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 52.1 m-20 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.57 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.556 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 40' ' ' THR . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.57 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.505 ' N ' HG21 ' A' ' 40' ' ' THR . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD11 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.522 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 5.5 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' ASN . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' O ' HD21 ' A' ' 16' ' ' LEU . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' CG1' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CG ' ' CG ' ' A' ' 35' ' ' ARG . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.531 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 28' ' ' GLY . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.536 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 12.7 m-80 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.592 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.472 ' O ' HD13 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 41' ' ' TRP . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.516 ' N ' HG21 ' A' ' 40' ' ' THR . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 38' ' ' LEU . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 40' ' ' THR . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 HG21 ' C ' ' A' ' 47' ' ' ASN . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 11.8 m-85 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE2' HD23 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' N ' HG11 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' CA ' ' HA ' ' A' ' 57' ' ' TYR . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.596 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.519 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 6.0 m-80 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.465 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 43' ' ' THR . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 44' ' ' ILE . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.518 ' O ' ' OG1' ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.546 ' CD2' ' C ' ' A' ' 48' ' ' THR . 24.1 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' OE2' ' A' ' 15' ' ' GLU . 40.1 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' HD23 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CE1' ' HB1' ' A' ' 23' ' ' ALA . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 20.7 m-80 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.57 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 ' CG2' ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' ARG . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 40' ' ' THR . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.515 ' C ' ' CG2' ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CD2' ' C ' ' A' ' 48' ' ' THR . 23.9 m-85 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.662 0.268 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.587 ' CE2' HD23 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.576 HG12 ' CE2' ' A' ' 10' ' ' TRP . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' OE1' ' CE1' ' A' ' 34' ' ' HIS . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' A' ' 16' ' ' LEU . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' N ' ' A' ' 41' ' ' TRP . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.525 ' N ' HG21 ' A' ' 40' ' ' THR . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.511 ' N ' HD11 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 ' O ' HG11 ' A' ' 56' ' ' VAL . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.547 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.564 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 12.2 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.504 ' CA ' HD22 ' A' ' 16' ' ' LEU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.49 ' N ' HD23 ' A' ' 16' ' ' LEU . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.431 ' C ' HG12 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.615 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 15.2 m-80 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 16' ' ' LEU . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.437 ' HA ' HD22 ' A' ' 42' ' ' LEU . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 38' ' ' LEU . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 40' ' ' THR . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 40' ' ' THR . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CD2' ' C ' ' A' ' 48' ' ' THR . 24.2 m-85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.528 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.529 ' CA ' HD22 ' A' ' 16' ' ' LEU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.536 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.59 ' CE2' HD23 ' A' ' 30' ' ' LEU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.511 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.552 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.523 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 69.7 m-20 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.458 ' HA ' HD22 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.511 ' O ' ' OG1' ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.526 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.551 ' CD2' HD21 ' A' ' 42' ' ' LEU . 18.2 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.629 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.582 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HG2' ' CE1' ' A' ' 34' ' ' HIS . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.573 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' CYS . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.49 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 9.0 m-80 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.4 m80 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' HD22 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 37' ' ' CYS . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' CB ' ' HB2' ' A' ' 47' ' ' ASN . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.509 ' N ' HD11 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.519 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 23.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.731 0.3 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' O ' HD22 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.576 ' CE2' HD23 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.6 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 41' ' ' TRP . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.554 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.518 ' O ' ' OG1' ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 24' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.554 ' CD2' HD21 ' A' ' 42' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 15' ' ' GLU . 69.9 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.505 ' HB2' HD13 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.517 ' N ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.668 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.546 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.61 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' ' HA3' ' A' ' 25' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.534 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' ARG . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 36' ' ' SER . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.554 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 48' ' ' THR . 13.7 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CG ' ' A' ' 15' ' ' GLU . 10.4 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.544 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' HG11 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.517 ' CG ' HG13 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 28.7 m-20 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG2' HD21 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.527 HD21 ' CG2' ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.447 ' O ' ' HB ' ' A' ' 43' ' ' THR . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CZ2' ' ND2' ' A' ' 47' ' ' ASN . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 43' ' ' THR . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD11 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.568 ' ND2' ' CZ2' ' A' ' 41' ' ' TRP . 30.1 m-20 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.529 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.455 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.487 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 4.7 t30 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.606 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 40.6 m-80 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.572 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.536 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' HD23 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 42' ' ' LEU . 85.9 m-20 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' HG11 ' A' ' 56' ' ' VAL . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.455 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.532 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 48' ' ' THR . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 HG13 ' HG2' ' A' ' 15' ' ' GLU . 38.9 t . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.78 0.324 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.542 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CA ' HD22 ' A' ' 16' ' ' LEU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' HD23 ' A' ' 30' ' ' LEU . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CD1' HD11 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' C ' HG12 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD22 ' CA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' CYS . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 75.6 m-20 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 11' ' ' ILE . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 43' ' ' THR . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 43' ' ' THR . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' HD13 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.541 ' CD2' ' C ' ' A' ' 48' ' ' THR . 28.0 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 7' ' ' PRO . 31.9 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD2' HG11 ' A' ' 6' ' ' VAL . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HD23 ' A' ' 30' ' ' LEU . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.55 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.461 ' HB3' HD12 ' A' ' 16' ' ' LEU . 15.3 m-80 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.562 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.511 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD13 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' O ' ' OG1' ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' VAL . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.456 HD11 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.498 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.302 0.572 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -10.57 55.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.9 m-20 -63.86 -9.07 13.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.467 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 7.4 pt-20 -49.68 -175.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.85 . . . . 0.0 110.555 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 7.7 t0 70.28 153.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG12 ' CA ' ' A' ' 17' ' ' GLY . 46.7 t -106.24 123.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.546 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' N ' HG11 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.43 ' O ' ' HD2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.515 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.592 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.546 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 67.2 m-20 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.552 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.586 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 33' ' ' VAL . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 41' ' ' TRP . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.539 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 -72.85 -35.5 67.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.441 ' OD1' ' HB ' ' A' ' 56' ' ' VAL . 15.4 m120 49.47 72.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.481 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 50.7 p -100.07 147.86 25.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 1.9 mmt180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.142 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.6 ttm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.925 0.393 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 1' ' ' MET . 10.4 pm0 35.25 -145.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.772 -0.58 . . . . 0.0 111.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 80.2 m-20 -95.29 -74.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.387 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -119.24 143.79 47.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.91 112.49 17.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.003 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -133.2 111.37 12.96 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.514 ' O ' HD22 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.504 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' N ' ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.613 ' CG ' ' CG ' ' A' ' 35' ' ' ARG . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' ASN . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.541 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.653 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.544 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.468 ' O ' ' CG2' ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' HD22 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.573 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 45' ' ' SER . 89.5 m-20 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.455 ' SG ' HG22 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.638 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 8.2 m-85 -73.55 62.47 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.89 121.63 12.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 0.0 110.473 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 33.2 p -90.86 116.79 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.913 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.217 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.2 0.524 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.2 -19.7 12.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.539 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.56 -163.52 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.41 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -49.77 -60.6 2.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.45 -175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.923 . . . . 0.0 110.149 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG13 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t -81.52 131.13 59.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.578 ' CE2' HD23 ' A' ' 30' ' ' LEU . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.491 ' N ' HG11 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 15.3 t30 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.591 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' CD1' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.541 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.5 m-80 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.548 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.591 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.556 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.513 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.501 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.511 ' N ' HD13 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.521 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.58 ' CD2' HD21 ' A' ' 42' ' ' LEU . 16.7 m-85 -74.91 -35.14 62.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 57' ' ' TYR . 26.9 t-20 40.59 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.469 HG23 ' CB ' ' A' ' 39' ' ' SER . 15.5 p -104.24 154.25 20.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.192 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.541 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.49 -23.15 15.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.325 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -142.25 -151.03 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.213 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -115.37 -101.94 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 t70 60.57 160.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' OE2' ' A' ' 15' ' ' GLU . 54.8 t -133.64 113.57 13.0 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 110.012 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' O ' HD22 ' A' ' 16' ' ' LEU . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.575 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 HG12 ' CH2' ' A' ' 10' ' ' TRP . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.536 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.571 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 79.7 m-20 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.585 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.502 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 57' ' ' TYR . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.496 ' N ' HD13 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.409 ' C ' HG21 ' A' ' 48' ' ' THR . 44.4 m-20 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.48 ' O ' HG11 ' A' ' 56' ' ' VAL . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 56' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 48' ' ' THR . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.572 ' CD2' HD21 ' A' ' 42' ' ' LEU . 26.4 m-85 -63.51 -37.06 85.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 57' ' ' TYR . 43.2 t30 43.94 92.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.4 p -94.11 130.18 40.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.977 . . . . 0.0 110.22 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.299 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.173 0.511 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' OE1' ' C ' ' A' ' 2' ' ' GLU . 0.7 OUTLIER -91.97 -12.47 33.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.4 -35.49 65.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.411 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.501 ' CG ' ' O ' ' A' ' 3' ' ' ASP . 33.9 mt-10 -157.35 -40.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.364 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -69.31 81.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 110.396 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG1' ' CA ' ' A' ' 17' ' ' GLY . 18.0 t -93.03 123.08 62.14 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.504 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.496 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.584 ' CE2' HD23 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.536 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.656 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.645 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.582 ' CA ' ' CG1' ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 28' ' ' GLY . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.584 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.528 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.583 ' CE1' HD11 ' A' ' 16' ' ' LEU . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.445 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 54.9 m-20 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.513 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.565 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 20.6 m-85 -66.46 -46.6 75.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 1.3 t30 68.37 43.7 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.558 HG23 ' CZ ' ' A' ' 21' ' ' PHE . 32.6 p -82.04 126.09 31.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.126 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.21 -76.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 110.454 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -103.43 -176.12 2.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.772 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 3.9 pt-20 -141.12 174.93 10.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.114 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 14.0 t0 56.19 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.186 -0.947 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 HG13 ' HG2' ' A' ' 15' ' ' GLU . 89.2 t -108.17 106.19 58.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 110.605 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.535 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.594 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.529 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.529 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.606 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 22.6 m-20 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.594 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 37' ' ' CYS . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.506 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.503 ' N ' HD11 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' C ' ' CG2' ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.527 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.43 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 52' ' ' ILE . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.529 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 -76.16 -36.23 58.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 52.92 65.26 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -1.0 . . . . 0.0 110.345 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.55 HG21 ' CZ ' ' A' ' 21' ' ' PHE . 68.2 p -88.75 150.49 22.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.19 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.184 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.085 0.469 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -179.03 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.44 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 110.158 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.49 147.48 26.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.57 114.11 9.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' CG1' ' HA3' ' A' ' 17' ' ' GLY . 12.1 t -105.32 141.35 22.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.453 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.564 ' CE2' HD23 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' C ' ' CG1' ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.607 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.554 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.557 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.564 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.545 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.586 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.545 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' HD13 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 HD11 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.508 ' N ' HD11 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 40' ' ' THR . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' HG11 ' A' ' 56' ' ' VAL . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.501 ' N ' ' O ' ' A' ' 55' ' ' VAL . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.475 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 -72.78 -39.48 66.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.1 64.66 1.76 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.431 -0.793 . . . . 0.0 110.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.3 p -88.04 156.88 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.56 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.79 -79.2 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.074 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.62 167.92 7.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.163 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -156.65 -163.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.227 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.96 97.69 10.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.139 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t -90.73 122.07 67.4 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 0.0 109.935 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.571 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.496 ' CE2' HD23 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.445 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.573 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' N ' ' CG ' ' A' ' 29' ' ' GLU . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 45.9 m-80 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.573 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' OG1' ' A' ' 43' ' ' THR . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.485 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.528 HD11 ' N ' ' A' ' 43' ' ' THR . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.528 ' N ' HD11 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.431 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.467 ' O ' HG11 ' A' ' 56' ' ' VAL . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.527 ' N ' ' O ' ' A' ' 55' ' ' VAL . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 50' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 48' ' ' THR . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 -70.79 -29.89 66.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 44.39 78.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.262 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -112.66 129.38 56.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.369 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.274 0.559 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -145.29 172.4 13.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.148 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER 49.12 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.16 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 6.9 mm-40 -88.69 -62.62 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.116 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER 57.72 -164.47 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HB ' ' OE2' ' A' ' 15' ' ' GLU . 86.1 t -118.01 133.21 23.42 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.617 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.59 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' N ' HG11 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.546 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.617 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 2.4 m-80 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.516 ' CG1' HD21 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.593 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.516 HD21 ' CG1' ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.484 ' N ' HG21 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.478 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 39' ' ' SER . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.501 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 7.4 m-85 -72.46 70.65 0.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 118.11 2.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -0.832 . . . . 0.0 110.395 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 57' ' ' TYR . 55.1 p -125.26 168.22 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.12 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.232 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.272 0.558 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER 62.01 -77.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 43.36 -152.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 0.7 OUTLIER -88.11 -140.58 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -0.825 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 26.2 t70 60.68 120.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.33 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.75 107.45 12.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.537 ' CA ' HD22 ' A' ' 16' ' ' LEU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 10.1 t-20 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.545 ' OE1' ' CE1' ' A' ' 34' ' ' HIS . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD22 ' CA ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.534 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' N ' ' HG2' ' A' ' 29' ' ' GLU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 67.7 m-80 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.59 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.527 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.509 HG21 ' N ' ' A' ' 41' ' ' TRP . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.509 ' N ' HG21 ' A' ' 40' ' ' THR . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 -72.05 -35.37 69.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.01 78.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.496 HG23 ' CE1' ' A' ' 21' ' ' PHE . 68.8 p -117.7 125.28 50.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.277 0.56 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -124.2 170.36 10.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.062 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.93 -35.69 2.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 48.9 mt-10 -144.35 138.74 28.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.323 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.3 t0 176.22 131.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -107.89 113.04 61.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.9 . . . . 0.0 110.035 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.515 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' HD23 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.492 ' CD1' HD11 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ASN . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 70.6 m-80 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.604 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' A' ' 41' ' ' TRP . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.523 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.516 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.523 ' CD2' ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.506 ' N ' HD13 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 HD13 ' HB ' ' A' ' 43' ' ' THR . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' O ' ' OG1' ' A' ' 48' ' ' THR . 24.2 m-20 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.53 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.447 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.529 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.552 ' CZ ' ' C ' ' A' ' 49' ' ' ALA . 17.2 m-85 -72.56 63.11 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' TYR . 3.4 m-80 -43.15 124.64 3.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 57' ' ' TYR . 5.8 p -135.13 119.41 17.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.284 0.564 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 3' ' ' ASP . 26.3 tt0 -151.06 -75.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.493 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -164.29 -171.98 2.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.127 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.15 -150.73 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -52.5 157.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.363 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.86 106.75 43.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.091 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.56 ' CE2' HD23 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.556 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' N ' HG11 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.54 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.593 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 66.9 m-80 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.53 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.527 ' N ' HD13 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.478 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 87.4 m-20 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.633 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 14.0 m-85 -74.62 67.34 1.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.5 t-20 -61.32 115.16 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.334 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 p -89.73 125.64 35.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.243 0.544 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 3.2 pt-20 -75.39 -140.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.82 -158.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.386 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 5' ' ' ASP . 39.1 mm-40 -108.15 -6.68 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 110.337 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 4' ' ' GLU . 6.6 p-10 -37.0 140.26 0.17 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.742 -0.599 . . . . 0.0 110.709 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG13 ' HG2' ' A' ' 15' ' ' GLU . 21.6 t -91.39 118.01 68.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 110.503 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.547 ' CA ' HD22 ' A' ' 16' ' ' LEU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 32' ' ' ASN . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.623 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' N ' HG11 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.572 ' CZ ' ' HB1' ' A' ' 23' ' ' ALA . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' A' ' 58' ' ' ASN . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.433 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 33.1 m-80 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.59 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 40' ' ' THR . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 35' ' ' ARG . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 36' ' ' SER . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.476 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.5 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 HD11 HG22 ' A' ' 52' ' ' ILE . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.406 ' SG ' HG22 ' A' ' 55' ' ' VAL . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.491 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG11 ' O ' ' A' ' 48' ' ' THR . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' CD2' ' C ' ' A' ' 48' ' ' THR . 12.8 m-85 -76.66 66.86 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -42.23 112.24 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.3 p -113.54 164.13 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 110.395 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.148 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.251 0.548 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.01 -47.29 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.923 . . . . 0.0 110.414 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLU . 91.1 m-20 40.91 -120.75 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.133 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.8 mm-40 -122.39 -14.64 7.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.768 -1.207 . . . . 0.0 110.259 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' GLU . 23.7 p30 -47.52 174.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.184 -0.948 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.466 HG11 ' HA3' ' A' ' 17' ' ' GLY . 67.5 t -114.95 127.33 26.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.529 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HA ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.558 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 28' ' ' GLY . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.6 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' CG2' HD21 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.535 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 40' ' ' THR . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD21 ' CG2' ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.476 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.469 ' O ' HD13 ' A' ' 44' ' ' ILE . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.5 ' N ' HD13 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 40' ' ' THR . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.522 ' C ' ' CG2' ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.542 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.524 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.542 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 -75.53 -44.31 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.496 ' OD1' ' CG1' ' A' ' 56' ' ' VAL . 2.4 m-20 61.8 80.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.5 p -113.92 131.1 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.333 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.313 0.578 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.85 -72.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -84.81 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.435 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.53 -10.09 12.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.378 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t0 -60.51 102.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 5' ' ' ASP . 47.4 t -135.87 139.67 31.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' CA ' HD22 ' A' ' 16' ' ' LEU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.598 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.518 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.573 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.589 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 52.1 m-20 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.556 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.596 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 40' ' ' THR . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.57 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.505 ' N ' HG21 ' A' ' 40' ' ' THR . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD11 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.438 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.518 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.514 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 -80.02 67.34 5.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 5.1 t-20 -57.09 136.41 56.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.166 -0.958 . . . . 0.0 110.215 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.2 164.2 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.391 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.365 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.358 0.599 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.25 -48.88 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.3 t0 53.02 176.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.8 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 -162.96 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 109.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 1.7 t0 -48.0 143.08 4.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 109.988 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 5.5 t -88.47 109.1 26.46 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' ASN . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.592 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' O ' HD21 ' A' ' 16' ' ' LEU . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' HG2' ' CG1' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.593 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.61 ' CG ' ' CG ' ' A' ' 35' ' ' ARG . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.563 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.531 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.443 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.519 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 28' ' ' GLY . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.536 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 12.7 m-80 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.472 ' O ' HD13 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 41' ' ' TRP . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.516 ' N ' HG21 ' A' ' 40' ' ' THR . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 38' ' ' LEU . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 40' ' ' THR . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.467 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 HG21 ' C ' ' A' ' 47' ' ' ASN . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 11.8 m-85 -77.73 71.17 4.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -46.07 124.62 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.442 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 57' ' ' TYR . 20.8 p -132.59 130.29 40.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.292 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' GLU . 14.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.0 mm-40 46.77 -171.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -152.6 -84.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.46 -72.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.415 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.86 121.49 26.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.352 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG11 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t -96.47 125.58 46.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.117 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.519 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE2' HD23 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.503 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' N ' HG11 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' CA ' ' HA ' ' A' ' 57' ' ' TYR . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.545 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.534 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.596 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.534 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.519 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 6.0 m-80 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.465 ' O ' ' CG2' ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.465 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.51 HD13 ' N ' ' A' ' 43' ' ' THR . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD12 HG22 ' A' ' 44' ' ' ILE . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.518 ' O ' ' OG1' ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.546 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.521 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.546 ' CD2' ' C ' ' A' ' 48' ' ' THR . 24.1 m-85 -59.82 -48.73 80.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t30 50.11 81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 109.972 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.5 p -87.06 144.8 26.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' OXT' ' HG2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.223 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.37 152.61 18.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.59 -146.57 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -103.19 -80.09 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -150.73 146.1 26.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' CG1' ' OE2' ' A' ' 15' ' ' GLU . 40.1 t -105.89 126.45 30.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.593 ' CE2' HD23 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.587 ' CE1' ' HB1' ' A' ' 23' ' ' ALA . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 20.7 m-80 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.528 ' CG2' HD21 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.57 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.484 ' O ' ' CG2' ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 HD21 ' CG2' ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 46' ' ' ARG . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 40' ' ' THR . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.515 ' C ' ' CG2' ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.459 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.504 ' CD2' ' C ' ' A' ' 48' ' ' THR . 23.9 m-85 -65.76 -40.53 92.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 50.35 70.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.394 -0.816 . . . . 0.0 110.146 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.53 HG23 ' CZ ' ' A' ' 21' ' ' PHE . 56.9 p -96.77 168.85 10.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.216 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' ASP . 2.2 mm-40 -119.67 -60.07 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 110.375 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 55.7 154.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.437 0.637 . . . . 0.0 110.805 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 67.5 mm-40 44.14 -170.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER 60.48 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 0.0 110.223 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG11 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t -112.22 115.07 50.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.61 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.538 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.587 ' CE2' HD23 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.576 HG12 ' CE2' ' A' ' 10' ' ' TRP . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' OE1' ' CE1' ' A' ' 34' ' ' HIS . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.55 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.603 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.538 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.549 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.55 ' NE2' ' HB3' ' A' ' 16' ' ' LEU . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.603 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.549 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.525 HG21 ' N ' ' A' ' 41' ' ' TRP . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.525 ' N ' HG21 ' A' ' 40' ' ' THR . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.511 ' N ' HD11 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 ' O ' HG11 ' A' ' 56' ' ' VAL . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.549 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.545 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.564 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.549 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 12.2 m-85 -79.99 -50.41 10.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.1 84.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.5 p -103.02 127.0 50.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.371 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.49 -175.61 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.17 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.4 m-20 -105.16 163.21 12.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . 20.2 pt-20 -56.18 -164.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.227 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.25 150.59 20.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.43 130.76 24.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.839 . . . . 0.0 109.944 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.504 ' CA ' HD22 ' A' ' 16' ' ' LEU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.49 ' N ' HD23 ' A' ' 16' ' ' LEU . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.615 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.431 ' C ' HG12 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' CB ' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.615 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.551 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 15.2 m-80 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.553 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 16' ' ' LEU . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.553 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.447 ' OG ' ' HB ' ' A' ' 59' ' ' THR . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.411 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 38' ' ' LEU . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 40' ' ' THR . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 40' ' ' THR . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' CD2' ' C ' ' A' ' 48' ' ' THR . 24.2 m-85 -63.04 -41.94 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.73 77.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.447 ' HB ' ' OG ' ' A' ' 39' ' ' SER . 13.8 p -109.07 146.89 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.104 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.245 0.545 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 3.2 mt-10 -155.0 -83.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 4.8 m-20 59.63 -170.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.41 -140.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.098 -1.001 . . . . 0.0 110.12 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -107.44 107.32 18.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.556 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.528 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -77.89 145.38 70.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.731 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.543 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.529 ' CA ' HD22 ' A' ' 16' ' ' LEU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.536 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.59 ' CE2' HD23 ' A' ' 30' ' ' LEU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.511 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.552 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.592 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 58' ' ' ASN . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.523 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.543 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 69.7 m-20 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.592 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.458 ' HA ' HD22 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.484 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.513 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.533 ' N ' HD13 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.511 ' O ' ' OG1' ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.526 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.551 ' CD2' HD21 ' A' ' 42' ' ' LEU . 18.2 m-85 -70.67 62.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 22' ' ' ARG . 5.0 t-20 -44.19 109.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 57' ' ' TYR . 30.8 p -95.26 120.2 35.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 110.013 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.145 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.316 0.579 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.9 -179.42 4.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -176.8 -74.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 110.464 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.3 -46.33 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 110.495 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.69 142.75 57.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.873 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.6 t -133.5 133.04 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.401 179.633 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.629 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.582 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.504 ' HG2' ' CE1' ' A' ' 34' ' ' HIS . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.573 ' HB3' ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.512 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.567 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' CYS . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.49 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.629 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.53 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 9.0 m-80 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.4 m80 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.567 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.461 ' HA ' HD22 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 37' ' ' CYS . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.437 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' CB ' ' HB2' ' A' ' 47' ' ' ASN . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.509 ' N ' HD11 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.513 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.519 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 23.3 m-85 -68.28 -38.76 82.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.2 t30 49.39 97.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.417 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 42.7 p -130.34 137.53 49.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.109 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.283 0.563 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.23 -70.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.197 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.32 -157.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.59 165.36 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.15 170.11 17.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.5 t -101.84 138.1 19.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.353 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' O ' HD22 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.576 ' CE2' HD23 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB3' ' SG ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HB3' ' NE2' ' A' ' 34' ' ' HIS . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.542 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.542 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.6 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.542 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 41' ' ' TRP . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.554 HD21 ' CD2' ' A' ' 57' ' ' TYR . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.518 ' O ' ' OG1' ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 24' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.554 ' CD2' HD21 ' A' ' 42' ' ' LEU . 57.4 m-85 -77.14 -29.53 54.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' TYR . 2.5 t-20 46.42 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.48 HG23 ' CZ ' ' A' ' 21' ' ' PHE . 47.4 p -124.09 141.87 51.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 110.303 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 14.4 ptm180 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.128 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 3' ' ' ASP . 2.4 pt-20 -145.23 -48.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 2' ' ' GLU . 0.4 OUTLIER 57.81 161.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.375 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 3' ' ' ASP . 29.2 mt-10 -157.14 -85.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.337 -0.852 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -178.29 3.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 109.924 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 15' ' ' GLU . 69.9 t -107.19 147.82 35.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.116 -0.99 . . . . 0.0 109.97 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.505 ' HB2' HD13 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.517 ' N ' HG11 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.668 ' CD1' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.546 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' CD2' ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' ' HA3' ' A' ' 25' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.534 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.649 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.551 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 35' ' ' ARG . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 36' ' ' SER . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.488 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.554 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.532 ' CE2' ' C ' ' A' ' 48' ' ' THR . 13.7 m-85 -65.24 -46.06 82.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 47.71 78.72 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.505 -0.747 . . . . 0.0 110.399 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 39' ' ' SER . 30.7 p -106.0 117.63 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.239 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.272 0.558 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.39 153.14 20.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -50.36 168.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 110.381 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -43.85 154.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.863 . . . . 0.0 110.171 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 177.25 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG13 ' CG ' ' A' ' 15' ' ' GLU . 10.4 t -121.89 110.28 33.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.544 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.572 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' N ' HG11 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' CG ' HG13 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.555 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.569 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 28.7 m-20 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG2' HD21 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.589 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.527 HD21 ' CG2' ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.447 ' O ' ' HB ' ' A' ' 43' ' ' THR . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CZ2' ' ND2' ' A' ' 47' ' ' ASN . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.539 HD11 ' N ' ' A' ' 43' ' ' THR . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD11 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.568 ' ND2' ' CZ2' ' A' ' 41' ' ' TRP . 30.1 m-20 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.529 ' CG2' ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.455 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 -73.79 -51.53 16.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER 67.56 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 110.428 179.741 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.418 HG21 ' C ' ' A' ' 58' ' ' ASN . 13.2 p -135.2 118.21 16.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 110.082 179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.14 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.256 0.551 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.4 -49.86 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.342 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 4' ' ' GLU . 8.6 t0 -102.37 -56.33 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 0.0 110.405 -179.762 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 3' ' ' ASP . 4.7 pt-20 -37.0 138.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 30.0 t70 54.52 168.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t -127.36 109.26 21.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.522 HG11 ' N ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.487 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 4.7 t30 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.569 ' CE2' ' HA ' ' A' ' 35' ' ' ARG . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.574 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.606 ' ND2' ' CB ' ' A' ' 7' ' ' PRO . 40.6 m-80 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.572 ' HB ' ' CD1' ' A' ' 10' ' ' TRP . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.536 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' HD23 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 43' ' ' THR . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.545 ' N ' HD13 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 42' ' ' LEU . 85.9 m-20 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' HG11 ' A' ' 56' ' ' VAL . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.455 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.532 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG11 ' O ' ' A' ' 48' ' ' THR . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 -73.94 68.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -49.5 114.23 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.843 . . . . 0.0 110.501 179.94 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -111.83 140.44 46.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.95 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.208 0.528 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -97.67 -144.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.482 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.21 167.87 6.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -111.98 -86.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.83 128.31 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 HG13 ' HG2' ' A' ' 15' ' ' GLU . 38.9 t -102.22 113.6 65.8 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.309 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.542 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' CA ' HD22 ' A' ' 16' ' ' LEU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CE2' HD23 ' A' ' 30' ' ' LEU . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.534 ' CD1' HD11 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' C ' HG12 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD22 ' CA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' CYS . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 75.6 m-20 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.534 HD11 ' CD1' ' A' ' 11' ' ' ILE . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.477 ' O ' ' HB ' ' A' ' 43' ' ' THR . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 43' ' ' THR . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.532 ' N ' HD13 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.507 ' C ' ' CG2' ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.54 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.515 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.515 ' CG2' ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.541 ' CD2' ' C ' ' A' ' 48' ' ' THR . 28.0 m-85 -68.4 -33.57 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 50.48 65.89 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 110.624 179.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 p -79.27 117.27 20.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.266 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 1' ' ' MET . 4.3 ttp . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -15.27 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' GLU . 17.8 t0 -101.31 -20.73 15.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.934 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 55.8 mt-10 42.65 -121.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.959 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 1.8 t0 69.81 143.82 0.05 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.738 -1.226 . . . . 0.0 110.377 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG11 ' HD2' ' A' ' 7' ' ' PRO . 31.9 t -122.01 130.77 24.59 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 0.0 109.922 179.687 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HD2' HG11 ' A' ' 6' ' ' VAL . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HD23 ' A' ' 30' ' ' LEU . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.55 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' HG11 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 35' ' ' ARG . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.522 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.512 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' HB3' HD12 ' A' ' 16' ' ' LEU . 15.3 m-80 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.562 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.597 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.445 ' O ' ' CG2' ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.544 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.511 ' HA ' ' CD2' ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.454 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD13 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' O ' ' OG1' ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.531 ' OG1' ' O ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.507 ' N ' ' O ' ' A' ' 55' ' ' VAL . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.456 HD11 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.498 ' SG ' ' CG2' ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 -70.28 -37.52 74.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 57' ' ' TYR . 0.6 OUTLIER 43.57 77.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.983 -179.766 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ARG . 17.9 p -92.9 140.08 29.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.9 . . . . 0.0 110.554 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.11 -0.948 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.904 HG13 ' HA2' ' A' ' 17' ' ' GLY . 46.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HB2' ' HB2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' C ' HG13 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.653 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.904 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.867 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.954 ' HB3' HD11 ' A' ' 16' ' ' LEU . 26.6 m120 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.936 ' HA ' HD21 ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.874 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.552 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.936 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 42' ' ' LEU . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.736 ' SG ' HG23 ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.736 HG23 ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.732 0.301 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.519 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 8' ' ' VAL . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 16' ' ' LEU . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.865 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.815 ' O ' HD12 ' A' ' 44' ' ' ILE . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.775 ' CD2' HD22 ' A' ' 42' ' ' LEU . 8.2 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.71 0.291 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HG12 ' A' ' 11' ' ' ILE . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.58 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.763 ' C ' HG13 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 28.4 t-20 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.823 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.3 m120 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 44' ' ' ILE . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.575 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 41' ' ' TRP . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.697 HG23 ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' HD22 ' A' ' 42' ' ' LEU . 16.7 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.8 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD2' ' HA2' ' A' ' 17' ' ' GLY . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.771 HG13 ' C ' ' A' ' 14' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 38' ' ' LEU . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.771 ' C ' HG13 ' A' ' 8' ' ' VAL . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.713 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.608 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.949 ' HB3' HD11 ' A' ' 16' ' ' LEU . 31.8 m120 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.028 HG21 HD22 ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.563 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 37' ' ' CYS . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.806 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.451 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' SG ' ' A' ' 53' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' CD2' HD22 ' A' ' 42' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG13 ' CA ' ' A' ' 17' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 17.7 t-20 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.807 ' HB2' HG12 ' A' ' 6' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.925 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.104 ' CA ' HG13 ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.928 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.856 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.843 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.883 ' HA ' HD21 ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HE3' HD12 ' A' ' 38' ' ' LEU . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.883 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.682 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 5.4 m120 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.722 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.722 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 20.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 17' ' ' GLY . 89.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CB ' ' OD1' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.541 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' C ' HG13 ' A' ' 8' ' ' VAL . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.689 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.895 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.895 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.835 ' HB3' HD11 ' A' ' 16' ' ' LEU . 10.1 m120 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.577 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.711 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 44' ' ' ILE . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.525 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.512 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.771 ' C ' HG23 ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.772 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' SG ' ' A' ' 53' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' A' ' 17' ' ' GLY . 12.1 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.812 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.592 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.789 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.706 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.907 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.574 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.812 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.414 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 32.3 m120 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.802 ' HA ' HD21 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.815 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG23 ' SG ' ' A' ' 53' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.626 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.7 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.626 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' H ' HD12 ' A' ' 16' ' ' LEU . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.569 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 23.9 m120 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.901 HG21 HD22 ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.561 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.901 HD22 HG21 ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.821 ' HA ' HD21 ' A' ' 42' ' ' LEU . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.425 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 52' ' ' ILE . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 50' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.673 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.673 HG23 ' SG ' ' A' ' 53' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HA2' ' A' ' 17' ' ' GLY . 86.1 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.871 HG22 ' HG3' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CZ3' HG12 ' A' ' 11' ' ' ILE . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.608 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.748 ' C ' HG13 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.871 ' HG3' HG22 ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.853 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.739 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' THR . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.67 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.7 m120 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.92 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' N ' HG23 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 42' ' ' LEU . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.727 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.727 HG23 ' SG ' ' A' ' 53' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 7.4 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.486 ' HB2' ' HB2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.94 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 1.1 t30 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.94 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.878 ' HB3' HD11 ' A' ' 16' ' ' LEU . 30.4 m120 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.978 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.556 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.544 ' HE3' HD12 ' A' ' 38' ' ' LEU . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.978 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 40' ' ' THR . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 15' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.609 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.693 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 HD13 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 8' ' ' VAL . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.954 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.795 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' GLU . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.693 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 31.5 m120 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.989 HG21 HD22 ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.989 HD22 HG21 ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.982 ' HA ' HD21 ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.571 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.53 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.778 ' C ' HG23 ' A' ' 48' ' ' THR . 3.8 m120 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.451 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.795 HG11 ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.552 ' CZ ' ' C ' ' A' ' 49' ' ' ALA . 17.2 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.508 HG13 ' CA ' ' A' ' 17' ' ' GLY . 22.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.627 ' NE1' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 38' ' ' LEU . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.765 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.969 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.872 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.969 ' HB3' HD11 ' A' ' 16' ' ' LEU . 32.4 m120 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 20.1 m120 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.762 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.762 HG23 ' SG ' ' A' ' 53' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.663 ' CD2' HD22 ' A' ' 42' ' ' LEU . 14.0 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.71 HG13 ' HA2' ' A' ' 17' ' ' GLY . 21.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.637 0.256 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 14' ' ' GLU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.622 ' SG ' HG23 ' A' ' 33' ' ' VAL . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 38' ' ' LEU . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.71 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.935 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.489 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' CD ' ' HA ' ' A' ' 27' ' ' THR . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.827 ' HB3' HD11 ' A' ' 16' ' ' LEU . 18.4 m120 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.935 HD23 ' CE2' ' A' ' 21' ' ' PHE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.558 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' CD2' ' C ' ' A' ' 48' ' ' THR . 12.8 m-85 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG13 ' HA2' ' A' ' 17' ' ' GLY . 67.5 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.958 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 38' ' ' LEU . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.933 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HG3' HD12 ' A' ' 30' ' ' LEU . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.834 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.942 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 43' ' ' THR . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.942 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.793 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.793 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.799 ' SG ' HG23 ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.799 HG23 ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.524 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' HG2' ' A' ' 15' ' ' GLU . 47.4 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.651 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.923 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.835 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.021 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.611 ' HB3' HD11 ' A' ' 16' ' ' LEU . 17.7 m120 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.579 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.021 HD23 ' CE2' ' A' ' 21' ' ' PHE . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.721 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.665 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.796 HG23 ' SG ' ' A' ' 53' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 17' ' ' GLY . 5.5 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 14' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.746 ' SG ' HG23 ' A' ' 33' ' ' VAL . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 38' ' ' LEU . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.619 ' C ' HG13 ' A' ' 8' ' ' VAL . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.61 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.499 ' OE2' ' CB ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.878 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.647 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 27' ' ' THR . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.751 ' HB3' HD11 ' A' ' 16' ' ' LEU . 9.2 m120 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.746 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 37' ' ' CYS . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.701 ' HE3' HD12 ' A' ' 38' ' ' LEU . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.772 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.487 HD12 ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 11.8 m-85 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG13 ' C ' ' A' ' 14' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CE2' HD22 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.718 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.808 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.0 p30 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.641 ' HB3' HD11 ' A' ' 16' ' ' LEU . 5.6 m120 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.887 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.591 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.739 ' C ' HG23 ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.739 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 53' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.1 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 HG11 ' OE2' ' A' ' 15' ' ' GLU . 40.1 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.69 HG13 ' N ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.56 ' N ' HD22 ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.665 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG12 ' CH2' ' A' ' 10' ' ' TRP . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.734 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.607 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.665 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 12.4 m120 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG21 HD22 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HG21 ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.93 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.846 ' O ' HD12 ' A' ' 44' ' ' ILE . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.93 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 42' ' ' LEU . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 40' ' ' THR . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.764 ' C ' HG23 ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG21 ' SG ' ' A' ' 26' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.625 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' SG ' ' A' ' 53' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.9 m-85 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.662 0.268 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG22 ' HG3' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.626 ' NE1' HD22 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 38' ' ' LEU . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.562 ' C ' HG13 ' A' ' 8' ' ' VAL . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.679 ' HG3' HG22 ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.936 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.1 p30 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' CB ' HD12 ' A' ' 16' ' ' LEU . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.6 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 31' ' ' GLU . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG21 HD22 ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.563 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.966 HD22 HG21 ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.919 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' HD12 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.547 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.785 HG23 ' SG ' ' A' ' 53' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 12.2 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.426 HG13 ' HA2' ' A' ' 17' ' ' GLY . 3.5 t . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.833 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.709 ' CE2' HD22 ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.8 t-20 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.587 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.833 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.938 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.938 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.783 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.826 ' HB3' HD11 ' A' ' 16' ' ' LEU . 11.6 m120 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.771 HD23 ' CE2' ' A' ' 21' ' ' PHE . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.864 ' HA ' HD21 ' A' ' 42' ' ' LEU . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.636 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.659 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.2 m-85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.551 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.694 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.694 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.691 ' HB3' HD11 ' A' ' 16' ' ' LEU . 29.5 m120 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.815 HG21 HD22 ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.879 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 41' ' ' TRP . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.531 ' N ' HG23 ' A' ' 40' ' ' THR . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.985 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.755 ' C ' HG23 ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.755 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG23 ' SG ' ' A' ' 53' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.985 ' CD2' HD22 ' A' ' 42' ' ' LEU . 18.2 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 17' ' ' GLY . 63.6 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.687 ' HB2' ' CD2' ' A' ' 34' ' ' HIS . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 14.7 p-10 -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.91 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.91 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 5.0 m120 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.687 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.687 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 91.9 m-70 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.733 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.53 ' HE3' HD12 ' A' ' 38' ' ' LEU . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 55' ' ' VAL . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.731 0.3 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.547 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.756 ' NE1' HD22 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.577 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HB2' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.93 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.93 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.6 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.774 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.774 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 55' ' ' VAL . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.704 ' CD2' HD22 ' A' ' 42' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' A' ' 7' ' ' PRO . 69.9 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.707 ' HD2' HG13 ' A' ' 6' ' ' VAL . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB2' HD12 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.658 ' CE2' HD22 ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' N ' HG12 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.945 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.918 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.903 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.903 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG21 HD22 ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.918 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 44' ' ' ILE . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.904 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.738 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' SG ' ' A' ' 53' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.532 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.904 ' CD2' HD22 ' A' ' 42' ' ' LEU . 13.7 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG12 ' HG2' ' A' ' 15' ' ' GLU . 10.4 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.588 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.579 ' C ' HG13 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.712 ' HG2' HG12 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.64 ' H ' HD12 ' A' ' 16' ' ' LEU . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 10.1 m120 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.057 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' ILE . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.637 ' N ' HD12 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.762 ' C ' HG23 ' A' ' 48' ' ' THR . 2.9 m120 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.762 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 55' ' ' VAL . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CB ' ' OD1' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' HG23 ' A' ' 33' ' ' VAL . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.614 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 6.8 t-20 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.585 HD22 ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.866 ' HB3' HD11 ' A' ' 16' ' ' LEU . 19.6 m120 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.616 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.874 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 25.3 m120 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.766 ' SG ' HG23 ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.766 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.78 0.324 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.54 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.842 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' N ' HD22 ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.511 ' CE2' HG12 ' A' ' 11' ' ' ILE . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.659 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' H ' HD12 ' A' ' 16' ' ' LEU . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.839 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 26.1 m120 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.06 HG21 HD22 ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.532 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.06 HD22 HG21 ' A' ' 33' ' ' VAL . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.876 ' HA ' HD21 ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' TRP . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.76 ' C ' HG23 ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.76 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.723 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.723 HG23 ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 28.0 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE2' HG12 ' A' ' 11' ' ' ILE . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.682 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.821 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.821 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.614 ' HB3' HD11 ' A' ' 16' ' ' LEU . 7.8 m120 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.003 HD22 HG21 ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.928 ' HA ' HD21 ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 36' ' ' SER . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.505 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.781 ' C ' HG23 ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 52' ' ' ILE . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.527 HD12 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 53' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.302 0.572 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -10.57 55.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.9 m-20 -63.86 -9.07 13.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.467 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 7.4 pt-20 -49.68 -175.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.85 . . . . 0.0 110.555 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 7.7 t0 70.28 153.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.904 HG13 ' HA2' ' A' ' 17' ' ' GLY . 46.7 t -106.24 123.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.505 ' HB2' ' HB2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' C ' HG13 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.653 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.904 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.867 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.954 ' HB3' HD11 ' A' ' 16' ' ' LEU . 26.6 m120 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.936 ' HA ' HD21 ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.874 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.552 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.936 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 42' ' ' LEU . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.736 ' SG ' HG23 ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.736 HG23 ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 -72.85 -35.5 67.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.451 ' H ' HG12 ' A' ' 56' ' ' VAL . 15.4 m120 49.47 72.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.545 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 50.7 p -100.07 147.86 25.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 1.9 mmt180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.142 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.6 ttm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.925 0.393 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 1' ' ' MET . 10.4 pm0 35.25 -145.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.772 -0.58 . . . . 0.0 111.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 80.2 m-20 -95.29 -74.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.387 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -119.24 143.79 47.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.91 112.49 17.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.003 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -133.2 111.37 12.96 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.519 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 8' ' ' VAL . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 16' ' ' LEU . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' ASN . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.865 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.815 ' O ' HD12 ' A' ' 44' ' ' ILE . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.775 ' CD2' HD22 ' A' ' 42' ' ' LEU . 8.2 m-85 -73.55 62.47 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.89 121.63 12.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 0.0 110.473 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 33.2 p -90.86 116.79 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.913 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.217 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.2 0.524 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.2 -19.7 12.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.539 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.56 -163.52 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.41 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -49.77 -60.6 2.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.45 -175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.923 . . . . 0.0 110.149 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t -81.52 131.13 59.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HG12 ' A' ' 11' ' ' ILE . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.58 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.763 ' C ' HG13 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 28.4 t-20 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.823 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.3 m120 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 44' ' ' ILE . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.575 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 41' ' ' TRP . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.697 HG23 ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' HD22 ' A' ' 42' ' ' LEU . 16.7 m-85 -74.91 -35.14 62.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' H ' HG12 ' A' ' 56' ' ' VAL . 26.9 t-20 40.59 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 15.5 p -104.24 154.25 20.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.192 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.541 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.49 -23.15 15.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.325 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -142.25 -151.03 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.213 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -115.37 -101.94 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 t70 60.57 160.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.8 t -133.64 113.57 13.0 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 110.012 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.408 ' HD2' ' HA2' ' A' ' 17' ' ' GLY . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.771 HG13 ' C ' ' A' ' 14' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 38' ' ' LEU . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.771 ' C ' HG13 ' A' ' 8' ' ' VAL . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.713 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.608 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.949 ' HB3' HD11 ' A' ' 16' ' ' LEU . 31.8 m120 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.028 HG21 HD22 ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.563 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 37' ' ' CYS . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.806 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' SG ' ' A' ' 53' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' CD2' HD22 ' A' ' 42' ' ' LEU . 26.4 m-85 -63.51 -37.06 85.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 57' ' ' TYR . 43.2 t30 43.94 92.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 39' ' ' SER . 68.4 p -94.11 130.18 40.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.977 . . . . 0.0 110.22 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.299 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.173 0.511 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' C ' ' OE1' ' A' ' 2' ' ' GLU . 0.7 OUTLIER -91.97 -12.47 33.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.4 -35.49 65.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.411 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.9 mt-10 -157.35 -40.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.364 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -69.31 81.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 110.396 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG13 ' CA ' ' A' ' 17' ' ' GLY . 18.0 t -93.03 123.08 62.14 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.504 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 17.7 t-20 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.807 ' HB2' HG12 ' A' ' 6' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.925 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.104 ' CA ' HG13 ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.928 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.856 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.843 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.883 ' HA ' HD21 ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HE3' HD12 ' A' ' 38' ' ' LEU . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.883 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.682 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 5.4 m120 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.722 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.722 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 20.6 m-85 -66.46 -46.6 75.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 1.3 t30 68.37 43.7 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 32.6 p -82.04 126.09 31.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.126 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.21 -76.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 110.454 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -103.43 -176.12 2.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.772 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.9 pt-20 -141.12 174.93 10.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.114 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' GLU . 14.0 t0 56.19 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.186 -0.947 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 17' ' ' GLY . 89.2 t -108.17 106.19 58.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 110.605 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CB ' ' OD1' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.541 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' C ' HG13 ' A' ' 8' ' ' VAL . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.689 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.895 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.895 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.835 ' HB3' HD11 ' A' ' 16' ' ' LEU . 10.1 m120 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.577 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.711 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 44' ' ' ILE . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.525 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.512 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.771 ' C ' HG23 ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.772 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' SG ' ' A' ' 53' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 -76.16 -36.23 58.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER 52.92 65.26 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -1.0 . . . . 0.0 110.345 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 68.2 p -88.75 150.49 22.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.19 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.184 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.085 0.469 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -179.03 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.44 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 110.158 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.49 147.48 26.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.57 114.11 9.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' A' ' 17' ' ' GLY . 12.1 t -105.32 141.35 22.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.812 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.592 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.789 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.706 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.907 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.574 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.812 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.414 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 32.3 m120 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.802 ' HA ' HD21 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.815 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG23 ' SG ' ' A' ' 53' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 -72.78 -39.48 66.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.1 64.66 1.76 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.431 -0.793 . . . . 0.0 110.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.409 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 14.3 p -88.04 156.88 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.56 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.79 -79.2 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.074 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.62 167.92 7.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.163 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -156.65 -163.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.227 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.96 97.69 10.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.139 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t -90.73 122.07 67.4 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 0.0 109.935 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.626 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.7 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.626 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' H ' HD12 ' A' ' 16' ' ' LEU . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.569 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 23.9 m120 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.901 HG21 HD22 ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.561 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.901 HD22 HG21 ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.821 ' HA ' HD21 ' A' ' 42' ' ' LEU . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.425 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 52' ' ' ILE . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 50' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.673 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.673 HG23 ' SG ' ' A' ' 53' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 -70.79 -29.89 66.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 44.39 78.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.262 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -112.66 129.38 56.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.369 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.274 0.559 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -145.29 172.4 13.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.148 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER 49.12 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.16 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 6.9 mm-40 -88.69 -62.62 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.116 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER 57.72 -164.47 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HA2' ' A' ' 17' ' ' GLY . 86.1 t -118.01 133.21 23.42 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.871 HG22 ' HG3' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CZ3' HG12 ' A' ' 11' ' ' ILE . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.608 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.748 ' C ' HG13 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.871 ' HG3' HG22 ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.853 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.739 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' THR . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.67 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.7 m120 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.92 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' N ' HG23 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 42' ' ' LEU . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.727 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.727 HG23 ' SG ' ' A' ' 53' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 59' ' ' THR . 7.4 m-85 -72.46 70.65 0.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 118.11 2.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -0.832 . . . . 0.0 110.395 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 57' ' ' TYR . 55.1 p -125.26 168.22 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.12 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.232 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.272 0.558 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER 62.01 -77.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 43.36 -152.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 0.7 OUTLIER -88.11 -140.58 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -0.825 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 26.2 t70 60.68 120.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.33 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.75 107.45 12.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.486 ' HB2' ' HB2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.94 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 1.1 t30 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.94 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.878 ' HB3' HD11 ' A' ' 16' ' ' LEU . 30.4 m120 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.978 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.556 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.544 ' HE3' HD12 ' A' ' 38' ' ' LEU . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.978 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 40' ' ' THR . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 -72.05 -35.37 69.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.01 78.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.708 HG22 ' CE1' ' A' ' 21' ' ' PHE . 68.8 p -117.7 125.28 50.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.277 0.56 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -124.2 170.36 10.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.062 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.93 -35.69 2.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 48.9 mt-10 -144.35 138.74 28.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.323 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.3 t0 176.22 131.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 15' ' ' GLU . 3.6 t -107.89 113.04 61.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.9 . . . . 0.0 110.035 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.609 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.693 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 HD13 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 8' ' ' VAL . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.954 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ASN . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.795 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' GLU . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.693 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 31.5 m120 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.989 HG21 HD22 ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.989 HD22 HG21 ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.982 ' HA ' HD21 ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.571 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.53 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.778 ' C ' HG23 ' A' ' 48' ' ' THR . 3.8 m120 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.451 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.795 HG11 ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' THR . 17.2 m-85 -72.56 63.11 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' TYR . 3.4 m-80 -43.15 124.64 3.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 57' ' ' TYR . 5.8 p -135.13 119.41 17.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.284 0.564 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 3' ' ' ASP . 26.3 tt0 -151.06 -75.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -164.29 -171.98 2.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.127 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.15 -150.73 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -52.5 157.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.363 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.508 HG13 ' CA ' ' A' ' 17' ' ' GLY . 22.9 t -118.86 106.75 43.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.091 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.627 ' NE1' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 38' ' ' LEU . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.765 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.969 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.872 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.969 ' HB3' HD11 ' A' ' 16' ' ' LEU . 32.4 m120 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 20.1 m120 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.762 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.762 HG23 ' SG ' ' A' ' 53' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.663 ' CD2' HD22 ' A' ' 42' ' ' LEU . 14.0 m-85 -74.62 67.34 1.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.5 t-20 -61.32 115.16 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.334 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.405 HG22 ' HD3' ' A' ' 35' ' ' ARG . 4.1 p -89.73 125.64 35.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.243 0.544 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 3.2 pt-20 -75.39 -140.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.82 -158.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.386 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 5' ' ' ASP . 39.1 mm-40 -108.15 -6.68 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 110.337 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 4' ' ' GLU . 6.6 p-10 -37.0 140.26 0.17 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.742 -0.599 . . . . 0.0 110.709 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.71 HG13 ' HA2' ' A' ' 17' ' ' GLY . 21.6 t -91.39 118.01 68.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 110.503 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.537 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 14' ' ' GLU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.622 ' SG ' HG23 ' A' ' 33' ' ' VAL . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 38' ' ' LEU . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.71 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.935 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 58' ' ' ASN . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.489 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' CD ' ' HA ' ' A' ' 27' ' ' THR . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.827 ' HB3' HD11 ' A' ' 16' ' ' LEU . 18.4 m120 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.935 HD23 ' CE2' ' A' ' 21' ' ' PHE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.5 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.744 ' O ' HG23 ' A' ' 59' ' ' THR . 12.8 m-85 -76.66 66.86 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -42.23 112.24 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 57' ' ' TYR . 12.3 p -113.54 164.13 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 110.395 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.148 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.251 0.548 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.01 -47.29 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.923 . . . . 0.0 110.414 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLU . 91.1 m-20 40.91 -120.75 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.133 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.8 mm-40 -122.39 -14.64 7.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.768 -1.207 . . . . 0.0 110.259 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' GLU . 23.7 p30 -47.52 174.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.184 -0.948 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG13 ' HA2' ' A' ' 17' ' ' GLY . 67.5 t -114.95 127.33 26.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.958 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 38' ' ' LEU . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.933 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HG3' HD12 ' A' ' 30' ' ' LEU . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.834 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.942 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 43' ' ' THR . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.942 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.793 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.793 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.799 ' SG ' HG23 ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.799 HG23 ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.563 HG12 ' OD1' ' A' ' 58' ' ' ASN . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 -75.53 -44.31 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.563 ' OD1' HG12 ' A' ' 56' ' ' VAL . 2.4 m-20 61.8 80.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.572 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 11.5 p -113.92 131.1 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.333 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.313 0.578 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.85 -72.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -84.81 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.435 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 2.3 mm-40 -114.53 -10.09 12.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.378 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t0 -60.51 102.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' GLU . 47.4 t -135.87 139.67 31.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.651 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.923 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.835 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.021 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.611 ' HB3' HD11 ' A' ' 16' ' ' LEU . 17.7 m120 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.579 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.021 HD23 ' CE2' ' A' ' 21' ' ' PHE . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.721 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.665 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.796 HG23 ' SG ' ' A' ' 53' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 -80.02 67.34 5.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 54.7 t30 -57.09 136.41 56.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.166 -0.958 . . . . 0.0 110.215 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.2 164.2 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.391 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.365 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.358 0.599 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.25 -48.88 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.3 t0 53.02 176.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.8 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 -162.96 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 109.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 1.7 t0 -48.0 143.08 4.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 109.988 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 17' ' ' GLY . 5.5 t -88.47 109.1 26.46 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 14' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.746 ' SG ' HG23 ' A' ' 33' ' ' VAL . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 38' ' ' LEU . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.619 ' C ' HG13 ' A' ' 8' ' ' VAL . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.61 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.499 ' OE2' ' CB ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.878 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.647 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 27' ' ' THR . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.751 ' HB3' HD11 ' A' ' 16' ' ' LEU . 9.2 m120 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.746 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 37' ' ' CYS . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.701 ' HE3' HD12 ' A' ' 38' ' ' LEU . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.772 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.487 HD12 ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 59' ' ' THR . 11.8 m-85 -77.73 71.17 4.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -46.07 124.62 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.442 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 57' ' ' TYR . 20.8 p -132.59 130.29 40.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.292 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' GLU . 14.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.0 mm-40 46.77 -171.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -152.6 -84.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.46 -72.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.415 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.86 121.49 26.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.352 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t -96.47 125.58 46.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.117 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG13 ' C ' ' A' ' 14' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CE2' HD22 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.718 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.808 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.0 p30 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.641 ' HB3' HD11 ' A' ' 16' ' ' LEU . 5.6 m120 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.887 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.591 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.739 ' C ' HG23 ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.739 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 53' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.1 m-85 -59.82 -48.73 80.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t30 50.11 81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 109.972 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 39' ' ' SER . 43.5 p -87.06 144.8 26.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HG2' ' OXT' ' A' ' 60' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.223 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.37 152.61 18.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.59 -146.57 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -103.19 -80.09 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -150.73 146.1 26.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 HG11 ' OE2' ' A' ' 15' ' ' GLU . 40.1 t -105.89 126.45 30.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.69 HG13 ' N ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.56 ' N ' HD22 ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.665 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG12 ' CH2' ' A' ' 10' ' ' TRP . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.888 ' CZ ' HG22 ' A' ' 59' ' ' THR . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.607 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.665 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 12.4 m120 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG21 HD22 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HG21 ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.93 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.846 ' O ' HD12 ' A' ' 44' ' ' ILE . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.93 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 42' ' ' LEU . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 40' ' ' THR . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.764 ' C ' HG23 ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG21 ' SG ' ' A' ' 26' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.625 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' SG ' ' A' ' 53' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.9 m-85 -65.76 -40.53 92.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 50.35 70.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.394 -0.816 . . . . 0.0 110.146 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.888 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 56.9 p -96.77 168.85 10.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.216 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' ASP . 2.2 mm-40 -119.67 -60.07 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 110.375 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 55.7 154.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.437 0.637 . . . . 0.0 110.805 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 67.5 mm-40 44.14 -170.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER 60.48 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 0.0 110.223 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t -112.22 115.07 50.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.61 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG22 ' HG3' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.626 ' NE1' HD22 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 38' ' ' LEU . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.562 ' C ' HG13 ' A' ' 8' ' ' VAL . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.679 ' HG3' HG22 ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.936 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.1 p30 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' CB ' HD12 ' A' ' 16' ' ' LEU . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.6 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 31' ' ' GLU . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG21 HD22 ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.563 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.966 HD22 HG21 ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.919 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' HD12 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.545 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.785 HG23 ' SG ' ' A' ' 53' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 12.2 m-85 -79.99 -50.41 10.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.1 84.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.508 HG21 ' HA ' ' A' ' 39' ' ' SER . 17.5 p -103.02 127.0 50.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.371 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.49 -175.61 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.17 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.4 m-20 -105.16 163.21 12.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . 20.2 pt-20 -56.18 -164.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.227 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.25 150.59 20.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.426 HG13 ' HA2' ' A' ' 17' ' ' GLY . 3.5 t -125.43 130.76 24.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.839 . . . . 0.0 109.944 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.833 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.709 ' CE2' HD22 ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.8 t-20 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.587 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.833 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.938 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.938 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.783 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.826 ' HB3' HD11 ' A' ' 16' ' ' LEU . 11.6 m120 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.771 HD23 ' CE2' ' A' ' 21' ' ' PHE . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.864 ' HA ' HD21 ' A' ' 42' ' ' LEU . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.636 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.659 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.2 m-85 -63.04 -41.94 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 49.73 77.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.45 ' HB ' ' OG ' ' A' ' 39' ' ' SER . 13.8 p -109.07 146.89 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.104 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.245 0.545 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 3.2 mt-10 -155.0 -83.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 4.8 m-20 59.63 -170.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.41 -140.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.098 -1.001 . . . . 0.0 110.12 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -107.44 107.32 18.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.556 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -77.89 145.38 70.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.731 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.551 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 58' ' ' ASN . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.694 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.694 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.691 ' HB3' HD11 ' A' ' 16' ' ' LEU . 29.5 m120 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.815 HG21 HD22 ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.879 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 41' ' ' TRP . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.531 ' N ' HG23 ' A' ' 40' ' ' THR . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.985 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.755 ' C ' HG23 ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.755 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG23 ' SG ' ' A' ' 53' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.985 ' CD2' HD22 ' A' ' 42' ' ' LEU . 18.2 m-85 -70.67 62.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 22' ' ' ARG . 5.0 t-20 -44.19 109.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' TYR . 30.8 p -95.26 120.2 35.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 110.013 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.145 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.316 0.579 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.9 -179.42 4.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -176.8 -74.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 110.464 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.3 -46.33 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 110.495 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.69 142.75 57.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.873 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 17' ' ' GLY . 63.6 t -133.5 133.04 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.401 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.661 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 14.7 p-10 -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.91 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.91 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 5.0 m120 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.687 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.4 m80 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.733 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.53 ' HE3' HD12 ' A' ' 38' ' ' LEU . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 55' ' ' VAL . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.3 m-85 -68.28 -38.76 82.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.469 ' H ' HG12 ' A' ' 56' ' ' VAL . 1.2 t30 49.39 97.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.723 HG22 ' CE1' ' A' ' 21' ' ' PHE . 42.7 p -130.34 137.53 49.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.109 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.283 0.563 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.23 -70.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.197 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.32 -157.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.59 165.36 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.15 170.11 17.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.5 t -101.84 138.1 19.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.353 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.547 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.756 ' NE1' HD22 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.577 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HB2' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.93 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.93 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.6 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.774 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.774 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 55' ' ' VAL . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.704 ' CD2' HD22 ' A' ' 42' ' ' LEU . 57.4 m-85 -77.14 -29.53 54.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' TYR . 2.5 t-20 46.42 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.74 HG22 ' CE1' ' A' ' 21' ' ' PHE . 47.4 p -124.09 141.87 51.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 110.303 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 14.4 ptm180 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.128 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 3' ' ' ASP . 2.4 pt-20 -145.23 -48.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 2' ' ' GLU . 0.4 OUTLIER 57.81 161.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.375 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 3' ' ' ASP . 29.2 mt-10 -157.14 -85.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.337 -0.852 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -178.29 3.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 109.924 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' A' ' 7' ' ' PRO . 69.9 t -107.19 147.82 35.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.116 -0.99 . . . . 0.0 109.97 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.707 ' HD2' HG13 ' A' ' 6' ' ' VAL . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB2' HD12 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.658 ' CE2' HD22 ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' N ' HG12 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.945 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.918 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.903 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.903 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG21 HD22 ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.918 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 44' ' ' ILE . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.904 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.738 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' SG ' ' A' ' 53' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.904 ' CD2' HD22 ' A' ' 42' ' ' LEU . 13.7 m-85 -65.24 -46.06 82.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 47.71 78.72 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.505 -0.747 . . . . 0.0 110.399 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.612 HG22 ' CE1' ' A' ' 21' ' ' PHE . 30.7 p -106.0 117.63 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.239 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.272 0.558 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.39 153.14 20.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -50.36 168.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 110.381 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -43.85 154.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.863 . . . . 0.0 110.171 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 177.25 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG12 ' HG2' ' A' ' 15' ' ' GLU . 10.4 t -121.89 110.28 33.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.588 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.579 ' C ' HG13 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.712 ' HG2' HG12 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.64 ' H ' HD12 ' A' ' 16' ' ' LEU . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 10.1 m120 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.057 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' ILE . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.637 ' N ' HD12 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.762 ' C ' HG23 ' A' ' 48' ' ' THR . 2.9 m120 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.762 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 55' ' ' VAL . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 -73.79 -51.53 16.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER 67.56 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 110.428 179.741 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -135.2 118.21 16.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.14 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.256 0.551 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.4 -49.86 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.342 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 4' ' ' GLU . 8.6 t0 -102.37 -56.33 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 0.0 110.405 -179.762 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 3' ' ' ASP . 4.7 pt-20 -37.0 138.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 30.0 t70 54.52 168.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t -127.36 109.26 21.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.456 ' CB ' ' OD1' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' HG23 ' A' ' 33' ' ' VAL . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.614 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 6.8 t-20 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.585 HD22 ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.866 ' HB3' HD11 ' A' ' 16' ' ' LEU . 19.6 m120 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.616 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.874 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 25.3 m120 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.766 ' SG ' HG23 ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.766 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 -73.94 68.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -49.5 114.23 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.843 . . . . 0.0 110.501 179.94 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -111.83 140.44 46.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.95 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.208 0.528 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -97.67 -144.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.482 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.21 167.87 6.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -111.98 -86.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.83 128.31 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.22 113.6 65.8 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.309 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.54 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.842 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' N ' HD22 ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.511 ' CE2' HG12 ' A' ' 11' ' ' ILE . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' H ' HD12 ' A' ' 16' ' ' LEU . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.839 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.54 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 26.1 m120 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.06 HG21 HD22 ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.532 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.06 HD22 HG21 ' A' ' 33' ' ' VAL . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.876 ' HA ' HD21 ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' TRP . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.76 ' C ' HG23 ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.76 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.723 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG23 ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 58' ' ' ASN . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 28.0 m-85 -68.4 -33.57 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.569 ' H ' HG12 ' A' ' 56' ' ' VAL . 6.6 t-20 50.48 65.89 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 110.624 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 p -79.27 117.27 20.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.266 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 1' ' ' MET . 4.3 ttp . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -15.27 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' GLU . 17.8 t0 -101.31 -20.73 15.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.934 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 55.8 mt-10 42.65 -121.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.959 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 1.8 t0 69.81 143.82 0.05 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.738 -1.226 . . . . 0.0 110.377 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.01 130.77 24.59 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 0.0 109.922 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE2' HG12 ' A' ' 11' ' ' ILE . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.682 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.821 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.821 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.614 ' HB3' HD11 ' A' ' 16' ' ' LEU . 7.8 m120 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.003 HD22 HG21 ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.928 ' HA ' HD21 ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 36' ' ' SER . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.505 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.781 ' C ' HG23 ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 52' ' ' ILE . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.527 HD12 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 53' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 -70.28 -37.52 74.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' H ' HG12 ' A' ' 56' ' ' VAL . 0.6 OUTLIER 43.57 77.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.983 -179.766 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ARG . 17.9 p -92.9 140.08 29.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.9 . . . . 0.0 110.554 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.11 -0.948 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.904 HG13 ' HA2' ' A' ' 17' ' ' GLY . 46.7 t . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.65 0.262 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.621 ' C ' HG13 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.653 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.904 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.867 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.954 ' HB3' HD11 ' A' ' 16' ' ' LEU . 67.2 m-20 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.936 ' HA ' HD21 ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.874 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.552 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.936 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 42' ' ' LEU . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.736 ' SG ' HG23 ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.736 HG23 ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.732 0.301 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.519 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 8' ' ' VAL . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 16' ' ' LEU . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.865 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.815 ' O ' HD12 ' A' ' 44' ' ' ILE . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 45' ' ' SER . 89.5 m-20 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.775 ' CD2' HD22 ' A' ' 42' ' ' LEU . 8.2 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.71 0.291 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HG12 ' A' ' 11' ' ' ILE . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.58 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.763 ' C ' HG13 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 15.3 t30 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.427 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.823 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.5 m-80 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 44' ' ' ILE . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.575 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 41' ' ' TRP . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.697 HG23 ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' HD22 ' A' ' 42' ' ' LEU . 16.7 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.8 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.771 HG13 ' C ' ' A' ' 14' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 38' ' ' LEU . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.771 ' C ' HG13 ' A' ' 8' ' ' VAL . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.713 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.608 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.949 ' HB3' HD11 ' A' ' 16' ' ' LEU . 79.7 m-20 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.028 HG21 HD22 ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.563 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 37' ' ' CYS . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.806 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.451 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' SG ' ' A' ' 53' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.666 ' CD2' HD22 ' A' ' 42' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.104 HG13 ' CA ' ' A' ' 17' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.807 ' HB2' HG12 ' A' ' 6' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.925 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.104 ' CA ' HG13 ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.928 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.856 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.843 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.883 ' HA ' HD21 ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HE3' HD12 ' A' ' 38' ' ' LEU . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.883 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.682 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 54.9 m-20 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.722 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.722 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 20.6 m-85 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 17' ' ' GLY . 89.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.541 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.541 ' C ' HG13 ' A' ' 8' ' ' VAL . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.689 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.835 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.895 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.895 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.554 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.835 ' HB3' HD11 ' A' ' 16' ' ' LEU . 22.6 m-20 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.577 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.711 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 44' ' ' ILE . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.525 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.512 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.771 ' C ' HG23 ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.772 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' SG ' ' A' ' 53' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' A' ' 17' ' ' GLY . 12.1 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.812 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.592 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.789 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.706 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.907 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.574 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.812 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.414 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 75.8 m-20 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.802 ' HA ' HD21 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.815 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG23 ' SG ' ' A' ' 53' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.626 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.7 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.626 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.532 ' H ' HD12 ' A' ' 16' ' ' LEU . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.569 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 45.9 m-80 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.901 HG21 HD22 ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.561 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.901 HD22 HG21 ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.821 ' HA ' HD21 ' A' ' 42' ' ' LEU . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.425 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 52' ' ' ILE . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 50' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.673 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.673 HG23 ' SG ' ' A' ' 53' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HA2' ' A' ' 17' ' ' GLY . 86.1 t . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.871 HG22 ' HG3' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CZ3' HG12 ' A' ' 11' ' ' ILE . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.608 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.748 ' C ' HG13 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.871 ' HG3' HG22 ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.853 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.739 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' THR . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.67 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.4 m-80 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.92 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.434 ' N ' HG23 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 42' ' ' LEU . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.727 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.727 HG23 ' SG ' ' A' ' 53' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 7.4 m-85 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.535 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.94 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 10.1 t-20 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.94 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.878 ' HB3' HD11 ' A' ' 16' ' ' LEU . 67.7 m-80 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.978 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.556 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.544 ' HE3' HD12 ' A' ' 38' ' ' LEU . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.978 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 40' ' ' THR . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 15' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.609 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.693 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 HD13 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 8' ' ' VAL . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.954 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.795 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' GLU . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.693 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 70.6 m-80 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.989 HG21 HD22 ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.989 HD22 HG21 ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.982 ' HA ' HD21 ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.571 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.982 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.53 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.778 ' C ' HG23 ' A' ' 48' ' ' THR . 24.2 m-20 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.451 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.795 HG11 ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.552 ' CZ ' ' C ' ' A' ' 49' ' ' ALA . 17.2 m-85 . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.508 HG13 ' CA ' ' A' ' 17' ' ' GLY . 22.9 t . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 120.875 0.369 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.593 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.627 ' NE1' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 38' ' ' LEU . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.765 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.969 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.872 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.969 ' HB3' HD11 ' A' ' 16' ' ' LEU . 66.9 m-80 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 87.4 m-20 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.762 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.762 HG23 ' SG ' ' A' ' 53' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.663 ' CD2' HD22 ' A' ' 42' ' ' LEU . 14.0 m-85 . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.71 HG13 ' HA2' ' A' ' 17' ' ' GLY . 21.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.637 0.256 . . . . 0.0 110.503 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 14' ' ' GLU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.622 ' SG ' HG23 ' A' ' 33' ' ' VAL . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 38' ' ' LEU . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.71 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.935 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.558 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.489 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' CD ' ' HA ' ' A' ' 27' ' ' THR . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.827 ' HB3' HD11 ' A' ' 16' ' ' LEU . 33.1 m-80 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.622 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.935 HD23 ' CE2' ' A' ' 21' ' ' PHE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.558 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' CD2' ' C ' ' A' ' 48' ' ' THR . 12.8 m-85 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.634 HG13 ' HA2' ' A' ' 17' ' ' GLY . 67.5 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.958 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 38' ' ' LEU . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.555 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.746 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.933 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HG3' HD12 ' A' ' 30' ' ' LEU . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.834 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.942 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 43' ' ' THR . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.942 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.793 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.793 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.799 ' SG ' HG23 ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.799 HG23 ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.524 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' HG2' ' A' ' 15' ' ' GLU . 47.4 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.651 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.923 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.835 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.021 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.611 ' HB3' HD11 ' A' ' 16' ' ' LEU . 52.1 m-20 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.579 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.021 HD23 ' CE2' ' A' ' 21' ' ' PHE . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.721 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.665 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.796 HG23 ' SG ' ' A' ' 53' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 17' ' ' GLY . 5.5 t . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 14' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.746 ' SG ' HG23 ' A' ' 33' ' ' VAL . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 38' ' ' LEU . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.619 ' C ' HG13 ' A' ' 8' ' ' VAL . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.61 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.499 ' OE2' ' CB ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.878 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.647 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 27' ' ' THR . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.751 ' HB3' HD11 ' A' ' 16' ' ' LEU . 12.7 m-80 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.746 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 37' ' ' CYS . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.701 ' HE3' HD12 ' A' ' 38' ' ' LEU . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.772 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.518 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.487 HD12 ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 11.8 m-85 . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG13 ' C ' ' A' ' 14' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CE2' HD22 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.718 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.808 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.733 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.641 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.0 m-80 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.887 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.591 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.739 ' C ' HG23 ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.739 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 53' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.1 m-85 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 HG11 ' OE2' ' A' ' 15' ' ' GLU . 40.1 t . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.69 HG13 ' N ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.56 ' N ' HD22 ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.665 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.523 HG12 ' CH2' ' A' ' 10' ' ' TRP . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.734 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.607 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.665 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 20.7 m-80 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.98 HG21 HD22 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HG21 ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.93 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.846 ' O ' HD12 ' A' ' 44' ' ' ILE . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.93 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 42' ' ' LEU . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 40' ' ' THR . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.764 ' C ' HG23 ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 HG21 ' SG ' ' A' ' 26' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.625 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' SG ' ' A' ' 53' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.9 m-85 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 120.662 0.268 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.679 HG22 ' HG3' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.626 ' NE1' HD22 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 38' ' ' LEU . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.562 ' C ' HG13 ' A' ' 8' ' ' VAL . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.679 ' HG3' HG22 ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.936 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.475 ' CB ' HD12 ' A' ' 16' ' ' LEU . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.6 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 31' ' ' GLU . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.966 HG21 HD22 ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.563 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.966 HD22 HG21 ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.919 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' HD12 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.547 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.785 HG23 ' SG ' ' A' ' 53' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 12.2 m-85 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.426 HG13 ' HA2' ' A' ' 17' ' ' GLY . 3.5 t . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.833 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.709 ' CE2' HD22 ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.587 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.833 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.938 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.938 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.783 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.826 ' HB3' HD11 ' A' ' 16' ' ' LEU . 15.2 m-80 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.771 HD23 ' CE2' ' A' ' 21' ' ' PHE . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.864 ' HA ' HD21 ' A' ' 42' ' ' LEU . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.636 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.659 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.2 m-85 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.551 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.694 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.694 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.691 ' HB3' HD11 ' A' ' 16' ' ' LEU . 69.7 m-20 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.815 HG21 HD22 ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.879 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 41' ' ' TRP . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.531 ' N ' HG23 ' A' ' 40' ' ' THR . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.985 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.755 ' C ' HG23 ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.755 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG23 ' SG ' ' A' ' 53' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.985 ' CD2' HD22 ' A' ' 42' ' ' LEU . 18.2 m-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 17' ' ' GLY . 63.6 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.661 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.6 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.91 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.91 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 9.0 m-80 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.687 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.4 m80 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.733 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.53 ' HE3' HD12 ' A' ' 38' ' ' LEU . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 55' ' ' VAL . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.3 m-85 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.5 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.731 0.3 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.547 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.756 ' NE1' HD22 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.577 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HB2' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.93 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.93 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.6 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.774 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.774 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 55' ' ' VAL . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.704 ' CD2' HD22 ' A' ' 42' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' A' ' 7' ' ' PRO . 69.9 t . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.707 ' HD2' HG13 ' A' ' 6' ' ' VAL . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB2' HD12 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.658 ' CE2' HD22 ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' N ' HG12 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.945 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.918 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.903 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.903 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.738 HG21 HD22 ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.918 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 44' ' ' ILE . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.904 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.738 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' SG ' ' A' ' 53' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.532 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.904 ' CD2' HD22 ' A' ' 42' ' ' LEU . 13.7 m-85 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.712 HG12 ' HG2' ' A' ' 15' ' ' GLU . 10.4 t . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.588 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.579 ' C ' HG13 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.712 ' HG2' HG12 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.64 ' H ' HD12 ' A' ' 16' ' ' LEU . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 28.7 m-20 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.057 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' ILE . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CZ2' ' ND2' ' A' ' 47' ' ' ASN . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.637 ' N ' HD12 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.762 ' C ' HG23 ' A' ' 48' ' ' THR . 30.1 m-20 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.762 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 55' ' ' VAL . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 120.821 0.343 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' HG23 ' A' ' 33' ' ' VAL . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.614 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 4.7 t30 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.585 HD22 ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.866 ' HB3' HD11 ' A' ' 16' ' ' LEU . 40.6 m-80 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.616 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.874 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 85.9 m-20 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.766 ' SG ' HG23 ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.766 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.78 0.324 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.581 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.842 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.504 ' N ' HD22 ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.511 ' CE2' HG12 ' A' ' 11' ' ' ILE . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.659 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' H ' HD12 ' A' ' 16' ' ' LEU . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.839 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 75.6 m-20 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.06 HG21 HD22 ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.532 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.06 HD22 HG21 ' A' ' 33' ' ' VAL . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.876 ' HA ' HD21 ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' TRP . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.76 ' C ' HG23 ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.76 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.723 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.723 HG23 ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 28.0 m-85 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE2' HG12 ' A' ' 11' ' ' ILE . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.682 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.821 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.821 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.614 ' HB3' HD11 ' A' ' 16' ' ' LEU . 15.3 m-80 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.003 HD22 HG21 ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.928 ' HA ' HD21 ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 36' ' ' SER . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.505 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.781 ' C ' HG23 ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 52' ' ' ILE . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.527 HD12 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 53' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.302 0.572 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -10.57 55.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.318 -0.864 . . . . 0.0 110.281 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.9 m-20 -63.86 -9.07 13.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.304 -0.873 . . . . 0.0 110.467 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.508 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 7.4 pt-20 -49.68 -175.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.339 -0.85 . . . . 0.0 110.555 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.508 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 7.7 t0 70.28 153.54 0.12 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.269 -0.894 . . . . 0.0 110.092 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.904 HG13 ' HA2' ' A' ' 17' ' ' GLY . 46.7 t -106.24 123.58 38.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.279 -0.888 . . . . 0.0 110.3 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.556 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 50.3 Cg_endo -73.06 162.33 41.13 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.911 1.479 . . . . 0.0 110.181 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.653 HG22 ' CD ' ' A' ' 15' ' ' GLU . 4.4 t -122.66 140.6 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.892 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.533 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 14.2 t -63.82 118.0 7.73 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.415 -0.803 . . . . 0.0 109.675 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.622 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -64.26 -13.18 47.95 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.726 . . . . 0.0 112.013 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 38' ' ' LEU . 16.1 mt -84.05 -57.74 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 0.0 111.091 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 21.6 p -99.69 1.85 43.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.1 m120 57.88 59.91 2.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 110.618 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.621 ' C ' HG13 ' A' ' 8' ' ' VAL . 8.7 tt0 -140.68 133.45 28.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.955 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.653 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.24 136.78 58.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.089 -1.007 . . . . 0.0 110.833 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.954 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -115.54 -28.89 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.904 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 76.62 -31.88 1.43 Allowed Glycine 0 N--CA 1.495 2.614 0 O-C-N 121.682 -0.636 . . . . 0.0 112.268 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 8.2 p-10 169.99 39.21 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.23 1.515 . . . . 0.0 111.223 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -59.31 106.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.736 -1.227 . . . . 0.0 109.113 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -62.26 96.15 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.166 -0.959 . . . . 0.0 110.495 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -149.87 99.79 2.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.575 -0.703 . . . . 0.0 109.662 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -73.3 95.48 2.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.14 -0.975 . . . . 0.0 109.748 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.867 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.8 -5.2 9.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.47 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 172.77 166.7 0.12 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 109.905 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -131.71 54.26 0.79 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -76.19 -161.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -1.046 . . . . 0.0 110.139 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 19.64 6.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -0.897 . . . . 0.0 110.161 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -138.27 -145.91 4.92 Favored Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.775 -1.202 . . . . 0.0 110.115 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 pt-20 -55.13 -40.32 70.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.615 -0.932 . . . . 0.0 111.067 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.622 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.46 -35.39 19.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 111.016 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.5 mm-40 -50.67 -33.6 23.2 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.087 -1.008 . . . . 0.0 110.106 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.954 ' HB3' HD11 ' A' ' 16' ' ' LEU . 67.2 m-20 -121.31 120.89 36.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 0.0 110.151 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.587 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -151.62 142.02 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.22 -0.925 . . . . 0.0 110.988 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 42.5 m80 -65.88 130.35 42.97 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.704 178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.572 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 7.8 ttp180 -68.42 -18.44 64.44 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.991 -1.068 . . . . 0.0 109.297 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.2 m -66.29 -59.85 3.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.55 -0.719 . . . . 0.0 111.05 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 8.7 p -80.78 -26.54 37.16 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.973 -1.079 . . . . 0.0 111.58 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -74.0 -60.06 2.43 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.587 -1.321 . . . . 0.0 109.891 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.936 ' HA ' HD21 ' A' ' 42' ' ' LEU . 15.4 t -49.74 -42.08 45.41 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.426 -0.796 . . . . 0.0 109.889 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.874 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -76.91 -37.03 56.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.552 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.7 t90 -59.52 -57.76 11.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.679 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.936 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -53.84 -34.32 58.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.06 -1.025 . . . . 0.0 109.433 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.561 ' N ' HD12 ' A' ' 42' ' ' LEU . 89.7 m -65.15 -40.74 94.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.081 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.874 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mt -76.77 -41.95 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.424 -0.797 . . . . 0.0 109.224 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 45.5 t -79.78 -7.57 58.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.422 -0.799 . . . . 0.0 109.735 179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.94 64.19 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.372 -0.83 . . . . 0.0 110.503 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 16.4 m-20 -134.58 148.78 50.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.325 -0.859 . . . . 0.0 109.815 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.48 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 43.8 p -120.76 -24.75 5.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -0.951 . . . . 0.0 110.53 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.51 153.93 44.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 0.0 110.677 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' O ' ' A' ' 55' ' ' VAL . 49.8 t -56.16 127.81 32.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.441 -0.787 . . . . 0.0 110.136 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -84.04 7.99 16.78 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.226 -0.922 . . . . 0.0 110.357 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 68.6 mt -96.45 -42.47 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.736 ' SG ' HG23 ' A' ' 55' ' ' VAL . 19.1 p -118.24 -17.3 9.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.282 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.36 35.21 7.08 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.736 HG23 ' SG ' ' A' ' 53' ' ' CYS . 44.0 t -107.46 138.17 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.286 . . . . 0.0 109.757 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 43.9 t -72.5 150.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -0.973 . . . . 0.0 110.729 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.656 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 29.0 m-85 -72.85 -35.5 67.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 110.638 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.451 ' H ' HG12 ' A' ' 56' ' ' VAL . 15.4 m120 49.47 72.63 0.29 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.314 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.545 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 50.7 p -100.07 147.86 25.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.239 -0.913 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HB2' ' NH2' ' A' ' 35' ' ' ARG . 1.9 mmt180 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.142 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' O ' ' HG2' ' A' ' 2' ' ' GLU . 2.6 ttm . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.925 0.393 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 1' ' ' MET . 10.4 pm0 35.25 -145.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.772 -0.58 . . . . 0.0 111.159 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 80.2 m-20 -95.29 -74.42 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.387 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -119.24 143.79 47.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.908 . . . . 0.0 110.426 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.91 112.49 17.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 0.0 110.003 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 t -133.2 111.37 12.96 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.413 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.635 ' O ' HD23 ' A' ' 16' ' ' LEU . 45.4 Cg_endo -71.49 162.73 41.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.011 1.532 . . . . 0.0 110.78 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.728 HG22 ' HG3' ' A' ' 15' ' ' GLU . 13.4 t -131.9 148.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.443 -0.786 . . . . 0.0 110.206 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 13.2 t -70.45 118.17 12.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.412 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.653 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 67.2 p-90 -66.1 -17.73 64.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.675 -178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.519 HG12 ' CH2' ' A' ' 10' ' ' TRP . 19.8 mt -74.6 -58.04 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.96 -1.087 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.415 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.4 p -104.44 -1.01 27.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 0.0 110.479 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.415 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.3 t-20 65.01 56.33 1.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.25 -0.906 . . . . 0.0 110.456 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 8' ' ' VAL . 58.9 tt0 -132.19 129.24 39.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 110.023 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.728 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -57.73 145.41 34.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 110.756 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.855 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.5 pt? -135.52 -21.91 1.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.476 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.0 -31.46 3.69 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.132 -0.98 . . . . 0.0 111.267 178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.648 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 7.0 t30 145.82 73.49 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 CA-C-N 117.835 0.817 . . . . 0.0 109.669 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.57 ' HB2' HD12 ' A' ' 16' ' ' LEU . 3.5 tp10 -71.05 121.9 19.07 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.953 -1.092 . . . . 0.0 109.463 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.56 96.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 109.235 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.717 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -149.44 115.29 5.66 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.421 -0.799 . . . . 0.0 110.58 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' ASN . 6.8 mmt85 -84.8 92.67 8.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 109.858 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.671 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.07 -27.49 2.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 0.0 110.952 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.865 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -170.27 168.03 8.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.08 -1.013 . . . . 0.0 110.394 -179.528 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.55 -46.31 0.36 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.539 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m 36.79 -158.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.425 -1.044 . . . . 0.0 110.976 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.21 -15.31 22.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.0 110.814 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 163.34 -57.47 0.28 Allowed Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.381 -1.39 . . . . 0.0 110.467 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.2 pt-20 -46.65 -47.3 20.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.136 -1.214 . . . . 0.0 110.791 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.865 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -88.92 -25.46 22.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 109.568 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' CG ' ' O ' ' A' ' 25' ' ' GLY . 0.2 OUTLIER -48.2 -51.09 26.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 109.597 179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 16.2 m-80 -99.39 121.0 40.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 109.383 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 38' ' ' LEU . 2.5 p -149.69 134.56 10.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.237 -0.915 . . . . 0.0 111.062 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.4 m170 -57.41 113.34 1.73 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.208 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.613 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.6 OUTLIER -58.97 -14.83 10.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.195 -0.941 . . . . 0.0 110.49 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.528 ' O ' HG22 ' A' ' 40' ' ' THR . 0.3 OUTLIER -79.05 -51.92 8.92 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 0.0 111.281 -179.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -81.83 -24.67 35.71 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 120.992 -1.068 . . . . 0.0 111.645 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 33' ' ' VAL . 4.0 tp -75.81 -59.76 2.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.555 -1.341 . . . . 0.0 110.572 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 42' ' ' LEU . 5.1 t -53.34 -32.6 49.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.051 -1.031 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.815 ' O ' HD12 ' A' ' 44' ' ' ILE . 15.0 t -86.06 -29.09 23.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.951 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.2 t90 -66.32 -58.12 6.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.2 pp -50.3 -29.73 10.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.427 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 m -65.27 -44.05 89.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.242 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -79.28 -36.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.809 . . . . 0.0 109.432 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.487 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 46.1 t -80.24 -9.67 59.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.849 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 67.19 55.68 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.855 . . . . 0.0 110.296 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' ND2' ' OG ' ' A' ' 45' ' ' SER . 89.5 m-20 -123.3 161.15 25.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 0.0 110.052 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.3 p -130.09 -27.74 2.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 110.72 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -148.46 147.58 29.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.009 -1.057 . . . . 0.0 110.868 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.638 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.3 t -53.85 121.42 7.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.534 -0.728 . . . . 0.0 110.18 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -81.17 5.1 17.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.216 -0.928 . . . . 0.0 110.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -89.57 -49.58 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 110.201 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.6 p -112.51 -16.64 12.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.19 -0.944 . . . . 0.0 110.038 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 50.55 2.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 55.7 t -121.88 144.08 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.048 -1.266 . . . . 0.0 109.649 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.8 t -84.6 146.52 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.919 -1.113 . . . . 0.0 111.146 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.775 ' CD2' HD22 ' A' ' 42' ' ' LEU . 8.2 m-85 -73.55 62.47 0.76 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 0.0 109.723 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' ARG . 0.7 OUTLIER -60.89 121.63 12.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.567 -0.708 . . . . 0.0 110.473 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.429 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 33.2 p -90.86 116.79 28.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.913 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' CG ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.217 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.2 0.524 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -111.2 -19.7 12.59 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.282 -0.886 . . . . 0.0 110.539 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.56 -163.52 1.03 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.41 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -49.77 -60.6 2.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 110.501 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 52.45 -175.13 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.923 . . . . 0.0 110.149 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 ' CG ' ' A' ' 15' ' ' GLU . 23.1 t -81.52 131.13 59.12 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.215 -0.928 . . . . 0.0 110.228 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.9 Cg_endo -74.11 161.51 40.75 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.855 1.45 . . . . 0.0 110.669 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.1 t -127.96 144.33 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -0.862 . . . . 0.0 110.515 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.588 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 8.1 t -70.98 114.51 9.11 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -0.815 . . . . 0.0 109.801 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.58 ' CE2' HG12 ' A' ' 11' ' ' ILE . 65.7 p-90 -58.05 -17.29 16.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.461 -0.774 . . . . 0.0 111.51 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.58 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.4 mt -77.0 -57.28 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.801 -1.187 . . . . 0.0 111.126 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 28.3 p -100.69 3.53 42.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.111 -0.993 . . . . 0.0 110.537 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 26.2 m-80 55.97 53.06 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.287 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.763 ' C ' HG13 ' A' ' 8' ' ' VAL . 21.6 tt0 -138.46 136.25 36.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 110.286 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.778 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.6 mp0 -57.93 140.37 52.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.136 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -123.02 -8.7 8.28 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.406 -0.808 . . . . 0.0 109.803 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.709 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 87.16 -28.64 5.52 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.709 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 15.3 t30 119.12 55.16 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' H ' HD12 ' A' ' 16' ' ' LEU . 4.0 mm-40 -58.61 124.19 18.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.557 -0.714 . . . . 0.0 109.945 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.62 98.47 0.09 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.525 -0.735 . . . . 0.0 110.213 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.823 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -144.56 102.96 3.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.358 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 57' ' ' TYR . 3.1 ttt180 -72.83 106.04 4.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.898 . . . . 0.0 110.109 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -139.13 -32.16 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.818 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.896 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -169.98 167.8 8.85 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.012 -1.055 . . . . 0.0 110.272 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.29 54.31 0.53 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.2 m -62.59 -101.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.375 -1.074 . . . . 0.0 110.632 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.1 p -127.38 -14.93 5.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.95 -1.094 . . . . 0.0 110.679 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 165.59 -62.32 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.555 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 10.7 pt-20 -51.59 -45.53 63.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.112 -1.228 . . . . 0.0 110.894 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.896 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -83.45 -20.71 33.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.0 -1.062 . . . . 0.0 109.402 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.4 mm-40 -56.22 -52.21 65.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.4 -0.812 . . . . 0.0 109.785 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.5 m-80 -100.67 121.23 41.29 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.963 HG21 HD22 ' A' ' 38' ' ' LEU . 2.7 p -150.06 142.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.068 -1.053 . . . . 0.0 111.285 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 4.6 m170 -67.53 125.75 27.14 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.66 -0.65 . . . . 0.0 110.083 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.4 ttp85 -67.26 -18.52 65.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.787 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -61.51 1.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.502 -0.749 . . . . 0.0 111.323 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.4 p -77.87 -21.23 51.67 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.891 -1.131 . . . . 0.0 111.777 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.963 HD22 HG21 ' A' ' 33' ' ' VAL . 4.2 tp -79.85 -59.83 2.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.478 -1.389 . . . . 0.0 109.782 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 20.6 p -55.53 -27.77 50.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.232 -0.917 . . . . 0.0 110.038 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.547 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 4.6 t -87.76 -33.56 18.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.14 -0.975 . . . . 0.0 109.936 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 44' ' ' ILE . 10.2 t90 -64.56 -57.5 8.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.3 pp -51.6 -27.8 12.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.575 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.8 m -68.65 -35.1 76.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 109.347 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 41' ' ' TRP . 24.2 mt -76.28 -45.76 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.403 -0.81 . . . . 0.0 109.772 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.8 t -84.81 6.5 24.31 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.0 109.912 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 57.1 75.91 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.439 -0.788 . . . . 0.0 110.417 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -135.5 155.41 50.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.29 -0.881 . . . . 0.0 109.806 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 32.2 p -129.23 -31.52 2.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.52 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.09 149.11 39.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.0 110.537 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.508 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 38.3 t -58.87 124.08 18.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.188 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.67 7.14 8.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.53 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 71.3 mt -93.26 -38.81 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.915 . . . . 0.0 110.399 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 55' ' ' VAL . 16.0 p -121.01 -16.3 8.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 110.175 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.76 16.03 52.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.697 HG23 ' SG ' ' A' ' 53' ' ' CYS . 43.9 t -89.16 145.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.325 . . . . 0.0 109.866 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 58.0 t -85.46 154.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.117 -0.989 . . . . 0.0 110.575 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.668 ' CD2' HD22 ' A' ' 42' ' ' LEU . 16.7 m-85 -74.91 -35.14 62.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.36 -0.837 . . . . 0.0 110.239 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' H ' HG12 ' A' ' 56' ' ' VAL . 26.9 t-20 40.59 82.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.59 -0.694 . . . . 0.0 110.445 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 15.5 p -104.24 154.25 20.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 110.193 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.192 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' O ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.237 0.541 . . . . 0.0 110.181 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -99.49 -23.15 15.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.244 -0.91 . . . . 0.0 110.325 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -142.25 -151.03 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.213 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -115.37 -101.94 0.42 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.214 -0.929 . . . . 0.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.4 t70 60.57 160.96 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.8 t -133.64 113.57 13.0 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 110.012 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 47.8 Cg_endo -72.01 162.5 41.66 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.93 1.489 . . . . 0.0 110.593 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.771 HG13 ' C ' ' A' ' 14' ' ' GLU . 21.3 t -125.33 149.67 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.387 -0.82 . . . . 0.0 110.325 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 40.5 t -67.92 128.14 35.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.884 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -71.67 -15.68 62.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.489 -0.757 . . . . 0.0 111.057 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 38' ' ' LEU . 12.1 mt -79.96 -57.3 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.169 -0.957 . . . . 0.0 111.059 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 18.9 p -101.9 -4.18 26.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.139 -0.975 . . . . 0.0 110.526 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.458 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.4 OUTLIER 64.92 45.52 3.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.938 . . . . 0.0 110.281 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.771 ' C ' HG13 ' A' ' 8' ' ' VAL . 2.4 tp10 -123.66 135.22 53.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.333 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.2 mt-10 -60.38 137.05 58.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 110.836 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.949 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.5 OUTLIER -120.05 -32.96 4.06 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.58 -30.14 1.98 Allowed Glycine 0 N--CA 1.496 2.663 0 O-C-N 121.554 -0.716 . . . . 0.0 112.235 177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 167.78 39.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.584 -1.539 . . . . 0.0 110.949 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.07 106.48 0.43 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.966 -1.084 . . . . 0.0 109.439 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.55 95.76 0.07 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 0.0 109.986 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.864 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -150.34 98.53 2.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.488 -0.758 . . . . 0.0 109.704 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.4 mpt_? -73.56 101.74 3.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 109.936 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.713 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -123.83 -3.74 8.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 110.262 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.588 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.05 166.74 0.14 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.228 -0.92 . . . . 0.0 109.89 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.03 52.96 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.2 m -79.6 -162.12 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.422 -1.046 . . . . 0.0 109.972 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 22.5 p -127.58 29.01 5.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 110.043 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -143.98 -159.28 7.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 1.9 pm0 -46.59 -26.26 0.86 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.497 -1.002 . . . . 0.0 111.021 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.608 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -61.58 -11.5 11.57 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.097 -1.002 . . . . 0.0 110.582 -178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -70.71 -47.36 60.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.949 ' HB3' HD11 ' A' ' 16' ' ' LEU . 79.7 m-20 -104.27 120.76 41.88 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.17 -0.956 . . . . 0.0 109.414 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.028 HG21 HD22 ' A' ' 38' ' ' LEU . 2.1 p -150.17 138.79 14.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.895 -1.128 . . . . 0.0 111.321 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.2 m170 -65.52 130.27 42.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.601 -0.687 . . . . 0.0 110.509 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.563 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 8.5 ttp-105 -70.14 -18.45 63.22 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.107 -0.995 . . . . 0.0 109.628 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -71.6 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.527 -0.733 . . . . 0.0 111.22 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.1 p -79.17 -22.65 44.69 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.896 -1.128 . . . . 0.0 111.545 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.028 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -76.86 -59.1 2.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.322 -1.486 . . . . 0.0 109.601 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.894 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.8 p -53.44 -33.88 55.73 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.362 -0.836 . . . . 0.0 109.889 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 37' ' ' CYS . 2.8 t -82.59 -40.97 20.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 0.0 109.853 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.502 ' N ' ' CG2' ' A' ' 40' ' ' THR . 23.0 t90 -55.17 -57.75 10.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.108 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.894 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.0 -34.57 68.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.332 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.806 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.7 m -64.98 -36.6 84.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.496 -0.752 . . . . 0.0 109.38 179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.2 mt -80.19 -37.78 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 109.551 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.1 t -85.86 -4.82 59.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.895 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 69.64 68.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.348 -0.845 . . . . 0.0 110.476 179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -140.7 148.85 41.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 48.8 p -126.32 -12.56 6.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 110.88 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.39 156.02 42.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.935 -1.103 . . . . 0.0 110.818 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.525 ' N ' ' O ' ' A' ' 55' ' ' VAL . 41.6 t -65.02 120.03 11.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.518 -0.739 . . . . 0.0 109.871 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -74.57 -0.8 18.92 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.247 -0.908 . . . . 0.0 110.833 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 52.9 mt -86.48 -54.32 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 0.0 110.384 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.72 ' SG ' HG23 ' A' ' 55' ' ' VAL . 25.6 p -104.43 -17.52 14.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.151 -0.968 . . . . 0.0 110.231 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.93 33.7 8.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.72 HG23 ' SG ' ' A' ' 53' ' ' CYS . 95.1 t -103.73 150.69 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.99 -1.3 . . . . 0.0 109.9 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.6 t -84.33 142.43 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.118 -0.989 . . . . 0.0 110.446 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.666 ' CD2' HD22 ' A' ' 42' ' ' LEU . 26.4 m-85 -63.51 -37.06 85.85 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.34 -0.85 . . . . 0.0 110.313 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 57' ' ' TYR . 43.2 t30 43.94 92.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.275 -0.89 . . . . 0.0 110.148 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 39' ' ' SER . 68.4 p -94.11 130.18 40.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.136 -0.977 . . . . 0.0 110.22 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.0 mtp180 . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.299 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.173 0.511 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.428 ' C ' ' OE1' ' A' ' 2' ' ' GLU . 0.7 OUTLIER -91.97 -12.47 33.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -0.848 . . . . 0.0 110.252 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER -73.4 -35.49 65.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.247 -0.908 . . . . 0.0 110.411 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 6' ' ' VAL . 33.9 mt-10 -157.35 -40.6 0.07 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.173 -0.954 . . . . 0.0 110.364 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER -69.31 81.63 0.36 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 110.396 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.104 HG13 ' CA ' ' A' ' 17' ' ' GLY . 18.0 t -93.03 123.08 62.14 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.408 -0.808 . . . . 0.0 109.504 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 15' ' ' GLU . 55.9 Cg_endo -71.71 150.0 55.61 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.715 1.376 . . . . 0.0 110.097 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.666 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.9 t -99.04 131.58 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.289 0.566 . . . . 0.0 111.613 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 14' ' ' GLU . 0.9 OUTLIER -65.53 115.21 5.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.219 -0.926 . . . . 0.0 108.689 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.477 ' NE1' HD22 ' A' ' 30' ' ' LEU . 65.5 p-90 -62.75 -10.77 13.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.627 -0.67 . . . . 0.0 112.367 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.701 HD11 HD13 ' A' ' 38' ' ' LEU . 15.3 mt -84.16 -57.62 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.69 -1.256 . . . . 0.0 111.777 -178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.5 p -102.86 3.74 36.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.069 . . . . 0.0 111.101 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.422 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 64.23 60.97 0.93 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.993 -1.067 . . . . 0.0 109.805 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.509 ' O ' ' CE1' ' A' ' 34' ' ' HIS . 2.5 tp10 -159.81 117.17 2.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.402 -0.811 . . . . 0.0 109.143 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.807 ' HB2' HG12 ' A' ' 6' ' ' VAL . 2.2 pt-20 -67.51 158.83 30.98 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 122.398 1.095 . . . . 0.0 112.376 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.925 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -113.79 -32.07 6.24 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.24 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.104 ' CA ' HG13 ' A' ' 6' ' ' VAL . . . 76.94 -28.26 1.63 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.15 -1.024 . . . . 0.0 111.9 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -168.71 32.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.389 -1.654 . . . . 0.0 111.588 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.485 ' HG3' ' HB3' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -76.72 103.79 6.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.85 -1.156 . . . . 0.0 109.549 179.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.61 95.2 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.928 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.96 105.82 3.3 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.402 -0.811 . . . . 0.0 109.987 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 88.88 7.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 110.07 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.856 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -105.51 1.11 27.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.733 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.843 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 171.79 167.86 0.1 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.768 -1.207 . . . . 0.0 110.532 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -103.5 -55.12 0.81 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 40.06 -158.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.468 -1.019 . . . . 0.0 110.341 179.791 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.79 -15.23 13.86 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.055 -1.028 . . . . 0.0 110.711 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.537 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 171.26 -63.95 0.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 14.4 tt0 -41.81 -61.7 1.05 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.32 -1.106 . . . . 0.0 110.293 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.843 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -75.49 -22.32 57.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.296 -0.878 . . . . 0.0 110.017 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.537 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -51.19 -44.55 61.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 110.003 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . 26.9 m-80 -109.91 123.02 48.88 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 110.448 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 6.6 p -148.44 144.47 18.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.15 -0.969 . . . . 0.0 110.557 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.6 m170 -72.18 113.0 8.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.478 -0.764 . . . . 0.0 110.308 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.5 OUTLIER -58.2 -15.64 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.093 . . . . 0.0 109.955 179.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.0 t -73.87 -57.76 3.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 0.0 110.405 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 1.2 p -81.13 -22.71 38.86 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.083 -1.011 . . . . 0.0 111.026 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 9.7 tp -80.7 -59.28 2.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 0.0 109.646 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.883 ' HA ' HD21 ' A' ' 42' ' ' LEU . 11.2 t -49.31 -39.72 32.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.534 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' N ' ' A' ' 41' ' ' TRP . 5.9 t -78.56 -38.53 40.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.384 -0.823 . . . . 0.0 109.503 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.553 ' HE3' HD12 ' A' ' 38' ' ' LEU . 30.7 t90 -58.5 -57.88 11.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.406 -0.809 . . . . 0.0 109.659 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.883 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -57.91 -35.99 71.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.14 -0.975 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.682 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -62.77 -42.92 99.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.482 -0.761 . . . . 0.0 109.588 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.7 mt -78.14 -37.18 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 109.826 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' OG ' ' ND2' ' A' ' 47' ' ' ASN . 60.5 p -86.05 0.44 53.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.979 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 tpm_? 61.59 63.25 1.19 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.802 . . . . 0.0 110.515 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.499 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 54.9 m-20 -128.51 153.44 47.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 109.654 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.3 p -133.64 -15.02 2.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.933 -1.104 . . . . 0.0 111.46 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 148.24 30.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.898 -1.126 . . . . 0.0 110.829 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.565 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 35.7 t -54.6 127.18 26.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 110.151 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.29 -9.95 58.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 110.183 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 35.2 mm -71.5 -50.11 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.242 -0.911 . . . . 0.0 110.335 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.722 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.9 p -117.2 -15.59 10.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.134 -0.978 . . . . 0.0 110.252 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.49 49.63 2.94 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.977 -1.106 . . . . 0.0 110.551 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.722 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.0 t -119.49 131.25 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.293 . . . . 0.0 109.485 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 26.4 t -64.61 143.45 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.139 -0.976 . . . . 0.0 111.368 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 20.6 m-85 -66.46 -46.6 75.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.493 -0.755 . . . . 0.0 110.137 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 1.3 t30 68.37 43.7 1.42 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.243 -0.911 . . . . 0.0 110.282 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 32.6 p -82.04 126.09 31.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 0.0 110.177 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.126 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.173 0.511 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.21 -76.77 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.903 . . . . 0.0 110.454 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -103.43 -176.12 2.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.294 -0.879 . . . . 0.0 110.772 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.9 pt-20 -141.12 174.93 10.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.436 -0.79 . . . . 0.0 110.114 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 4' ' ' GLU . 14.0 t0 56.19 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.186 -0.947 . . . . 0.0 110.162 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.513 HG13 ' CA ' ' A' ' 17' ' ' GLY . 89.2 t -108.17 106.19 58.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.991 . . . . 0.0 110.605 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 52.2 Cg_endo -76.94 162.59 31.98 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 124.162 1.612 . . . . 0.0 110.378 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 15' ' ' GLU . 16.5 t -114.75 142.05 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.434 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.581 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 17.2 t -63.36 125.02 22.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 109.686 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.541 ' CH2' HG12 ' A' ' 11' ' ' ILE . 70.2 p-90 -71.18 -15.52 62.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.371 -0.831 . . . . 0.0 111.651 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.541 HG12 ' CH2' ' A' ' 10' ' ' TRP . 10.1 mt -77.92 -57.42 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.791 -1.193 . . . . 0.0 111.111 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.9 p -104.11 -1.12 27.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.004 -1.06 . . . . 0.0 110.547 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 64.34 52.19 1.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.003 . . . . 0.0 110.301 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.541 ' C ' HG13 ' A' ' 8' ' ' VAL . 61.3 tt0 -130.33 133.97 46.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.928 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.689 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -60.85 138.82 58.1 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.971 -1.081 . . . . 0.0 111.089 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.835 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -120.74 -32.37 4.03 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.23 -30.7 2.12 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.532 -0.73 . . . . 0.0 111.783 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 167.0 44.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.702 -1.47 . . . . 0.0 110.637 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 11.4 tp10 -59.1 105.37 0.32 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.802 -1.187 . . . . 0.0 109.116 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.09 95.56 0.06 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.117 -0.989 . . . . 0.0 110.087 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.895 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.91 98.79 2.77 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.621 -0.674 . . . . 0.0 109.338 179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' TYR . 1.1 mpp_? -72.94 94.26 1.83 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.0 109.663 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.895 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 -10.07 12.75 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.075 -1.015 . . . . 0.0 110.532 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.554 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 176.42 166.68 0.46 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.163 -0.961 . . . . 0.0 110.181 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.85 51.69 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.467 ' O ' ' OE2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -76.2 -168.49 0.95 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.421 -1.046 . . . . 0.0 110.08 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.5 t -127.43 28.18 5.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 110.266 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -150.19 5.17 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.525 -1.322 . . . . 0.0 110.196 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB2' ' HB3' ' A' ' 10' ' ' TRP . 25.1 pt-20 -52.27 -32.04 35.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.555 -0.968 . . . . 0.0 110.93 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.523 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -58.49 -11.6 3.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.169 -0.957 . . . . 0.0 111.18 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' O ' ' A' ' 26' ' ' CYS . 2.3 mm-40 -72.3 -38.02 68.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.932 -1.105 . . . . 0.0 110.36 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.835 ' HB3' HD11 ' A' ' 16' ' ' LEU . 22.6 m-20 -114.82 119.44 36.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.915 -1.115 . . . . 0.0 110.008 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.577 HG21 HD22 ' A' ' 38' ' ' LEU . 5.6 p -152.42 140.54 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 110.936 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 39.8 m80 -66.19 122.61 17.84 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.922 -1.111 . . . . 0.0 109.654 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 15.9 ttp180 -60.72 -15.53 30.15 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.012 -1.055 . . . . 0.0 109.356 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 t -70.1 -61.27 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.608 -0.683 . . . . 0.0 111.213 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 12.3 p -78.41 -23.02 46.9 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.819 -1.175 . . . . 0.0 111.362 -178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.711 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.4 tp -77.25 -59.66 2.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 0.0 109.661 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 42' ' ' LEU . 24.8 p -52.53 -34.64 50.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.389 -0.819 . . . . 0.0 109.971 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.749 ' O ' HD12 ' A' ' 44' ' ' ILE . 5.4 t -83.99 -32.46 24.95 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.889 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.525 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.3 t90 -65.31 -57.64 7.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.457 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.962 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -50.29 -27.46 6.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.167 -0.958 . . . . 0.0 109.873 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.512 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.1 m -67.92 -35.88 79.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.536 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.749 HD12 ' O ' ' A' ' 40' ' ' THR . 1.2 mp -76.38 -39.56 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.288 -0.883 . . . . 0.0 109.491 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 46' ' ' ARG . 1.5 t -95.05 11.47 31.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.907 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 45' ' ' SER . 9.0 tpt180 39.79 73.86 0.11 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -0.764 . . . . 0.0 110.854 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.771 ' C ' HG23 ' A' ' 48' ' ' THR . 2.8 m-20 -108.88 -58.2 2.05 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.377 -0.827 . . . . 0.0 109.812 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.771 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.38 -26.15 0.19 Allowed 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.807 -0.558 . . . . 0.0 111.835 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.94 144.65 24.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.703 -1.248 . . . . 0.0 110.509 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' OH ' ' A' ' 57' ' ' TYR . 39.0 t -59.91 114.19 2.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.84 . . . . 0.0 110.014 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -72.02 -4.86 31.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 110.321 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.41 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 21.6 mm -76.8 -46.0 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.296 -0.878 . . . . 0.0 110.164 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.772 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.0 p -118.85 -16.56 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.271 -0.893 . . . . 0.0 109.874 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.71 27.96 15.58 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 120.155 -1.021 . . . . 0.0 110.777 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.772 HG23 ' SG ' ' A' ' 53' ' ' CYS . 40.6 t -99.79 132.42 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.923 -1.339 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 60.3 t -69.69 152.15 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 110.365 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 26.8 m-85 -76.16 -36.23 58.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 110.481 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.453 ' H ' HG12 ' A' ' 56' ' ' VAL . 0.8 OUTLIER 52.92 65.26 1.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.101 -1.0 . . . . 0.0 110.345 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.565 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 68.2 p -88.75 150.49 22.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -0.956 . . . . 0.0 110.19 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.184 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.085 0.469 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.73 -179.03 2.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.0 110.16 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 49.44 -168.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.0 110.158 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.49 147.48 26.89 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.57 114.11 9.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.0 110.256 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG13 ' HA2' ' A' ' 17' ' ' GLY . 12.1 t -105.32 141.35 22.43 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 110.199 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.548 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 39.7 Cg_endo -64.83 162.03 33.74 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 N-CA-C 108.423 -1.414 . . . . 0.0 108.423 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.789 HG13 ' N ' ' A' ' 15' ' ' GLU . 1.4 t -134.83 151.3 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 118.429 -1.308 . . . . 0.0 112.92 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 10.0 t -82.47 115.19 21.36 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.585 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.812 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.2 p-90 -67.17 -7.7 25.57 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.514 -0.741 . . . . 0.0 111.581 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 38' ' ' LEU . 6.2 mt -82.81 -55.01 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 0.0 111.131 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 15.0 p -104.15 -5.03 22.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.856 -1.153 . . . . 0.0 110.937 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER 66.8 78.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.034 -1.041 . . . . 0.0 110.348 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.592 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.4 tp10 -168.87 127.02 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.329 -0.857 . . . . 0.0 109.412 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.789 ' N ' HG13 ' A' ' 8' ' ' VAL . 2.5 pt-20 -59.34 143.04 50.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.95 -1.094 . . . . 0.0 110.157 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.706 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -119.43 -11.85 9.44 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.576 -0.702 . . . . 0.0 109.774 -179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.806 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 74.3 -32.13 0.96 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 121.581 -0.699 . . . . 0.0 112.399 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 4.5 t-20 156.79 78.19 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 119.043 1.422 . . . . 0.0 109.947 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' H ' HD12 ' A' ' 16' ' ' LEU . 25.7 mm-40 -87.92 111.68 21.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.0 109.313 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -62.19 95.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.052 -1.03 . . . . 0.0 109.761 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.907 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.75 98.98 2.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.525 -0.735 . . . . 0.0 110.226 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -73.23 90.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.108 -0.995 . . . . 0.0 109.535 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.907 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -114.28 0.9 14.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 0.0 110.423 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 171.14 152.5 0.06 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.336 -0.853 . . . . 0.0 110.164 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' H ' HG21 ' A' ' 55' ' ' VAL . . . -115.05 55.42 0.53 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -72.17 -162.4 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.473 -1.016 . . . . 0.0 109.708 -179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.8 t -128.34 29.7 5.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.0 110.948 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -173.85 -129.15 1.14 Allowed Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.985 -1.579 . . . . 0.0 111.204 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.574 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 7.9 tp10 -41.56 -61.13 1.13 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.749 -0.854 . . . . 0.0 112.841 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.812 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -48.59 -19.66 0.36 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.745 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 96.3 mt-10 -57.09 -36.27 70.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.522 -1.361 . . . . 0.0 110.113 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.414 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 75.8 m-20 -112.25 121.05 43.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.998 -1.064 . . . . 0.0 109.988 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.012 HG21 HD22 ' A' ' 38' ' ' LEU . 3.5 p -150.1 137.27 13.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.113 -0.992 . . . . 0.0 110.719 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 5.5 m170 -62.57 124.2 20.35 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.396 -0.815 . . . . 0.0 110.092 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -66.91 -15.51 63.71 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.091 -1.005 . . . . 0.0 109.933 179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.11 -60.21 2.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.422 -0.799 . . . . 0.0 111.171 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HA ' ' CG2' ' A' ' 40' ' ' THR . 2.4 p -78.2 -23.34 47.58 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.991 -1.068 . . . . 0.0 111.801 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.012 HD22 HG21 ' A' ' 33' ' ' VAL . 6.2 tp -74.95 -58.83 3.04 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.491 -1.38 . . . . 0.0 109.73 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.802 ' HA ' HD21 ' A' ' 42' ' ' LEU . 28.8 t -53.27 -38.6 63.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.348 -0.845 . . . . 0.0 110.122 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.589 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 11.9 t -79.21 -34.85 42.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.114 -0.991 . . . . 0.0 109.905 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 32.0 t90 -62.56 -57.71 10.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.815 HD12 ' N ' ' A' ' 43' ' ' THR . 3.5 pp -58.75 -37.0 75.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 109.688 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.815 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.0 m -61.31 -41.37 96.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.393 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.0 mt -80.37 -43.46 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.617 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -75.61 -2.67 30.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.374 -0.829 . . . . 0.0 109.914 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.11 58.14 0.47 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.388 -0.82 . . . . 0.0 110.745 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.1 m120 -126.58 135.31 51.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.846 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.8 p -113.6 -14.12 12.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.947 . . . . 0.0 110.338 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.498 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.12 146.56 25.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.105 -0.997 . . . . 0.0 110.933 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.541 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 48.7 t -52.96 126.32 20.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.526 -0.733 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.46 9.92 8.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.228 -0.92 . . . . 0.0 110.662 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 94.3 mt -101.11 -37.83 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 110.196 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.612 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.1 p -117.63 -17.97 9.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.107 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.41 29.25 17.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG23 ' SG ' ' A' ' 53' ' ' CYS . 60.6 t -104.71 149.44 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.097 -1.237 . . . . 0.0 110.178 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 77.2 t -80.69 150.3 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.338 -0.851 . . . . 0.0 110.464 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 39.7 m-85 -72.78 -39.48 66.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 110.192 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 52.1 64.66 1.76 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.431 -0.793 . . . . 0.0 110.358 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.409 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 14.3 p -88.04 156.88 19.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.178 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.939 -1.029 . . . . 0.0 110.178 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.277 0.56 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.79 -79.2 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 110.074 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.62 167.92 7.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.163 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -156.65 -163.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.227 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.96 97.69 10.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 0.0 110.139 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.487 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 21.5 t -90.73 122.07 67.4 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 0.0 109.935 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.0 Cg_endo -72.25 160.02 48.2 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.002 1.527 . . . . 0.0 110.336 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.626 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.1 t -129.93 139.36 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 110.715 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 16' ' ' LEU . 13.3 t -72.18 114.97 10.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.7 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.5 p-90 -64.18 -12.71 42.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 111.333 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 7.3 mt -79.14 -54.66 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.939 -1.101 . . . . 0.0 110.952 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 27.5 p -100.32 -4.99 28.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.986 -1.071 . . . . 0.0 110.623 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER 65.71 70.33 0.44 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.626 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.6 tp10 -166.71 140.79 4.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.192 -0.942 . . . . 0.0 110.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.607 ' N ' HG13 ' A' ' 8' ' ' VAL . 1.2 mp0 -57.18 139.18 53.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.978 . . . . 0.0 109.592 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -113.01 4.94 16.97 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.707 -179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.22 14.15 63.51 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.591 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 80.5 53.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.745 -0.856 . . . . 0.0 108.96 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.532 ' H ' HD12 ' A' ' 16' ' ' LEU . 6.8 tp10 -58.87 105.72 0.34 Allowed 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.945 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -59.2 96.26 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.696 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -148.93 103.15 3.33 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.15 106.52 5.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 110.64 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -135.41 -1.92 2.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.867 . . . . 0.0 110.767 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.817 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER 169.57 167.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.123 -0.986 . . . . 0.0 109.937 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -147.77 52.79 0.54 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 5.7 m -62.7 -103.29 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -1.166 . . . . 0.0 110.099 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -127.19 -15.28 5.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.96 -1.088 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 164.2 -62.94 0.25 Allowed Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.552 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 20.6 pt-20 -47.18 -45.8 23.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -1.169 . . . . 0.0 110.569 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.817 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.19 -24.16 28.01 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 109.671 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 5.3 mt-10 -52.02 -43.23 63.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.898 . . . . 0.0 109.66 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.569 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 45.9 m-80 -107.04 120.77 42.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.901 HG21 HD22 ' A' ' 38' ' ' LEU . 3.4 p -150.05 138.68 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.096 -1.002 . . . . 0.0 110.698 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.5 m80 -62.16 126.62 27.98 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.511 -0.743 . . . . 0.0 110.448 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.561 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 1.9 ttp180 -69.98 -15.61 63.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' HG22 ' A' ' 40' ' ' THR . 9.7 t -77.38 -56.7 4.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.342 -0.849 . . . . 0.0 110.829 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.0 p -81.05 -22.32 39.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.964 -1.085 . . . . 0.0 111.562 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.901 HD22 HG21 ' A' ' 33' ' ' VAL . 4.7 tp -79.75 -59.59 2.68 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.431 -1.418 . . . . 0.0 109.613 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.821 ' HA ' HD21 ' A' ' 42' ' ' LEU . 6.0 t -51.17 -36.0 38.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.178 -0.951 . . . . 0.0 109.763 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.6 t -83.56 -33.03 25.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 109.792 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.4 t90 -63.77 -57.56 9.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 0.0 109.335 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.821 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -56.26 -31.71 63.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.626 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.7 m -65.37 -49.42 69.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.33 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.7 -40.63 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.283 -0.886 . . . . 0.0 109.32 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -80.17 -4.41 52.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.46 -0.775 . . . . 0.0 109.716 179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 0.0 OUTLIER 65.55 70.8 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -0.817 . . . . 0.0 110.499 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 46' ' ' ARG . 15.2 m-20 -135.94 145.72 46.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.425 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 69.5 p -118.69 -23.23 7.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.376 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 55' ' ' VAL . . . -147.37 152.32 37.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.205 -0.935 . . . . 0.0 110.271 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 52' ' ' ILE . 47.5 t -54.59 139.45 38.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.119 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -91.41 2.53 56.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 50' ' ' CYS . 3.8 mt -94.77 -44.74 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 110.352 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.673 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -113.3 -17.47 12.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.15 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.09 26.62 25.73 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.673 HG23 ' SG ' ' A' ' 53' ' ' CYS . 89.3 t -94.41 149.73 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.011 -1.287 . . . . 0.0 109.899 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 3.8 t -83.7 147.36 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 110.39 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 30.7 m-85 -70.79 -29.89 66.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.823 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 44.39 78.24 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.495 -0.753 . . . . 0.0 110.262 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.0 p -112.66 129.38 56.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.266 -0.896 . . . . 0.0 110.11 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.369 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttt . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.274 0.559 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 3' ' ' ASP . 0.9 OUTLIER -145.29 172.4 13.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.868 . . . . 0.0 110.148 -179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.3 OUTLIER 49.12 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 110.16 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 6.9 mm-40 -88.69 -62.62 1.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.945 . . . . 0.0 110.116 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER 57.72 -164.47 0.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 110.334 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.853 HG13 ' HA2' ' A' ' 17' ' ' GLY . 86.1 t -118.01 133.21 23.42 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.239 -0.913 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -73.88 162.08 40.04 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.928 1.488 . . . . 0.0 110.77 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.871 HG22 ' HG3' ' A' ' 15' ' ' GLU . 6.7 t -127.91 146.11 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.484 -0.76 . . . . 0.0 110.761 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 11.7 t -64.02 110.08 2.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.44 -0.788 . . . . 0.0 109.663 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CZ3' HG12 ' A' ' 11' ' ' ILE . 66.5 p-90 -56.35 -12.96 1.87 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.394 -0.816 . . . . 0.0 111.35 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.608 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 33.4 mt -84.66 -57.43 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.822 -1.174 . . . . 0.0 111.541 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.439 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.8 p -99.8 -3.38 32.83 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.868 -1.145 . . . . 0.0 110.584 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.439 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.8 OUTLIER 65.73 51.29 1.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 110.314 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.748 ' C ' HG13 ' A' ' 8' ' ' VAL . 6.7 tp10 -131.81 129.97 41.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 110.256 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.871 ' HG3' HG22 ' A' ' 8' ' ' VAL . 4.1 mt-10 -59.06 136.86 58.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.816 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.785 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -116.2 -31.08 5.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.359 -0.838 . . . . 0.0 108.911 178.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.853 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.0 -29.85 2.7 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.461 -0.774 . . . . 0.0 111.691 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 167.65 42.97 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.805 -1.409 . . . . 0.0 110.474 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 40.8 tp10 -59.7 106.5 0.48 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.19 94.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.133 -0.979 . . . . 0.0 110.104 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.739 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.77 110.95 4.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.561 -0.712 . . . . 0.0 109.754 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -73.57 88.03 1.65 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 110.107 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -105.12 -92.66 0.37 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.566 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 2.7 t -123.19 164.99 17.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.542 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.518 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -97.71 -64.54 0.89 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 53.8 -150.69 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -1.175 . . . . 0.0 110.674 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 27' ' ' THR . 21.6 m -117.99 29.21 7.94 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.036 -1.04 . . . . 0.0 111.259 -178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 129.59 -56.9 0.73 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.502 -1.332 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' HB3' HD12 ' A' ' 30' ' ' LEU . 8.8 tt0 -41.77 -58.93 1.83 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.382 -1.069 . . . . 0.0 110.533 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.649 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -88.41 -15.21 36.1 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.544 -0.722 . . . . 0.0 111.326 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -49.75 -24.47 2.36 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.816 -1.154 . . . . 0.0 108.104 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.67 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.4 m-80 -131.9 120.99 23.3 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.9 HG21 HD22 ' A' ' 38' ' ' LEU . 10.9 p -150.15 138.86 14.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.802 -1.186 . . . . 0.0 111.478 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.4 m80 -67.03 119.65 12.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.479 -0.763 . . . . 0.0 109.67 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.4 ttp180 -66.26 -15.59 63.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.057 -1.027 . . . . 0.0 109.996 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 72.1 m -75.56 -51.31 13.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 110.573 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -82.97 -23.44 33.39 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.114 -0.991 . . . . 0.0 110.793 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 33' ' ' VAL . 4.6 tp -80.21 -60.01 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.815 -1.178 . . . . 0.0 110.106 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.92 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.9 t -48.91 -32.31 8.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.296 -0.877 . . . . 0.0 109.905 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.558 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.0 t -86.59 -36.65 18.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.372 -0.83 . . . . 0.0 109.755 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.434 ' N ' HG23 ' A' ' 40' ' ' THR . 27.5 t90 -61.47 -57.62 11.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 109.727 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.5 pp -52.94 -24.81 10.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.485 ' N ' HD12 ' A' ' 42' ' ' LEU . 24.9 m -73.36 -51.16 18.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.317 -0.864 . . . . 0.0 109.933 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.558 HD12 ' O ' ' A' ' 40' ' ' THR . 2.0 mp -64.63 -34.74 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.27 -0.894 . . . . 0.0 109.953 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.5 t -92.96 -4.4 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 110.032 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 62.8 67.04 0.72 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 110.33 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 24.1 m-20 -131.64 152.64 50.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.879 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.444 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 45.2 p -132.83 -31.42 1.32 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.955 . . . . 0.0 110.667 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -139.04 135.59 34.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.102 -0.999 . . . . 0.0 110.921 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.1 t -52.21 152.38 3.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 0.0 110.114 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.465 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 6.9 pt20 -99.93 -25.12 14.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.095 -1.003 . . . . 0.0 110.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.465 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 38.5 mt -54.54 -46.89 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.156 -0.965 . . . . 0.0 110.405 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.727 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.8 p -121.72 -17.22 7.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 42.96 5.02 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.228 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.727 HG23 ' SG ' ' A' ' 53' ' ' CYS . 22.0 t -100.99 132.82 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.09 -1.241 . . . . 0.0 109.635 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.3 t -81.78 142.68 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.139 -0.976 . . . . 0.0 110.655 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.841 ' O ' HG23 ' A' ' 59' ' ' THR . 7.4 m-85 -72.46 70.65 0.9 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.99 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.24 118.11 2.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -0.832 . . . . 0.0 110.395 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 57' ' ' TYR . 55.1 p -125.26 168.22 13.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -0.888 . . . . 0.0 110.12 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.232 179.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.498 ' O ' ' N ' ' A' ' 3' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.272 0.558 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER 62.01 -77.23 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -0.932 . . . . 0.0 110.204 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.498 ' N ' ' O ' ' A' ' 1' ' ' MET . 0.3 OUTLIER 43.36 -152.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 110.274 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.446 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 0.7 OUTLIER -88.11 -140.58 0.12 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.38 -0.825 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 26.2 t70 60.68 120.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.94 . . . . 0.0 110.33 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -132.75 107.45 12.89 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.159 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.535 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.97 161.84 40.37 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.023 1.538 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.94 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.3 t -125.56 147.88 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.267 -0.896 . . . . 0.0 110.406 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.6 t -68.15 114.37 6.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.23 -0.919 . . . . 0.0 109.613 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.581 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 62.8 p-90 -58.21 -14.69 7.63 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.366 -0.834 . . . . 0.0 111.339 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 7.0 mt -84.22 -57.37 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.946 -1.096 . . . . 0.0 111.623 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 31.6 p -99.44 -3.23 34.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.884 -1.135 . . . . 0.0 110.882 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 10.1 t-20 64.57 46.41 3.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.166 -0.959 . . . . 0.0 110.206 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 35.8 tt0 -127.06 131.25 50.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 110.107 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.94 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -59.52 135.78 57.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.364 -0.835 . . . . 0.0 110.51 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.878 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -116.93 -28.68 6.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 80.0 -31.24 2.3 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.646 -0.659 . . . . 0.0 111.649 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 162.64 45.66 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 118.796 1.298 . . . . 0.0 110.913 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.41 116.95 4.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.83 -1.169 . . . . 0.0 109.033 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.19 95.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.067 . . . . 0.0 110.465 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.2 t80 -150.9 98.03 2.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.45 -0.781 . . . . 0.0 109.678 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' TYR . 19.3 mtt180 -77.02 96.41 4.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.98 . . . . 0.0 109.882 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -121.35 -6.06 9.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 110.307 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER 173.83 166.87 0.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.18 -0.95 . . . . 0.0 109.937 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -128.26 50.95 0.87 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' CB ' ' HB3' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -69.05 -159.51 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.188 -1.184 . . . . 0.0 109.72 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.18 29.79 5.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.037 -1.04 . . . . 0.0 110.764 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.22 -135.93 2.02 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 118.936 -1.602 . . . . 0.0 111.252 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 1.2 pm0 -49.75 -36.65 26.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.747 -0.855 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -73.32 -10.96 60.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.657 -1.277 . . . . 0.0 110.469 -179.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -74.75 -41.19 60.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 109.301 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.878 ' HB3' HD11 ' A' ' 16' ' ' LEU . 67.7 m-80 -113.15 120.91 42.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.905 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -150.99 141.6 16.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.08 -1.013 . . . . 0.0 111.047 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.587 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 25.6 m80 -63.27 126.64 28.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.372 -0.83 . . . . 0.0 110.078 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 4.8 ttp180 -63.61 -14.74 54.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.038 -1.039 . . . . 0.0 109.517 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -56.35 5.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.49 -0.756 . . . . 0.0 111.227 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -81.51 -28.72 33.89 Favored 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 118.778 -1.169 . . . . 0.0 111.72 -179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.867 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.2 tp -74.41 -58.95 2.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.337 -1.477 . . . . 0.0 109.731 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.978 ' HA ' HD21 ' A' ' 42' ' ' LEU . 22.0 p -49.36 -35.54 18.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.347 -0.846 . . . . 0.0 110.169 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.556 ' O ' HD12 ' A' ' 44' ' ' ILE . 9.7 t -82.97 -32.76 26.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 0.0 109.896 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.544 ' HE3' HD12 ' A' ' 38' ' ' LEU . 15.8 t90 -63.79 -58.09 7.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.113 -0.992 . . . . 0.0 109.416 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.978 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.1 pp -52.3 -24.97 8.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.678 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 40' ' ' THR . 28.7 m -68.36 -42.87 78.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.796 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.556 HD12 ' O ' ' A' ' 40' ' ' THR . 3.2 mt -74.04 -40.47 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.208 -0.933 . . . . 0.0 109.631 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.5 t -85.09 2.99 40.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 109.795 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.31 77.18 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -143.38 150.87 39.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.727 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 p -128.85 -18.69 3.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.142 -0.974 . . . . 0.0 111.193 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -142.98 148.04 36.16 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 0.0 110.97 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 49.3 t -59.34 140.97 55.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.432 -0.792 . . . . 0.0 109.835 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -98.46 10.04 41.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -0.941 . . . . 0.0 110.438 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.7 mm -97.22 -39.89 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.116 -0.99 . . . . 0.0 110.281 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' A' ' 55' ' ' VAL . 6.2 p -121.44 -17.49 7.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.24 49.12 3.35 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.626 HG23 ' SG ' ' A' ' 53' ' ' CYS . 16.0 t -120.9 123.19 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.864 -1.374 . . . . 0.0 109.755 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 19.3 t -62.44 151.72 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.831 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.684 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 18.0 m-85 -72.05 -35.37 69.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 110.362 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 50.01 78.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 110.187 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.708 HG22 ' CE1' ' A' ' 21' ' ' PHE . 68.8 p -117.7 125.28 50.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.161 -0.962 . . . . 0.0 110.159 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.276 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.277 0.56 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -124.2 170.36 10.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.899 . . . . 0.0 110.062 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -44.93 -35.69 2.98 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.267 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 48.9 mt-10 -144.35 138.74 28.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.908 . . . . 0.0 110.323 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.3 t0 176.22 131.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 110.202 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 15' ' ' GLU . 3.6 t -107.89 113.04 61.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.261 -0.9 . . . . 0.0 110.035 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.609 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.57 161.71 43.35 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.864 1.455 . . . . 0.0 110.427 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.4 t -132.58 137.75 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 110.182 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 20.0 t -66.15 114.46 5.29 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.172 -0.955 . . . . 0.0 109.897 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.693 ' NE1' HD22 ' A' ' 30' ' ' LEU . 69.3 p-90 -65.41 -11.22 40.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.338 -0.851 . . . . 0.0 110.961 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.652 HD11 HD13 ' A' ' 38' ' ' LEU . 4.1 mt -79.81 -56.35 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.009 -1.057 . . . . 0.0 110.942 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 19.0 p -102.06 3.05 38.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.033 -1.042 . . . . 0.0 110.643 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 6.0 m120 58.22 60.83 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 110.365 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 8' ' ' VAL . 41.0 tt0 -146.04 139.77 26.32 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.675 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 8' ' ' VAL . 2.5 mt-10 -67.6 146.24 54.07 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 110.521 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.861 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.1 pt? -132.09 -9.36 3.41 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.423 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.665 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -32.86 1.16 Allowed Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.36 -0.837 . . . . 0.0 112.388 178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.665 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 8.3 t30 144.48 64.53 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.601 0 CA-C-N 118.598 1.199 . . . . 0.0 109.311 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 34' ' ' HIS . 20.8 tt0 -68.12 125.03 25.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.678 -1.263 . . . . 0.0 109.045 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.428 ' O ' ' NH1' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -61.86 96.1 0.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.158 -0.964 . . . . 0.0 110.006 -179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.954 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -150.29 99.28 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.496 -0.752 . . . . 0.0 110.268 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' ASN . 3.9 mpt_? -73.71 90.49 1.84 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.08 -1.013 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -108.43 -32.24 7.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.297 -0.877 . . . . 0.0 110.062 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.795 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -175.27 166.86 3.41 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.304 -0.873 . . . . 0.0 109.981 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -105.61 -58.53 0.64 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' O ' ' O ' ' A' ' 25' ' ' GLY . 0.8 OUTLIER 43.62 -171.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.511 -0.994 . . . . 0.0 110.519 179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.44 17.94 6.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 110.105 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 31' ' ' GLU . . . -135.67 -151.85 6.28 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.647 -1.263 . . . . 0.0 110.45 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 17.2 pt-20 -53.08 -33.94 54.34 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.612 -0.934 . . . . 0.0 111.378 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.693 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -49.2 -23.55 1.36 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.969 -1.082 . . . . 0.0 110.555 -178.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 25' ' ' GLY . 4.8 mm-40 -57.22 -44.88 84.14 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.109 -0.995 . . . . 0.0 109.591 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 70.6 m-80 -111.7 122.42 47.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.565 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.989 HG21 HD22 ' A' ' 38' ' ' LEU . 3.6 p -146.26 138.94 20.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.07 -1.019 . . . . 0.0 110.776 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 3.5 m170 -60.4 127.11 30.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.618 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.555 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -71.39 -15.8 62.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.259 -0.901 . . . . 0.0 110.079 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.7 p -76.86 -57.2 3.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.473 -0.767 . . . . 0.0 110.931 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.7 p -81.83 -23.34 36.5 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.048 -1.032 . . . . 0.0 111.725 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.989 HD22 HG21 ' A' ' 33' ' ' VAL . 11.4 tp -77.18 -59.75 2.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.516 -1.365 . . . . 0.0 109.97 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.982 ' HA ' HD21 ' A' ' 42' ' ' LEU . 33.1 t -50.18 -38.9 42.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 109.949 179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.1 t -80.17 -35.1 36.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.326 -0.859 . . . . 0.0 110.139 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.571 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.2 t90 -62.46 -57.6 10.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.215 -0.928 . . . . 0.0 109.571 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.982 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.2 pp -51.76 -27.06 10.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.193 -0.942 . . . . 0.0 109.985 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.53 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.3 m -64.71 -46.05 83.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 0.0 109.584 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 44' ' ' ILE . 3.0 mp -78.39 -46.04 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 41' ' ' TRP . 2.2 p -71.79 -13.92 61.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.323 -0.861 . . . . 0.0 109.742 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 55.58 74.97 0.35 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.475 -0.766 . . . . 0.0 110.381 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.778 ' C ' HG23 ' A' ' 48' ' ' THR . 24.2 m-20 -121.45 -58.93 1.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.749 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.778 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 74.66 -31.23 0.21 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.881 -0.512 . . . . 0.0 111.571 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -139.26 149.98 44.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.682 -1.262 . . . . 0.0 110.78 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.542 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.1 t -62.84 142.46 58.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 110.221 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -99.3 10.21 41.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 0.0 110.003 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.451 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 38.2 mm -102.67 -36.33 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.309 -0.869 . . . . 0.0 110.395 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.689 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.8 p -121.06 -17.4 7.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.117 -0.989 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.31 27.86 16.75 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.825 -1.178 . . . . 0.0 110.368 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.795 HG11 ' HA ' ' A' ' 24' ' ' CYS . 73.0 t -99.55 150.49 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.931 -1.335 . . . . 0.0 110.03 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 72.3 t -89.67 147.74 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -0.956 . . . . 0.0 110.445 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' THR . 17.2 m-85 -72.56 63.11 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 57' ' ' TYR . 3.4 m-80 -43.15 124.64 3.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 57' ' ' TYR . 5.8 p -135.13 119.41 17.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.251 -0.906 . . . . 0.0 110.141 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.284 0.564 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.488 ' HG2' ' N ' ' A' ' 3' ' ' ASP . 26.3 tt0 -151.06 -75.63 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' N ' ' HG2' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -164.29 -171.98 2.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.439 -0.788 . . . . 0.0 110.127 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -95.15 -150.73 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.922 . . . . 0.0 110.229 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -52.5 157.28 1.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.363 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.508 HG13 ' CA ' ' A' ' 17' ' ' GLY . 22.9 t -118.86 106.75 43.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.288 -0.882 . . . . 0.0 110.091 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.593 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 50.4 Cg_endo -73.65 162.89 38.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.183 1.623 . . . . 0.0 110.411 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.765 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.5 t -119.01 137.48 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 111.026 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 31.8 t -64.08 121.3 13.83 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.786 . . . . 0.0 109.521 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.627 ' NE1' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -67.94 -14.0 62.62 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.577 -0.702 . . . . 0.0 111.408 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.693 HD11 HD13 ' A' ' 38' ' ' LEU . 5.1 mt -79.86 -57.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.946 -1.097 . . . . 0.0 111.023 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 30.5 p -103.2 3.48 35.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 57.65 65.17 1.38 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.828 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 8' ' ' VAL . 42.5 tt0 -145.75 128.84 16.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 110.317 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.765 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.9 mt-10 -57.5 134.13 55.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.268 -0.895 . . . . 0.0 110.478 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.969 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -113.46 -27.53 7.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.292 -0.88 . . . . 0.0 109.043 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.66 -30.44 1.98 Allowed Glycine 0 N--CA 1.495 2.578 0 O-C-N 121.486 -0.759 . . . . 0.0 111.94 177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.3 p30 166.41 42.87 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.78 -1.424 . . . . 0.0 110.846 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 0.0 OUTLIER -59.57 106.05 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.936 -1.103 . . . . 0.0 109.425 179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.9 mtt85 -62.03 96.19 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.0 . . . . 0.0 109.756 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.872 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -149.77 102.1 3.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.502 -0.749 . . . . 0.0 110.127 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -73.16 87.91 1.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.823 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -109.5 -15.95 14.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -0.918 . . . . 0.0 110.438 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.757 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 177.13 164.89 0.53 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.901 . . . . 0.0 110.027 -179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.449 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -123.46 54.18 0.72 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.17 -164.62 0.71 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.382 -1.069 . . . . 0.0 109.985 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.4 t -127.67 10.46 6.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.371 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -125.93 -145.49 6.43 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.567 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 24.3 pt-20 -57.33 -38.87 74.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.481 -1.011 . . . . 0.0 110.922 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.757 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -50.91 -20.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 111.293 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 2.8 mt-10 -63.67 -43.78 95.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.937 -1.102 . . . . 0.0 110.074 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.969 ' HB3' HD11 ' A' ' 16' ' ' LEU . 66.9 m-80 -108.97 121.37 44.99 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.0 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.889 HG21 HD22 ' A' ' 38' ' ' LEU . 7.5 p -149.91 137.94 14.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 110.824 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 24.3 m80 -64.36 127.59 32.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.31 -0.869 . . . . 0.0 110.322 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -66.05 -14.53 61.86 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.062 -1.024 . . . . 0.0 109.272 178.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 -61.38 1.88 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.475 -0.765 . . . . 0.0 111.351 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 9.6 p -79.3 -21.91 45.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.864 -1.148 . . . . 0.0 111.67 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.889 HD22 HG21 ' A' ' 33' ' ' VAL . 6.6 tp -78.09 -59.64 2.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.619 -1.3 . . . . 0.0 110.133 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.1 p -53.04 -34.96 58.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.951 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 8.8 t -82.78 -33.74 27.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.954 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' HE3' HD12 ' A' ' 38' ' ' LEU . 9.9 t90 -64.3 -57.98 7.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.147 -0.971 . . . . 0.0 109.464 179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.903 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.02 -24.44 17.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.805 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 42' ' ' LEU . 23.9 m -73.31 -46.94 46.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 109.362 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.7 mt -78.85 -27.91 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.589 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 40.3 t -90.03 -5.21 56.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.838 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 69.07 58.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.49 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 87.4 m-20 -130.26 153.71 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 109.805 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.525 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 22.2 p -135.98 -31.99 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.077 -1.014 . . . . 0.0 110.501 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.499 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -134.95 147.96 49.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.991 . . . . 0.0 110.676 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.633 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 47.6 t -52.2 136.78 29.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.52 -0.738 . . . . 0.0 110.15 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -86.71 -4.67 59.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.269 -0.894 . . . . 0.0 110.184 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.5 mt -86.94 -49.3 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.762 ' SG ' HG23 ' A' ' 55' ' ' VAL . 21.6 p -109.76 -17.68 13.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.148 -0.97 . . . . 0.0 110.133 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.02 15.83 55.36 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.98 -1.105 . . . . 0.0 110.484 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.762 HG23 ' SG ' ' A' ' 53' ' ' CYS . 67.2 t -80.57 149.08 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.868 -1.372 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 2.9 t -85.08 149.55 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.069 -1.019 . . . . 0.0 110.811 -179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.663 ' CD2' HD22 ' A' ' 42' ' ' LEU . 14.0 m-85 -74.62 67.34 1.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.434 -0.791 . . . . 0.0 110.187 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.458 ' O ' ' O ' ' A' ' 22' ' ' ARG . 1.5 t-20 -61.32 115.16 3.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 110.334 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.405 HG22 ' HD3' ' A' ' 35' ' ' ARG . 4.1 p -89.73 125.64 35.36 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.337 -0.852 . . . . 0.0 110.235 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttm . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.243 0.544 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 3.2 pt-20 -75.39 -140.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.083 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 57.82 -158.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 110.386 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 5' ' ' ASP . 39.1 mm-40 -108.15 -6.68 16.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.866 . . . . 0.0 110.337 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 4' ' ' GLU . 6.6 p-10 -37.0 140.26 0.17 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.742 -0.599 . . . . 0.0 110.709 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.71 HG13 ' HA2' ' A' ' 17' ' ' GLY . 21.6 t -91.39 118.01 68.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.415 -0.803 . . . . 0.0 110.503 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.571 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 51.8 Cg_endo -74.57 162.36 38.11 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.923 1.486 . . . . 0.0 110.269 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG13 ' C ' ' A' ' 14' ' ' GLU . 5.9 t -123.4 148.19 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.232 -0.917 . . . . 0.0 110.603 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.622 ' SG ' HG23 ' A' ' 33' ' ' VAL . 13.3 t -69.42 126.68 30.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.228 -0.92 . . . . 0.0 109.763 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.623 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 67.3 p-90 -70.25 -20.76 63.04 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.344 -0.848 . . . . 0.0 111.443 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.713 HD11 HD13 ' A' ' 38' ' ' LEU . 16.2 mt -75.96 -57.87 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.994 -1.066 . . . . 0.0 111.507 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.3 p -104.15 -0.4 28.59 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.887 -1.133 . . . . 0.0 110.502 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 61.33 67.13 0.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.621 179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.3 tt0 -145.0 131.75 20.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 109.635 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.544 ' CD ' HG22 ' A' ' 8' ' ' VAL . 0.8 OUTLIER -58.4 136.24 57.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.125 -0.984 . . . . 0.0 110.858 -179.257 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -118.71 -17.13 9.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.304 -0.873 . . . . 0.0 109.549 179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.71 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 85.72 -31.18 3.99 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.671 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 12.0 t30 141.42 60.57 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.66 0 CA-C-N 117.687 0.744 . . . . 0.0 109.455 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.8 120.85 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.829 -1.17 . . . . 0.0 109.627 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.5 95.22 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 110.044 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.935 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -150.6 98.79 2.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 0.0 109.391 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 58' ' ' ASN . 2.2 tpp180 -73.58 87.17 1.62 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.03 -1.044 . . . . 0.0 109.882 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -99.04 -30.68 12.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.386 -0.821 . . . . 0.0 110.426 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -157.93 -156.0 0.54 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.103 -0.998 . . . . 0.0 110.699 -179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -151.36 18.81 0.91 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 69.4 m -54.69 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.456 -1.026 . . . . 0.0 110.231 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.489 ' HA ' ' CD ' ' A' ' 31' ' ' GLU . 75.1 p -127.94 29.01 5.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.334 -0.854 . . . . 0.0 110.372 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -151.89 -144.06 3.84 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.451 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.558 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 18.9 pt-20 -47.83 -39.82 19.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.939 . . . . 0.0 111.181 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.69 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -62.71 -8.82 7.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.196 -0.94 . . . . 0.0 111.063 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' CD ' ' HA ' ' A' ' 27' ' ' THR . 45.8 mt-10 -75.57 -37.57 59.83 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.986 -1.071 . . . . 0.0 110.509 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.827 ' HB3' HD11 ' A' ' 16' ' ' LEU . 33.1 m-80 -122.48 123.21 40.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.075 -1.015 . . . . 0.0 110.519 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.622 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.2 p -148.96 142.64 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 110.766 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.8 m80 -64.38 120.68 12.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.554 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -56.66 -17.22 8.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.053 -1.029 . . . . 0.0 109.376 179.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.6 m -70.0 -60.66 2.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.709 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.0 p -72.8 -32.65 65.7 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.899 -1.125 . . . . 0.0 111.337 -178.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.935 HD23 ' CE2' ' A' ' 21' ' ' PHE . 15.4 tp -74.88 -59.92 2.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.831 -1.168 . . . . 0.0 110.312 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.846 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.0 t -48.98 -36.3 17.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.403 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.1 p -84.0 -38.53 20.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.96 . . . . 0.0 109.967 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.63 ' HE3' HD12 ' A' ' 38' ' ' LEU . 22.3 t90 -60.53 -57.4 12.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.901 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.846 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -53.9 -35.29 61.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 110.185 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.703 ' N ' HD12 ' A' ' 42' ' ' LEU . 15.3 m -64.57 -45.88 85.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.9 mt -79.64 -19.92 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.358 -0.839 . . . . 0.0 109.759 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 25.2 t -101.12 -5.59 25.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.316 -0.865 . . . . 0.0 109.987 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 42' ' ' LEU . 2.0 ttp180 56.24 65.74 1.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 110.548 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 48' ' ' THR . 1.7 m120 -116.13 -70.32 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.222 -0.924 . . . . 0.0 109.591 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.567 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER 74.81 -21.11 0.3 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.711 -0.618 . . . . 0.0 112.171 179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' N ' ' CE2' ' A' ' 57' ' ' TYR . . . -150.58 134.01 16.38 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.491 -1.381 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.5 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 50.4 t -58.88 140.07 55.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.588 -0.695 . . . . 0.0 109.955 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.6 9.86 37.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.211 -0.931 . . . . 0.0 110.855 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 15.4 mt -91.99 -40.78 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.991 . . . . 0.0 109.97 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 3.7 p -121.97 -17.64 7.22 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.31 -0.869 . . . . 0.0 110.329 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.97 22.77 31.94 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.611 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' SG ' ' A' ' 24' ' ' CYS . 52.1 t -94.24 130.33 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.392 . . . . 0.0 109.971 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.0 t -72.91 156.31 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.208 -0.932 . . . . 0.0 110.999 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.744 ' O ' HG23 ' A' ' 59' ' ' THR . 12.8 m-85 -76.66 66.86 2.69 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.429 -0.795 . . . . 0.0 110.592 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.538 ' HB3' ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -42.23 112.24 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.22 -0.925 . . . . 0.0 110.175 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 57' ' ' TYR . 12.3 p -113.54 164.13 14.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.078 -1.014 . . . . 0.0 110.395 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.148 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttm . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.251 0.548 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.01 -47.29 0.21 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.222 -0.923 . . . . 0.0 110.414 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 2' ' ' GLU . 91.1 m-20 40.91 -120.75 0.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.133 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.8 mm-40 -122.39 -14.64 7.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.768 -1.207 . . . . 0.0 110.259 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' GLU . 23.7 p30 -47.52 174.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.184 -0.948 . . . . 0.0 110.287 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.634 HG13 ' HA2' ' A' ' 17' ' ' GLY . 67.5 t -114.95 127.33 26.93 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.5 Cg_endo -72.99 162.02 42.04 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.949 1.499 . . . . 0.0 110.655 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.958 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.0 t -126.37 140.74 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.438 -0.789 . . . . 0.0 110.413 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 39.6 t -63.64 124.38 21.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.264 -0.898 . . . . 0.0 109.507 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.607 ' CD1' ' HG ' ' A' ' 30' ' ' LEU . 69.4 p-90 -70.81 -11.9 61.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.425 -0.797 . . . . 0.0 111.425 -178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.602 HD11 HD13 ' A' ' 38' ' ' LEU . 4.9 mt -82.64 -56.79 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.855 -1.153 . . . . 0.0 110.738 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 29.1 p -102.45 3.46 37.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -0.976 . . . . 0.0 110.388 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 57.01 53.28 8.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.555 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.8 tp10 -132.19 131.43 42.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.176 -0.952 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.958 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -57.8 136.86 57.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.343 -0.848 . . . . 0.0 110.795 -179.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.3 OUTLIER -117.53 -30.58 5.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.409 -0.807 . . . . 0.0 109.001 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.634 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 77.51 -30.58 1.69 Allowed Glycine 0 N--CA 1.496 2.657 0 O-C-N 121.457 -0.777 . . . . 0.0 111.908 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.566 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 5.2 t-20 167.12 72.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.952 -1.322 . . . . 0.0 110.168 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -88.21 106.3 18.1 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.888 -1.132 . . . . 0.0 108.896 179.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -61.94 94.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 0.0 109.604 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.746 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.4 t80 -151.26 98.82 2.59 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.72 -0.612 . . . . 0.0 109.575 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -73.32 93.06 1.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.964 -1.085 . . . . 0.0 109.942 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.635 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -114.14 -81.2 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 0.0 110.622 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.533 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 1.5 t -113.76 165.54 12.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.087 -1.008 . . . . 0.0 110.849 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.533 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -104.99 -54.32 0.77 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.933 ' SG ' HD13 ' A' ' 30' ' ' LEU . 0.7 OUTLIER 41.43 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.401 -1.058 . . . . 0.0 110.452 179.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.4 t -126.81 29.9 5.59 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.646 -1.283 . . . . 0.0 111.51 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 134.02 -58.05 0.69 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.661 ' HG3' HD12 ' A' ' 30' ' ' LEU . 1.5 pm0 -41.5 -58.66 1.83 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -1.079 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.933 HD13 ' SG ' ' A' ' 26' ' ' CYS . 2.1 mp -87.94 -13.8 40.88 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 111.126 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 11.8 mt-10 -48.71 -25.73 1.96 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 118.73 -1.188 . . . . 0.0 107.86 178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.834 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.6 m-80 -128.7 120.98 27.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.896 HG21 HD22 ' A' ' 38' ' ' LEU . 11.6 p -150.29 133.36 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 120.935 -1.103 . . . . 0.0 111.018 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.618 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 15.3 m170 -64.28 118.09 8.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -60.14 -15.33 22.79 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.826 -1.171 . . . . 0.0 109.402 179.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 m -72.33 -61.44 1.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.577 -0.702 . . . . 0.0 111.547 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.4 p -77.14 -27.59 53.93 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.831 -1.168 . . . . 0.0 111.23 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.896 HD22 HG21 ' A' ' 33' ' ' VAL . 5.9 tp -73.81 -60.01 2.45 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.58 -1.325 . . . . 0.0 110.11 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.942 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -49.57 -41.96 43.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.401 ' O ' ' HB ' ' A' ' 43' ' ' THR . 61.1 p -77.97 -39.36 42.75 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.532 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 47.2 t90 -58.89 -57.34 13.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 109.962 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.942 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.8 pp -54.15 -27.15 31.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.156 -0.965 . . . . 0.0 110.231 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.58 ' N ' HD12 ' A' ' 42' ' ' LEU . 53.3 m -73.73 -41.72 62.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.976 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -75.72 -31.17 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 0.0 109.979 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 44.1 p -99.01 -4.62 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.221 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 56.8 78.42 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.482 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.793 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m120 -120.08 -58.93 1.83 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.793 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.28 -35.67 0.29 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.804 -0.56 . . . . 0.0 111.165 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -143.52 151.47 40.3 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.694 -1.254 . . . . 0.0 110.879 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 52.8 t -59.57 145.24 45.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.448 -0.782 . . . . 0.0 109.903 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -99.34 -12.01 20.69 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.0 110.473 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mt -77.38 -42.19 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.47 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.799 ' SG ' HG23 ' A' ' 55' ' ' VAL . 8.8 p -119.56 -17.52 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.112 -0.993 . . . . 0.0 110.38 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.76 45.04 5.0 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.794 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.799 HG23 ' SG ' ' A' ' 53' ' ' CYS . 15.9 t -111.58 127.29 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.808 -1.407 . . . . 0.0 109.529 179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.563 HG12 ' OD1' ' A' ' 58' ' ' ASN . 21.4 t -69.13 149.45 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.2 -0.938 . . . . 0.0 110.985 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 19.7 m-85 -75.53 -44.31 44.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.43 -0.794 . . . . 0.0 110.648 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.563 ' OD1' HG12 ' A' ' 56' ' ' VAL . 2.4 m-20 61.8 80.25 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 109.892 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.572 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 11.5 p -113.92 131.1 56.42 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 0.0 110.093 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.333 -179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.502 ' N ' ' O ' ' A' ' 5' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.313 0.578 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.85 -72.39 0.71 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.312 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.77 -84.81 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.404 -0.81 . . . . 0.0 110.435 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 6' ' ' VAL . 2.3 mm-40 -114.53 -10.09 12.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.279 -0.888 . . . . 0.0 110.378 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.502 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t0 -60.51 102.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.144 -0.973 . . . . 0.0 110.364 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' GLU . 47.4 t -135.87 139.67 31.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.904 . . . . 0.0 109.811 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 51.2 Cg_endo -73.57 156.57 49.46 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 123.979 1.515 . . . . 0.0 110.56 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.923 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.8 t -139.12 146.81 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.705 . . . . 0.0 110.442 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.548 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 16.3 t -74.07 121.08 20.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 63.6 p-90 -63.04 -19.64 64.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.574 -0.704 . . . . 0.0 111.698 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.641 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 32.3 mt -78.37 -57.55 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 120.926 -1.109 . . . . 0.0 111.657 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 21.0 p -102.42 3.4 37.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.931 -1.106 . . . . 0.0 110.547 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 56.33 61.87 2.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.417 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.651 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.4 tp10 -138.55 134.03 33.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.89 . . . . 0.0 109.887 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.923 ' HG3' HG22 ' A' ' 8' ' ' VAL . 5.4 mt-10 -65.67 136.81 56.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.835 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -113.16 -25.08 9.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.277 -0.889 . . . . 0.0 108.764 178.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 79.48 -31.51 2.14 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.754 -0.591 . . . . 0.0 112.226 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 22.1 t-20 171.57 35.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 119.185 1.492 . . . . 0.0 111.19 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 1.9 tm-20 -59.81 105.45 0.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.246 -1.533 . . . . 0.0 109.234 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -62.77 96.35 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.166 -0.959 . . . . 0.0 110.63 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.021 ' CE2' HD23 ' A' ' 38' ' ' LEU . 0.8 OUTLIER -149.4 98.25 2.76 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.448 -0.782 . . . . 0.0 109.443 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 1.8 tpm_? -74.83 89.99 2.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 110.1 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.759 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.37 -9.4 13.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.37 -0.831 . . . . 0.0 110.764 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.621 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.3 OUTLIER 178.12 -157.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.017 -1.052 . . . . 0.0 111.44 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -176.52 33.92 0.09 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 85.2 m -50.65 -104.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.341 -1.094 . . . . 0.0 110.863 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.89 -15.98 4.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 0.0 111.222 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 31' ' ' GLU . . . 169.82 -76.94 0.1 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.48 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.566 ' HG2' ' N ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -46.0 -40.58 10.7 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.054 -1.262 . . . . 0.0 110.478 -179.196 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.621 HD12 ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -84.98 -11.82 54.65 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.13 -0.981 . . . . 0.0 109.463 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -71.98 -39.71 69.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.4 -0.813 . . . . 0.0 109.962 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.611 ' HB3' HD11 ' A' ' 16' ' ' LEU . 52.1 m-20 -112.72 120.62 42.15 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.157 -0.965 . . . . 0.0 110.264 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.595 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 2.4 p -151.87 137.61 11.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.106 -0.996 . . . . 0.0 110.966 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.57 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 51.2 m80 -64.19 130.12 42.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.138 -0.976 . . . . 0.0 110.334 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.579 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -65.14 -15.43 62.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.15 -0.969 . . . . 0.0 109.425 178.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.6 m -72.58 -55.4 6.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 111.329 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 21.9 p -80.75 -31.48 35.92 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.843 -1.16 . . . . 0.0 111.6 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.021 HD23 ' CE2' ' A' ' 21' ' ' PHE . 13.9 tp -74.7 -59.69 2.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.667 -1.271 . . . . 0.0 110.436 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 4.0 t -50.35 -32.72 18.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 110.31 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 41' ' ' TRP . 9.3 t -87.18 -36.21 18.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.053 . . . . 0.0 109.992 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.721 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.8 t90 -60.79 -57.75 11.34 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.599 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.64 -36.66 46.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.951 . . . . 0.0 109.655 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.665 ' N ' HD12 ' A' ' 42' ' ' LEU . 1.4 m -60.56 -45.36 94.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.337 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mt -77.04 -38.89 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 0.0 109.704 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -81.35 0.07 38.91 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.86 . . . . 0.0 109.948 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 45' ' ' SER . 15.8 ttt85 60.83 60.34 1.9 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.347 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 10.5 m-20 -127.61 157.69 39.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.11 -0.994 . . . . 0.0 109.887 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.57 ' O ' ' CD2' ' A' ' 57' ' ' TYR . 1.4 p -136.56 -40.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.167 -0.958 . . . . 0.0 110.359 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -138.86 133.9 32.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.937 . . . . 0.0 110.279 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.523 ' HB3' ' SG ' ' A' ' 24' ' ' CYS . 8.0 t -53.47 147.66 10.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.37 -0.831 . . . . 0.0 110.167 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -94.89 -25.4 16.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.986 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 17.2 mm -49.68 -53.62 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.4 -0.813 . . . . 0.0 110.176 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.796 ' SG ' HG23 ' A' ' 55' ' ' VAL . 9.6 p -117.29 -17.93 10.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.194 -0.941 . . . . 0.0 110.387 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 29.26 12.98 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.705 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.796 HG23 ' SG ' ' A' ' 53' ' ' CYS . 31.5 t -94.89 121.57 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.763 -1.434 . . . . 0.0 109.987 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 4.2 t -65.15 156.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.26 -0.9 . . . . 0.0 110.721 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 48' ' ' THR . 10.1 m-85 -80.02 67.34 5.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 110.384 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 5.1 t-20 -57.09 136.41 56.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.166 -0.958 . . . . 0.0 110.215 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.2 164.2 20.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.391 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.365 179.955 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.358 0.599 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -121.25 -48.88 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.273 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 45.3 t0 53.02 176.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.8 . . . . 0.0 110.323 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.71 -162.96 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.24 -0.913 . . . . 0.0 109.924 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 1.7 t0 -48.0 143.08 4.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.077 -1.014 . . . . 0.0 109.988 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.635 HG13 ' HA2' ' A' ' 17' ' ' GLY . 5.5 t -88.47 109.1 26.46 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 109.957 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 46.8 Cg_endo -71.03 161.81 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.98 1.516 . . . . 0.0 110.475 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.619 HG13 ' C ' ' A' ' 14' ' ' GLU . 11.9 t -120.6 144.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 0.0 110.649 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.746 ' SG ' HG23 ' A' ' 33' ' ' VAL . 19.4 t -66.28 128.73 37.28 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.38 -0.825 . . . . 0.0 109.635 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CD1' ' HB ' ' A' ' 33' ' ' VAL . 67.8 p-90 -70.29 -20.31 63.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.287 -0.883 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 38' ' ' LEU . 10.9 mt -77.38 -57.44 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.958 -1.089 . . . . 0.0 111.427 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.5 p -102.21 -4.44 25.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.948 -1.095 . . . . 0.0 110.686 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.21 54.05 1.67 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.096 -1.003 . . . . 0.0 110.633 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.619 ' C ' HG13 ' A' ' 8' ' ' VAL . 12.5 tp10 -128.91 135.98 49.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.604 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.61 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -64.97 131.16 45.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.838 -1.164 . . . . 0.0 110.793 -179.472 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.77 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.06 -24.85 9.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.306 -0.871 . . . . 0.0 108.909 179.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.635 ' HA2' HG13 ' A' ' 6' ' ' VAL . . . 81.6 -32.02 2.66 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.589 -0.695 . . . . 0.0 111.472 178.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.4 OUTLIER 157.71 40.39 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.395 0 CA-C-N 118.526 1.163 . . . . 0.0 110.93 179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.499 ' OE2' ' CB ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -59.5 120.15 8.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.581 -1.324 . . . . 0.0 109.272 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.97 96.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 111.391 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.878 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.2 t80 -149.84 103.19 3.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.888 . . . . 0.0 109.95 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 mtt-85 -73.69 92.73 2.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.946 -1.096 . . . . 0.0 109.769 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -103.25 -11.55 17.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.206 -0.933 . . . . 0.0 110.264 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.647 ' HA ' HG11 ' A' ' 55' ' ' VAL . 0.1 OUTLIER 175.87 -157.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.977 -1.077 . . . . 0.0 110.647 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -148.2 20.77 1.39 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 83.7 m -58.26 -172.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.541 -0.976 . . . . 0.0 110.249 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.502 ' HA ' ' OE2' ' A' ' 31' ' ' GLU . 2.6 m -128.39 22.04 6.07 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.381 -0.824 . . . . 0.0 110.154 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.46 ' N ' ' HG3' ' A' ' 31' ' ' GLU . . . -137.92 -150.24 5.65 Favored Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.11 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 16.9 pt-20 -46.21 -38.22 8.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.545 -0.974 . . . . 0.0 110.66 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -61.38 -8.64 4.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.428 -0.795 . . . . 0.0 111.044 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 27' ' ' THR . 6.7 mt-10 -73.71 -41.33 62.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 0.0 110.854 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.751 ' HB3' HD11 ' A' ' 16' ' ' LEU . 12.7 m-80 -119.39 122.04 40.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.846 -1.158 . . . . 0.0 110.587 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.746 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.4 p -150.64 142.49 16.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 110.472 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 56.9 m80 -66.71 128.38 36.05 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.999 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.61 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -63.12 -15.2 55.94 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.3 m -73.58 -52.96 11.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.462 -0.774 . . . . 0.0 111.343 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 22.1 p -81.07 -33.72 33.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.885 -1.134 . . . . 0.0 111.532 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD23 ' CE2' ' A' ' 21' ' ' PHE . 6.9 tp -73.24 -59.86 2.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.675 -1.265 . . . . 0.0 110.533 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 27.7 t -51.03 -32.07 20.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.237 -0.915 . . . . 0.0 110.645 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 37' ' ' CYS . 6.9 t -85.58 -37.63 19.36 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.984 -1.073 . . . . 0.0 110.254 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.701 ' HE3' HD12 ' A' ' 38' ' ' LEU . 3.4 t90 -61.94 -57.29 12.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.4 pp -53.82 -33.28 55.68 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.078 -1.014 . . . . 0.0 109.924 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.772 ' N ' HD12 ' A' ' 42' ' ' LEU . 7.7 m -59.31 -44.09 92.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.069 -1.019 . . . . 0.0 109.421 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -79.31 -37.23 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.739 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -82.18 4.24 24.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.837 179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' SER . 2.0 ttp85 58.28 42.07 22.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.378 -0.827 . . . . 0.0 110.431 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 3.2 m-20 -104.53 140.93 37.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.117 -0.99 . . . . 0.0 109.737 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 p -127.37 -23.4 3.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.183 -0.948 . . . . 0.0 110.739 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.16 139.18 19.11 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.003 -1.061 . . . . 0.0 110.693 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 37.9 t -55.11 152.31 8.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.465 -0.772 . . . . 0.0 110.276 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -97.98 -24.48 15.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.155 -0.965 . . . . 0.0 110.047 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.487 HD12 ' SG ' ' A' ' 50' ' ' CYS . 6.7 mt -55.36 -45.12 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.415 -0.803 . . . . 0.0 110.386 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 7.9 p -119.87 -17.73 8.42 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.028 -1.045 . . . . 0.0 110.375 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.33 27.15 26.09 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.888 -1.149 . . . . 0.0 110.346 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.647 HG11 ' HA ' ' A' ' 24' ' ' CYS . 17.5 t -94.74 148.44 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.907 -1.349 . . . . 0.0 109.606 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 2.5 t -86.84 156.02 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.152 -0.968 . . . . 0.0 110.853 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.74 ' O ' HG23 ' A' ' 59' ' ' THR . 11.8 m-85 -77.73 71.17 4.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.413 -0.804 . . . . 0.0 109.779 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -46.07 124.62 5.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.387 -0.821 . . . . 0.0 110.442 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 57' ' ' TYR . 20.8 p -132.59 130.29 40.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.315 -0.866 . . . . 0.0 109.925 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.292 -179.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' GLU . 14.0 ttm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.173 0.511 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' MET . 7.0 mm-40 46.77 -171.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -152.6 -84.68 0.07 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.295 -0.878 . . . . 0.0 110.074 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -158.46 -72.75 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 110.415 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -80.86 121.49 26.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.352 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG12 ' HG2' ' A' ' 15' ' ' GLU . 39.1 t -96.47 125.58 46.83 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.284 -0.885 . . . . 0.0 110.117 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.539 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.05 161.1 41.73 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.941 1.495 . . . . 0.0 110.859 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG13 ' C ' ' A' ' 14' ' ' GLU . 10.6 t -130.53 140.37 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.466 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.561 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 15.2 t -63.3 116.19 5.25 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.36 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.608 ' CE2' HD22 ' A' ' 30' ' ' LEU . 64.3 p-90 -63.61 -12.3 32.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.652 -0.655 . . . . 0.0 111.659 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 38' ' ' LEU . 5.9 mt -79.85 -57.41 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.746 -1.221 . . . . 0.0 110.921 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 26.1 p -102.9 4.04 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.967 -1.083 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 3.7 m120 58.24 54.98 5.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.301 -0.874 . . . . 0.0 110.4 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.718 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.0 tt0 -133.87 130.76 38.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.192 -0.942 . . . . 0.0 110.349 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 8' ' ' VAL . 9.5 mt-10 -57.54 137.12 56.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.306 -0.871 . . . . 0.0 110.623 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.808 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.84 -22.12 7.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.119 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 78.33 -31.45 1.85 Allowed Glycine 0 N--CA 1.494 2.561 0 O-C-N 121.517 -0.74 . . . . 0.0 111.965 177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER 164.49 52.12 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 118.863 1.331 . . . . 0.0 110.74 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 25.2 tp10 -62.86 110.01 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.0 -1.063 . . . . 0.0 109.778 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -65.14 95.19 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 0.0 109.882 -179.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.796 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 1.0 OUTLIER -150.63 98.53 2.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.0 109.953 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' O ' ' O ' ' A' ' 57' ' ' TYR . 13.2 ttt180 -76.48 99.14 4.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.025 -1.047 . . . . 0.0 109.991 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -134.16 0.64 3.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.915 . . . . 0.0 110.508 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.733 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 171.67 168.74 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 109.982 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.545 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -150.38 50.29 0.54 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.52 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 12.4 m -62.1 -109.2 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.117 -1.226 . . . . 0.0 110.345 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.5 m -127.85 -15.35 4.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.693 -1.255 . . . . 0.0 111.012 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.87 -64.8 0.16 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' TRP . 29.9 tt0 -43.18 -61.82 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.252 -1.146 . . . . 0.0 110.522 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.733 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -76.73 -16.37 59.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 0.0 110.256 -179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -56.3 -50.82 70.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 110.182 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.641 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.0 m-80 -105.8 121.81 44.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.115 -0.991 . . . . 0.0 109.84 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.93 HG21 HD22 ' A' ' 38' ' ' LEU . 4.6 p -149.82 135.41 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.98 -1.075 . . . . 0.0 111.541 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.608 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 14.8 m170 -60.59 123.52 17.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.833 . . . . 0.0 109.86 178.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.537 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -65.45 -15.84 63.04 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.951 -1.093 . . . . 0.0 109.881 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.641 ' O ' HG22 ' A' ' 40' ' ' THR . 4.3 m -73.69 -61.41 1.85 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 0.0 111.481 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.608 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 5.9 p -76.4 -25.8 54.9 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.873 -1.142 . . . . 0.0 111.33 -178.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 33' ' ' VAL . 3.0 tp -75.64 -59.73 2.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.546 -1.347 . . . . 0.0 110.173 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.887 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.4 p -50.32 -43.02 53.63 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.465 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' SER . 10.7 t -75.0 -35.1 62.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.231 -0.918 . . . . 0.0 110.271 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.591 ' HE3' HD12 ' A' ' 38' ' ' LEU . 8.5 t90 -64.72 -57.86 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 109.602 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.8 pp -54.98 -26.35 36.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.119 -0.988 . . . . 0.0 109.92 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.715 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.1 m -66.82 -43.74 82.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.52 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.9 mt -77.22 -36.6 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.814 . . . . 0.0 109.623 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.9 t -81.73 -13.92 57.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.318 -0.864 . . . . 0.0 109.734 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER 62.1 82.04 0.18 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.43 -0.793 . . . . 0.0 110.746 179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.739 ' C ' HG23 ' A' ' 48' ' ' THR . 88.4 m-20 -133.7 -61.15 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 0.0 109.744 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.739 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 71.96 -9.51 0.97 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.944 -0.473 . . . . 0.0 111.5 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.02 143.06 22.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.784 -1.197 . . . . 0.0 110.412 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.509 ' N ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -69.26 124.07 22.85 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 109.78 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -78.71 -14.58 59.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.123 -0.986 . . . . 0.0 110.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.52 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 34.7 mm -67.32 -52.25 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 55' ' ' VAL . 26.2 p -108.15 -17.45 14.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 110.154 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 24.29 28.88 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 53' ' ' CYS . 94.5 t -93.87 146.31 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.079 -1.248 . . . . 0.0 109.904 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 73.5 t -82.65 138.01 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 0.0 110.324 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.613 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.1 m-85 -59.82 -48.73 80.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.192 -0.943 . . . . 0.0 110.969 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.1 t30 50.11 81.64 0.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.081 -1.012 . . . . 0.0 109.972 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 39' ' ' SER . 43.5 p -87.06 144.8 26.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.91 . . . . 0.0 110.22 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.442 ' HG2' ' OXT' ' A' ' 60' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.223 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptt? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.224 0.535 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -97.37 152.61 18.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.189 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.59 -146.57 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.331 -0.856 . . . . 0.0 110.328 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -103.19 -80.09 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -150.73 146.1 26.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 0.0 110.323 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 HG11 ' OE2' ' A' ' 15' ' ' GLU . 40.1 t -105.89 126.45 30.65 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.029 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 48.9 Cg_endo -73.33 161.27 43.14 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 123.881 1.464 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.69 HG13 ' N ' ' A' ' 15' ' ' GLU . 4.2 t -136.79 140.5 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -0.758 . . . . 0.0 110.652 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.56 ' N ' HD22 ' A' ' 16' ' ' LEU . 18.5 t -63.95 116.72 6.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.338 -0.852 . . . . 0.0 109.694 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.665 ' NE1' HD22 ' A' ' 30' ' ' LEU . 70.4 p-90 -67.44 -14.12 62.64 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.423 -0.798 . . . . 0.0 111.109 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.523 HG12 ' CH2' ' A' ' 10' ' ' TRP . 23.5 mt -75.47 -57.67 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.801 -1.187 . . . . 0.0 110.546 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.0 p -104.4 3.06 31.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.061 -1.025 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.57 57.8 2.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 110.329 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.6 ' C ' HG13 ' A' ' 8' ' ' VAL . 5.0 tp10 -136.12 128.68 30.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 8' ' ' VAL . 5.3 mt-10 -57.81 138.39 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.399 -0.813 . . . . 0.0 110.747 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.754 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -120.73 -27.24 5.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.54 -0.725 . . . . 0.0 109.159 179.035 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 79.46 -31.5 2.14 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.543 -0.723 . . . . 0.0 111.949 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 2.1 p30 163.38 46.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 118.87 1.335 . . . . 0.0 110.992 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.58 115.56 3.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.847 -1.158 . . . . 0.0 109.157 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -62.51 95.8 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.975 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.888 ' CZ ' HG22 ' A' ' 59' ' ' THR . 1.1 t80 -150.41 98.51 2.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.386 -0.821 . . . . 0.0 110.419 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -75.46 93.99 3.05 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 109.448 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . . . -122.98 -8.18 8.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.903 . . . . 0.0 110.913 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.607 ' HB3' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 174.46 168.0 0.24 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.974 -1.079 . . . . 0.0 110.319 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -110.96 -48.81 0.7 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER 37.85 -156.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.512 -0.993 . . . . 0.0 110.388 179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.3 m -111.4 -12.27 14.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.867 -1.146 . . . . 0.0 110.881 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 169.78 -65.51 0.17 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.523 -1.322 . . . . 0.0 110.044 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 28' ' ' GLY . 17.4 tt0 -41.91 -61.41 1.13 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.369 -1.077 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.665 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -77.33 -11.91 59.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -61.37 -34.25 75.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.912 . . . . 0.0 110.211 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 20.7 m-80 -121.09 120.52 35.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.253 -0.904 . . . . 0.0 109.577 179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.98 HG21 HD22 ' A' ' 38' ' ' LEU . 5.9 p -150.29 137.79 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.984 -1.073 . . . . 0.0 111.554 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.589 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m170 -61.85 123.27 17.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 0.0 109.973 178.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.3 ttt180 -66.57 -15.14 63.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.745 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.586 ' O ' HG22 ' A' ' 40' ' ' THR . 12.5 p -73.7 -61.37 1.86 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 0.0 111.152 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -78.19 -22.22 48.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.927 -1.108 . . . . 0.0 111.352 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.98 HD22 HG21 ' A' ' 33' ' ' VAL . 4.1 tp -78.48 -59.67 2.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.531 -1.356 . . . . 0.0 110.048 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.93 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.9 t -52.38 -34.89 49.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.96 . . . . 0.0 110.1 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.846 ' O ' HD12 ' A' ' 44' ' ' ILE . 14.7 t -83.53 -33.46 25.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.0 109.719 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 19.3 t90 -63.44 -57.78 9.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.93 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.0 pp -52.53 -27.77 17.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.212 -0.93 . . . . 0.0 109.925 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.504 ' N ' HD12 ' A' ' 42' ' ' LEU . 56.3 m -65.93 -44.72 84.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 40' ' ' THR . 2.2 mp -80.55 -22.81 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.403 -0.81 . . . . 0.0 109.63 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 10.0 t -91.35 -22.98 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.796 . . . . 0.0 109.548 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 70.55 69.75 0.2 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.449 -0.782 . . . . 0.0 110.345 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.764 ' C ' HG23 ' A' ' 48' ' ' THR . 15.9 m-20 -127.74 -60.34 1.17 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.058 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.764 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 72.73 -11.44 0.85 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.83 -0.544 . . . . 0.0 111.653 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.65 140.73 20.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.624 -1.297 . . . . 0.0 110.586 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.519 ' N ' ' O ' ' A' ' 55' ' ' VAL . 43.8 t -59.23 127.82 34.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.368 -0.832 . . . . 0.0 109.791 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.06 0.53 55.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG21 ' SG ' ' A' ' 26' ' ' CYS . 16.2 mm -83.19 -42.54 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.625 ' SG ' HG23 ' A' ' 55' ' ' VAL . 1.7 p -121.84 -14.93 7.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.2 43.64 4.61 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.625 HG23 ' SG ' ' A' ' 53' ' ' CYS . 9.0 t -113.3 135.0 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -1.186 . . . . 0.0 109.933 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 92.5 t -73.04 139.89 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 110.755 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.9 m-85 -65.76 -40.53 92.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.302 -0.874 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 50.35 70.33 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.394 -0.816 . . . . 0.0 110.146 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.888 HG22 ' CZ ' ' A' ' 21' ' ' PHE . 56.9 p -96.77 168.85 10.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.275 -0.891 . . . . 0.0 110.266 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.216 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mtm . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.169 0.509 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' ASP . 2.2 mm-40 -119.67 -60.07 1.75 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 110.375 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 55.7 154.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.437 0.637 . . . . 0.0 110.805 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 5' ' ' ASP . 67.5 mm-40 44.14 -170.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.346 -0.846 . . . . 0.0 110.519 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER 60.48 134.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.262 -0.899 . . . . 0.0 110.223 -179.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 15' ' ' GLU . 55.7 t -112.22 115.07 50.43 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.264 -0.897 . . . . 0.0 110.61 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.646 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.0 Cg_endo -77.18 163.16 30.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 124.028 1.541 . . . . 0.0 110.259 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.679 HG22 ' HG3' ' A' ' 15' ' ' GLU . 4.1 t -130.05 139.08 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.0 t -63.84 115.54 4.93 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.471 -0.768 . . . . 0.0 109.762 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.626 ' NE1' HD22 ' A' ' 30' ' ' LEU . 57.2 p-90 -61.75 -10.41 8.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.539 -0.726 . . . . 0.0 111.275 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 38' ' ' LEU . 3.5 mt -83.97 -57.88 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.932 -1.105 . . . . 0.0 111.107 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 26.4 p -101.31 3.57 40.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 0.0 110.685 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.13 50.0 10.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.107 -0.996 . . . . 0.0 109.843 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.562 ' C ' HG13 ' A' ' 8' ' ' VAL . 30.2 tt0 -130.75 134.28 46.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.343 -0.848 . . . . 0.0 110.05 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.679 ' HG3' HG22 ' A' ' 8' ' ' VAL . 24.2 mt-10 -63.68 146.51 53.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.956 . . . . 0.0 111.023 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.936 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -128.06 -19.69 3.93 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.385 0.612 . . . . 0.0 109.702 179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.85 -32.21 1.26 Allowed Glycine 0 N--CA 1.496 2.681 0 O-C-N 121.362 -0.837 . . . . 0.0 112.701 177.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 162.46 45.83 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.021 1.41 . . . . 0.0 110.6 -179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.475 ' CB ' HD12 ' A' ' 16' ' ' LEU . 18.5 tp10 -59.26 112.15 1.62 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.965 -1.084 . . . . 0.0 109.446 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 96.25 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -0.944 . . . . 0.0 109.738 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.3 t80 -149.29 99.13 2.89 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.421 -0.8 . . . . 0.0 109.863 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 57' ' ' TYR . 4.4 ttt180 -73.12 93.3 1.79 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 109.844 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -126.41 -12.8 6.15 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 110.589 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.6 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.5 OUTLIER -171.06 -158.69 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 110.841 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' HA2' ' OE1' ' A' ' 31' ' ' GLU . . . -173.87 31.41 0.1 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 75.2 m -56.31 -115.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.262 -1.14 . . . . 0.0 110.42 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.21 -15.25 4.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.502 -1.374 . . . . 0.0 111.727 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' GLU . . . 175.54 -82.4 0.07 OUTLIER Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.109 -1.519 . . . . 0.0 110.482 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 15.1 pt-20 -42.27 -47.18 4.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.176 -1.191 . . . . 0.0 110.414 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -88.86 -36.3 16.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 109.255 179.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 7.0 tp10 -53.9 -27.31 29.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.14 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 57.6 m-80 -123.01 121.35 35.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.319 179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.966 HG21 HD22 ' A' ' 38' ' ' LEU . 4.8 p -150.42 140.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.463 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 13.3 m80 -62.13 127.3 30.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.569 -0.707 . . . . 0.0 110.386 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.563 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -68.24 -14.85 63.29 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 110.058 179.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -61.27 1.99 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.3 -0.875 . . . . 0.0 111.167 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -77.32 -23.72 50.94 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.022 -1.049 . . . . 0.0 111.607 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.966 HD22 HG21 ' A' ' 33' ' ' VAL . 5.3 tp -76.54 -59.89 2.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.591 -1.318 . . . . 0.0 109.846 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.919 ' HA ' HD21 ' A' ' 42' ' ' LEU . 10.7 p -50.59 -36.5 35.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 7.5 t -82.24 -34.76 28.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.67 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.499 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.5 t90 -61.55 -57.98 9.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.0 109.682 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -52.76 -31.94 40.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.278 -0.889 . . . . 0.0 109.79 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.554 ' N ' HD12 ' A' ' 42' ' ' LEU . 85.4 m -67.07 -45.29 77.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.244 -0.91 . . . . 0.0 109.635 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.0 mt -76.57 -39.13 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.35 -0.844 . . . . 0.0 109.834 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -82.73 -6.65 59.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.917 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 68.13 66.81 0.34 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 110.269 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 89.7 m-20 -129.0 169.75 14.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.994 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.8 p -145.81 -37.62 0.26 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 110.457 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.67 135.81 21.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.163 -0.961 . . . . 0.0 110.576 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.545 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 5.0 t -48.85 149.71 1.72 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.168 -0.957 . . . . 0.0 109.481 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.77 -25.93 15.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.998 -1.064 . . . . 0.0 110.671 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 42.4 mt -54.76 -55.25 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.064 -1.023 . . . . 0.0 110.21 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.785 ' SG ' HG23 ' A' ' 55' ' ' VAL . 20.2 p -110.6 -17.33 13.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.027 -1.046 . . . . 0.0 110.089 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 85.33 38.13 9.27 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.988 -1.101 . . . . 0.0 110.929 178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.785 HG23 ' SG ' ' A' ' 53' ' ' CYS . 36.2 t -101.96 122.82 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.738 -1.448 . . . . 0.0 109.506 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 10.8 t -62.42 157.01 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.292 -0.88 . . . . 0.0 111.875 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 12.2 m-85 -79.99 -50.41 10.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 110.48 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.1 84.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.176 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.508 HG21 ' HA ' ' A' ' 39' ' ' SER . 17.5 p -103.02 127.0 50.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.899 . . . . 0.0 110.371 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.128 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptm . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.228 0.537 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -73.49 -175.61 2.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.912 . . . . 0.0 110.17 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' GLU . 4.4 m-20 -105.16 163.21 12.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.02 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 3' ' ' ASP . 20.2 pt-20 -56.18 -164.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.227 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.25 150.59 20.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.241 -0.912 . . . . 0.0 110.595 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.426 HG13 ' HA2' ' A' ' 17' ' ' GLY . 3.5 t -125.43 130.76 24.01 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.839 . . . . 0.0 109.944 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.572 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 50.2 Cg_endo -74.45 161.67 39.64 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.848 1.446 . . . . 0.0 111.5 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.833 HG22 ' HG3' ' A' ' 15' ' ' GLU . 7.9 t -131.88 142.0 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.619 -0.675 . . . . 0.0 110.272 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.492 ' HB2' ' ND1' ' A' ' 34' ' ' HIS . 30.2 t -64.92 123.11 18.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.174 -0.954 . . . . 0.0 110.038 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.709 ' CE2' HD22 ' A' ' 30' ' ' LEU . 65.9 p-90 -67.51 -17.1 64.54 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.614 -0.678 . . . . 0.0 111.893 -179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 6.3 mt -80.48 -57.54 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.661 -1.274 . . . . 0.0 111.247 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 26.2 p -99.35 -3.87 32.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.97 -1.081 . . . . 0.0 110.503 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.403 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER 63.67 54.79 1.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 0.0 110.683 179.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.587 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.6 tp10 -134.02 135.75 43.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 109.836 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -61.0 139.04 58.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.059 -1.026 . . . . 0.0 110.995 -179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.833 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -122.1 -25.94 4.82 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.51 -0.744 . . . . 0.0 109.311 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.601 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 82.14 -31.21 2.89 Favored Glycine 0 N--CA 1.494 2.501 0 O-C-N 121.374 -0.829 . . . . 0.0 111.323 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.601 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 0.3 OUTLIER 158.86 50.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 118.378 1.089 . . . . 0.0 110.572 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.79 112.8 1.97 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 109.479 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.6 95.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 110.012 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.938 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.4 t80 -149.87 103.18 3.2 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.379 -0.826 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 89.57 3.86 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.954 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.938 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -124.7 -11.42 7.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 110.599 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.783 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.6 OUTLIER 174.06 167.37 0.21 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.078 -1.014 . . . . 0.0 110.257 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.526 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -152.32 48.95 0.54 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 8.9 m -53.74 -102.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.283 -1.128 . . . . 0.0 110.106 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.0 m -127.36 -15.15 5.2 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.039 -1.038 . . . . 0.0 110.644 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 31' ' ' GLU . . . 165.78 -62.39 0.23 Allowed Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 20.4 pt-20 -48.73 -45.91 40.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -1.222 . . . . 0.0 110.623 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.783 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -85.0 -24.26 28.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.0 109.606 179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA2' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -50.71 -50.48 55.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.374 -0.829 . . . . 0.0 110.557 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.826 ' HB3' HD11 ' A' ' 16' ' ' LEU . 15.2 m-80 -103.34 119.97 39.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.06 -1.025 . . . . 0.0 110.578 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 38' ' ' LEU . 1.7 p -152.56 136.59 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.26 -0.9 . . . . 0.0 110.86 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 54.1 m80 -63.53 124.57 21.68 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.846 -1.159 . . . . 0.0 109.538 178.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.584 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 23.0 ttp85 -62.24 -15.01 44.32 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.904 -1.122 . . . . 0.0 109.447 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.9 p -69.55 -56.68 6.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.47 -0.769 . . . . 0.0 111.035 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 15.9 p -80.25 -30.5 38.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.986 -1.071 . . . . 0.0 111.653 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.771 HD23 ' CE2' ' A' ' 21' ' ' PHE . 4.2 tp -73.29 -59.3 2.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.57 -1.331 . . . . 0.0 110.011 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.864 ' HA ' HD21 ' A' ' 42' ' ' LEU . 17.1 t -51.5 -35.89 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.296 -0.877 . . . . 0.0 110.326 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.422 ' O ' ' HB ' ' A' ' 43' ' ' THR . 1.2 t -83.99 -32.79 24.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.935 . . . . 0.0 110.221 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.467 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 12.0 t90 -65.3 -57.92 7.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.458 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.7 pp -53.73 -31.2 47.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 0.0 109.776 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.636 ' N ' HD12 ' A' ' 42' ' ' LEU . 2.1 m -63.17 -44.37 95.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.1 mt -75.35 -39.87 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.519 -0.738 . . . . 0.0 109.575 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 2.2 t -78.07 -9.12 59.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.529 -0.732 . . . . 0.0 109.908 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.7 OUTLIER 70.65 60.4 0.21 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.402 -0.811 . . . . 0.0 110.457 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 29.7 m-20 -133.91 141.95 47.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.783 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.511 ' C ' ' CD2' ' A' ' 57' ' ' TYR . 35.0 p -119.73 -15.81 8.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.0 110.259 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -147.15 141.36 26.19 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.935 . . . . 0.0 110.376 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -59.85 121.92 12.96 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 0.0 110.293 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.54 -4.06 49.69 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.197 -0.939 . . . . 0.0 110.13 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 43.3 mm -78.76 -44.63 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 0.0 110.036 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 55' ' ' VAL . 31.9 p -115.19 -17.51 11.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.879 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.96 25.3 25.05 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' SG ' ' A' ' 53' ' ' CYS . 97.9 t -98.58 143.75 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.895 -1.356 . . . . 0.0 110.03 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 28.0 t -80.47 141.87 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.098 -1.001 . . . . 0.0 110.272 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.659 ' CD2' HD22 ' A' ' 42' ' ' LEU . 24.2 m-85 -63.04 -41.94 99.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.646 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.73 77.45 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 110.1 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.45 ' HB ' ' OG ' ' A' ' 39' ' ' SER . 13.8 p -109.07 146.89 33.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.173 -0.954 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 53.3 ttt-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.104 179.94 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.245 0.545 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 3.2 mt-10 -155.0 -83.95 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 110.309 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 2' ' ' GLU . 4.8 m-20 59.63 -170.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.338 -0.851 . . . . 0.0 109.875 -179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.41 -140.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.098 -1.001 . . . . 0.0 110.12 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -107.44 107.32 18.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 110.556 -179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG1' ' HD2' ' A' ' 7' ' ' PRO . 13.8 t -77.89 145.38 70.04 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.731 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.583 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 48.4 Cg_endo -70.71 157.78 57.56 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.924 1.486 . . . . 0.0 110.327 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.1 t -135.17 136.32 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.396 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.57 ' N ' HD22 ' A' ' 16' ' ' LEU . 16.1 t -68.98 113.22 6.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.625 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.551 ' HB3' ' CG ' ' A' ' 29' ' ' GLU . 67.7 p-90 -59.21 -16.05 18.56 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.549 -0.72 . . . . 0.0 111.598 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.529 HG12 ' CE2' ' A' ' 10' ' ' TRP . 5.3 mt -77.1 -56.92 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.993 -1.067 . . . . 0.0 111.202 -179.101 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 25.0 p -100.62 3.12 42.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.114 -0.991 . . . . 0.0 110.388 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 m120 56.23 61.58 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.385 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.1 tp10 -148.65 138.1 21.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 110.196 179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 7' ' ' PRO . 2.9 mt-10 -59.24 139.27 57.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.513 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.747 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.5 -14.85 9.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 109.518 179.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 85.53 -30.42 4.14 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.681 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 20.4 t-20 133.11 57.24 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -59.3 123.09 15.57 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.944 -1.098 . . . . 0.0 109.368 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.86 95.67 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 0.0 109.957 -179.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.8 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -150.28 98.72 2.71 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.488 -0.757 . . . . 0.0 110.102 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 58' ' ' ASN . 15.3 mtt-85 -73.32 93.95 1.97 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.065 -1.022 . . . . 0.0 109.624 179.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.8 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -115.47 -12.21 11.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.138 -0.976 . . . . 0.0 110.28 -179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.694 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 173.24 162.78 0.14 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.807 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -125.54 56.67 0.7 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 1.1 m -75.56 -163.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -1.157 . . . . 0.0 110.161 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.35 26.95 5.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.069 -1.019 . . . . 0.0 110.802 -179.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -144.95 -131.41 2.37 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 10' ' ' TRP . 23.2 pt-20 -70.55 -38.34 74.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.529 -0.983 . . . . 0.0 110.772 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.694 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -51.55 -27.79 11.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 111.314 -178.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -54.21 -52.16 62.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.062 -1.023 . . . . 0.0 110.199 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.691 ' HB3' HD11 ' A' ' 16' ' ' LEU . 69.7 m-20 -102.17 121.18 41.72 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.088 -1.007 . . . . 0.0 109.843 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.815 HG21 HD22 ' A' ' 38' ' ' LEU . 3.3 p -149.83 140.21 16.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 C-N-CA 119.299 -0.961 . . . . 0.0 110.983 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 10.7 m170 -63.68 127.69 32.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.541 -0.724 . . . . 0.0 110.125 179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 45.4 ttp85 -68.59 -16.81 63.98 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.063 -1.023 . . . . 0.0 109.501 179.041 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.6 t -72.52 -60.02 2.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 111.126 -179.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -79.55 -21.41 45.19 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.0 111.417 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 33' ' ' VAL . 3.4 tp -81.09 -60.24 2.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.612 -1.305 . . . . 0.0 110.13 179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.879 ' HA ' HD21 ' A' ' 42' ' ' LEU . 30.3 p -50.21 -36.16 29.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.268 -0.895 . . . . 0.0 109.941 179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.531 HG23 ' N ' ' A' ' 41' ' ' TRP . 8.2 t -82.33 -39.96 22.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.361 -0.837 . . . . 0.0 110.094 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.531 ' N ' HG23 ' A' ' 40' ' ' THR . 17.1 t90 -56.46 -57.55 11.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.115 -0.991 . . . . 0.0 109.853 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.985 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.7 pp -54.01 -35.37 61.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.129 -0.982 . . . . 0.0 110.353 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.588 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.6 m -58.57 -36.23 73.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.126 -0.984 . . . . 0.0 109.632 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -80.06 -47.57 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.396 -0.815 . . . . 0.0 109.795 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -73.4 -16.64 61.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.223 -0.923 . . . . 0.0 110.026 179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.6 OUTLIER 69.73 73.21 0.24 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.196 -0.94 . . . . 0.0 110.44 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.755 ' C ' HG23 ' A' ' 48' ' ' THR . 5.7 m-20 -128.27 -63.32 1.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.755 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 70.74 -4.69 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.928 -0.483 . . . . 0.0 111.038 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.55 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -153.58 142.4 21.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.841 -1.162 . . . . 0.0 110.757 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.503 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 32.7 t -61.9 152.6 31.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.356 -0.84 . . . . 0.0 109.779 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -98.44 -8.93 25.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 29.5 mm -86.52 -47.51 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.111 -0.993 . . . . 0.0 110.553 -179.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.65 ' SG ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -109.79 -11.1 14.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.21 -0.931 . . . . 0.0 110.322 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.53 1.45 88.83 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG23 ' SG ' ' A' ' 53' ' ' CYS . 51.9 t -65.75 135.16 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -1.212 . . . . 0.0 109.764 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 94.7 t -75.27 151.13 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 110.061 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.985 ' CD2' HD22 ' A' ' 42' ' ' LEU . 18.2 m-85 -70.67 62.17 0.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.307 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.462 ' O ' ' O ' ' A' ' 22' ' ' ARG . 5.0 t-20 -44.19 109.59 0.16 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 57' ' ' TYR . 30.8 p -95.26 120.2 35.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 110.013 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.145 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.316 0.579 . . . . 0.0 110.187 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -123.9 -179.42 4.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.17 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -176.8 -74.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 110.464 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.3 -46.33 0.46 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 110.495 -179.548 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.69 142.75 57.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.157 -0.965 . . . . 0.0 110.873 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 17' ' ' GLY . 63.6 t -133.5 133.04 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.453 -0.78 . . . . 0.0 109.401 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 49.4 Cg_endo -73.18 161.04 44.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.849 1.447 . . . . 0.0 111.112 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.819 HG22 ' HG3' ' A' ' 15' ' ' GLU . 3.9 t -134.16 146.49 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.509 -0.744 . . . . 0.0 110.458 -179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.661 ' SG ' HG23 ' A' ' 33' ' ' VAL . 15.1 t -71.92 122.88 21.57 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.285 -0.884 . . . . 0.0 109.969 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.685 ' CE2' HD22 ' A' ' 30' ' ' LEU . 67.5 p-90 -66.23 -20.44 66.12 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 111.405 -179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.6 HG12 ' CH2' ' A' ' 10' ' ' TRP . 31.9 mt -75.69 -57.76 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.942 -1.099 . . . . 0.0 111.656 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 18.7 p -104.14 3.8 33.4 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 111.024 -179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 0.9 OUTLIER 58.17 62.78 1.92 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.11 -0.994 . . . . 0.0 110.622 179.564 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 8' ' ' VAL . 14.4 tt0 -141.2 132.09 25.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.152 -0.968 . . . . 0.0 109.87 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.819 ' HG3' HG22 ' A' ' 8' ' ' VAL . 7.4 mt-10 -63.03 136.02 57.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -0.996 . . . . 0.0 110.644 -179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.811 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -112.0 -33.2 6.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 108.726 178.645 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 18' ' ' ASN . . . 82.38 -30.26 3.09 Favored Glycine 0 N--CA 1.493 2.484 0 O-C-N 121.395 -0.816 . . . . 0.0 112.354 177.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -178.68 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.543 -1.563 . . . . 0.0 111.75 -179.477 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 34' ' ' HIS . 2.2 tp10 -66.07 103.51 0.97 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.762 -1.211 . . . . 0.0 109.63 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.49 97.35 2.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.91 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 1.1 t80 -148.48 99.93 3.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 110.047 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 57' ' ' TYR . 8.4 tpt180 -73.53 92.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.91 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.51 -6.26 9.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.424 -0.797 . . . . 0.0 110.175 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.0 OUTLIER 170.29 166.3 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.21 -0.931 . . . . 0.0 110.074 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -111.3 -48.26 0.71 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 40.28 -156.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.456 -1.026 . . . . 0.0 110.682 179.425 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 m -106.42 -14.81 14.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.005 . . . . 0.0 111.121 -179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.13 -71.42 0.13 Allowed Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.295 -1.431 . . . . 0.0 110.689 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.554 ' HG3' ' N ' ' A' ' 30' ' ' LEU . 7.4 pt-20 -41.42 -47.88 3.7 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -1.198 . . . . 0.0 110.965 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.685 HD22 ' CE2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -85.44 -8.28 58.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.895 -1.128 . . . . 0.0 109.787 179.856 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -68.7 -31.77 71.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.408 -0.807 . . . . 0.0 110.58 179.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 9.0 m-80 -124.84 120.07 30.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.948 -1.095 . . . . 0.0 109.984 179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.687 HG21 ' HB2' ' A' ' 38' ' ' LEU . 2.6 p -151.65 142.32 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.951 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 47.4 m80 -64.56 121.74 15.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.03 -1.044 . . . . 0.0 109.801 178.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 3.8 ttt180 -58.68 -15.0 9.87 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.929 179.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.3 t -76.39 -50.54 13.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.264 -0.898 . . . . 0.0 111.478 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 27.5 p -81.07 -33.41 33.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.703 -1.248 . . . . 0.0 111.792 -178.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.733 HD23 ' CE2' ' A' ' 21' ' ' PHE . 3.2 tp -71.39 -57.54 4.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.62 -1.3 . . . . 0.0 110.27 -179.564 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.87 ' HA ' HD21 ' A' ' 42' ' ' LEU . 12.3 t -53.52 -33.67 55.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.512 ' O ' HD12 ' A' ' 44' ' ' ILE . 1.6 t -86.89 -30.09 21.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.993 -1.067 . . . . 0.0 110.283 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.53 ' HE3' HD12 ' A' ' 38' ' ' LEU . 5.8 t90 -66.72 -57.88 6.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.4 pp -51.08 -27.89 9.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.945 179.506 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.602 ' N ' HD12 ' A' ' 42' ' ' LEU . 8.3 m -67.06 -44.75 79.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.711 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 40' ' ' THR . 1.3 mp -73.46 -37.15 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.676 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 2.2 t -89.28 9.84 24.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 110.066 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 10.9 ttt85 54.88 70.89 0.57 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 110.252 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.529 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . 97.2 m-20 -135.74 141.05 44.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.944 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.9 p -125.13 -13.07 6.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.23 152.95 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.612 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 45.2 t -64.02 130.32 43.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.376 -0.828 . . . . 0.0 110.217 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -88.66 -5.34 58.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.893 . . . . 0.0 110.292 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.674 HG21 ' SG ' ' A' ' 26' ' ' CYS . 17.6 mm -77.61 -42.86 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.878 . . . . 0.0 110.07 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 55' ' ' VAL . 2.8 p -121.87 -17.16 7.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.269 -0.894 . . . . 0.0 110.247 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 42.53 4.85 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' CG1' ' HA ' ' A' ' 24' ' ' CYS . 36.0 t -113.99 126.55 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.12 -1.224 . . . . 0.0 110.028 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 72.4 t -63.1 147.54 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.1 -1.0 . . . . 0.0 110.6 -179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.736 ' CD2' HD22 ' A' ' 42' ' ' LEU . 23.3 m-85 -68.28 -38.76 82.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 0.0 110.381 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.469 ' H ' HG12 ' A' ' 56' ' ' VAL . 1.2 t30 49.39 97.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.43 -0.794 . . . . 0.0 110.253 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.723 HG22 ' CE1' ' A' ' 21' ' ' PHE . 42.7 p -130.34 137.53 49.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.332 -0.855 . . . . 0.0 110.126 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 117.999 -1.001 . . . . 0.0 110.109 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.283 0.563 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -53.23 -70.74 0.08 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -0.863 . . . . 0.0 110.197 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.32 -157.11 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 110.234 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.59 165.36 13.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 0.0 110.141 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.15 170.11 17.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 HG12 ' HG2' ' A' ' 15' ' ' GLU . 54.5 t -101.84 138.1 19.72 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 110.353 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.547 ' O ' HD23 ' A' ' 16' ' ' LEU . 48.3 Cg_endo -72.75 161.84 42.79 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.087 1.572 . . . . 0.0 110.093 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.577 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.4 t -138.43 140.46 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.675 179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 31.6 t -68.19 120.61 14.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.409 -0.807 . . . . 0.0 109.64 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.756 ' NE1' HD22 ' A' ' 30' ' ' LEU . 68.7 p-90 -69.45 -8.71 49.2 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.35 -0.843 . . . . 0.0 111.244 -179.04 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 38' ' ' LEU . 6.9 mt -83.84 -55.13 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.984 -1.072 . . . . 0.0 111.024 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 27.4 p -101.78 -3.64 27.73 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.06 -1.025 . . . . 0.0 110.762 -179.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 1.2 t-20 65.01 55.0 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 110.158 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.577 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER -140.44 132.82 28.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.814 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.57 ' N ' HG13 ' A' ' 8' ' ' VAL . 24.8 mt-10 -59.24 147.2 36.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.196 -0.94 . . . . 0.0 110.473 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.914 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.3 pt? -130.69 -14.96 3.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.281 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 81.35 -31.37 2.65 Favored Glycine 0 N--CA 1.495 2.609 0 O-C-N 121.175 -0.953 . . . . 0.0 111.703 178.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.667 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 9.7 t30 143.1 63.32 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.636 0 CA-C-N 117.946 0.873 . . . . 0.0 109.339 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HB2' HD12 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.15 117.62 8.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.828 -1.17 . . . . 0.0 109.536 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.1 ttp85 -62.42 95.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.098 -1.002 . . . . 0.0 109.808 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.93 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.8 OUTLIER -149.76 99.02 2.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.579 -179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -73.25 89.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.874 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.93 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.27 -1.39 15.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 110.458 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.2 OUTLIER 179.72 -157.17 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 110.97 179.896 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.66 24.22 0.2 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 57.9 m -54.92 -164.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 0.0 110.353 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -126.68 25.91 6.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.362 -0.836 . . . . 0.0 110.319 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.13 -155.07 6.4 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 18.1 pt-20 -43.64 -42.14 5.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.35 -1.088 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.756 HD22 ' NE1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -49.47 -21.92 1.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.125 -0.985 . . . . 0.0 110.382 -179.057 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 3.2 mt-10 -64.05 -46.38 84.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 0.0 109.216 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -104.8 121.01 42.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.323 -0.861 . . . . 0.0 109.1 178.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.008 HG21 HD22 ' A' ' 38' ' ' LEU . 4.7 p -149.33 139.02 15.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 120.97 -1.081 . . . . 0.0 111.213 -179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.584 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 6.1 m170 -60.83 125.36 23.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.521 -0.737 . . . . 0.0 110.091 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.55 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -70.08 -15.67 63.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.0 110.261 179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -76.16 -57.05 4.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 111.013 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.3 p -81.19 -24.5 37.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.994 -1.066 . . . . 0.0 111.566 -179.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.008 HD22 HG21 ' A' ' 33' ' ' VAL . 4.3 tp -75.01 -59.49 2.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.577 -1.327 . . . . 0.0 110.103 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.935 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.3 t -51.44 -42.52 61.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.2 t -75.76 -39.1 57.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.529 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 25.1 t90 -58.19 -57.99 10.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.985 . . . . 0.0 109.662 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.935 HD21 ' HA ' ' A' ' 39' ' ' SER . 2.9 pp -54.15 -27.25 32.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.952 . . . . 0.0 109.767 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.6 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.5 m -74.09 -43.32 58.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 0.0 109.655 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.6 mt -73.24 -30.0 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.463 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 41.3 t -95.72 -12.05 26.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.266 -0.897 . . . . 0.0 109.704 179.38 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.9 OUTLIER 68.41 74.6 0.27 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 110.404 179.909 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.774 ' C ' HG23 ' A' ' 48' ' ' THR . 2.6 m-20 -119.6 -58.24 1.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.324 -0.86 . . . . 0.0 109.744 179.529 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.774 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 73.23 -42.9 0.54 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.788 -0.57 . . . . 0.0 110.981 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -141.56 134.28 28.62 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.867 -1.146 . . . . 0.0 110.814 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.538 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 13.6 t -53.12 149.78 6.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.561 -0.712 . . . . 0.0 109.952 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HG3' ' N ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -97.68 -24.15 15.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.215 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.499 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.5 mm -53.38 -49.58 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.631 ' SG ' HG23 ' A' ' 55' ' ' VAL . 5.7 p -121.58 -17.93 7.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.149 -0.969 . . . . 0.0 110.181 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 50' ' ' CYS . . . 86.84 50.99 3.53 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.05 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.631 HG23 ' SG ' ' A' ' 53' ' ' CYS . 10.7 t -117.37 117.52 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.925 -1.338 . . . . 0.0 109.362 178.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 11.5 t -53.6 151.74 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.628 -179.318 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.704 ' CD2' HD22 ' A' ' 42' ' ' LEU . 57.4 m-85 -77.14 -29.53 54.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.443 -0.786 . . . . 0.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 57' ' ' TYR . 2.5 t-20 46.42 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 0.0 109.969 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.74 HG22 ' CE1' ' A' ' 21' ' ' PHE . 47.4 p -124.09 141.87 51.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.15 -0.969 . . . . 0.0 110.303 -179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' O ' ' CG ' ' A' ' 60' ' ' ARG . 14.4 ptm180 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.128 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.225 0.536 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.574 ' CG ' ' N ' ' A' ' 3' ' ' ASP . 2.4 pt-20 -145.23 -48.14 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 110.03 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' N ' ' CG ' ' A' ' 2' ' ' GLU . 0.4 OUTLIER 57.81 161.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.488 -0.757 . . . . 0.0 110.375 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 3' ' ' ASP . 29.2 mt-10 -157.14 -85.72 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.337 -0.852 . . . . 0.0 110.019 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.33 -178.29 3.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.907 . . . . 0.0 109.924 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.707 HG13 ' HD2' ' A' ' 7' ' ' PRO . 69.9 t -107.19 147.82 35.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.116 -0.99 . . . . 0.0 109.97 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.707 ' HD2' HG13 ' A' ' 6' ' ' VAL . 56.3 Cg_endo -70.2 144.12 50.73 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.724 1.381 . . . . 0.0 110.071 -179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 15' ' ' GLU . 1.8 t -105.31 134.41 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.513 0.673 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB2' HD12 ' A' ' 16' ' ' LEU . 1.2 t -63.43 109.78 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.528 -0.732 . . . . 0.0 109.034 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.658 ' CE2' HD22 ' A' ' 30' ' ' LEU . 56.9 p-90 -53.1 -14.07 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.629 -0.669 . . . . 0.0 112.143 -178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 38' ' ' LEU . 4.2 mt -81.26 -57.23 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.728 -1.232 . . . . 0.0 111.585 -179.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 29.6 p -102.44 -3.88 26.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.914 -1.116 . . . . 0.0 110.745 -179.265 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 3.3 t-20 68.88 48.79 0.71 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.18 -0.95 . . . . 0.0 110.63 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' N ' HG12 ' A' ' 8' ' ' VAL . 2.8 tp10 -138.49 131.13 29.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.397 -0.814 . . . . 0.0 109.67 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -63.02 142.14 58.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.083 . . . . 0.0 111.062 -179.385 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.945 ' N ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -104.43 -1.5 26.68 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.959 179.111 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 75.43 -31.96 1.17 Allowed Glycine 0 N--CA 1.496 2.642 0 O-C-N 121.466 -0.771 . . . . 0.0 111.928 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.617 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 3.6 t-20 151.08 40.04 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 118.486 1.143 . . . . 0.0 108.985 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -59.58 123.92 18.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.586 -1.321 . . . . 0.0 110.429 -179.613 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.73 97.62 3.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.344 -0.847 . . . . 0.0 110.042 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.918 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.1 t80 -146.86 100.93 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.908 . . . . 0.0 110.009 -179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 57' ' ' TYR . 0.9 OUTLIER -73.83 99.06 3.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.867 . . . . 0.0 110.179 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -131.82 -9.62 3.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.872 . . . . 0.0 110.787 -179.65 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.903 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.5 OUTLIER 172.24 167.25 0.11 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.039 -1.038 . . . . 0.0 110.097 -179.966 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 52.95 0.51 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.472 ' SG ' ' CG2' ' A' ' 52' ' ' ILE . 3.4 m -66.09 -101.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.368 -1.077 . . . . 0.0 110.693 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.1 p -121.16 -15.42 8.19 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 110.735 -179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 157.4 -61.0 0.33 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.565 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 7.8 pt-20 -48.01 -46.25 32.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.0 109.965 -179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.903 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -87.15 -31.55 20.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.276 -0.89 . . . . 0.0 109.3 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 1.1 tm-20 -48.88 -42.21 35.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.381 -0.824 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 27.3 m-80 -112.53 121.7 45.56 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.498 -0.751 . . . . 0.0 109.809 179.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.738 HG21 HD22 ' A' ' 38' ' ' LEU . 2.4 p -150.12 146.86 16.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.075 . . . . 0.0 111.086 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 12.9 m80 -66.1 126.66 29.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.494 -0.754 . . . . 0.0 110.455 179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.559 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 18.3 ttt-85 -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 109.54 178.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -75.32 -61.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.81 . . . . 0.0 111.259 -179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -78.43 -22.98 46.88 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.893 -1.129 . . . . 0.0 111.753 -178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.918 HD23 ' CE2' ' A' ' 21' ' ' PHE . 7.7 tp -78.03 -60.36 2.4 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.369 -1.457 . . . . 0.0 110.216 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.903 ' HA ' HD21 ' A' ' 42' ' ' LEU . 31.1 t -50.78 -33.33 22.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.392 -0.818 . . . . 0.0 109.898 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.407 ' O ' HG13 ' A' ' 44' ' ' ILE . 38.6 p -86.36 -37.92 17.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 0.0 109.841 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.542 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 20.4 t90 -57.38 -58.13 9.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.467 179.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.904 HD22 ' CD2' ' A' ' 57' ' ' TYR . 1.8 pp -51.6 -39.51 58.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.113 -0.992 . . . . 0.0 109.801 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.738 ' N ' HD12 ' A' ' 42' ' ' LEU . 3.1 m -61.76 -44.3 97.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 109.455 179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 40' ' ' THR . 57.8 mt -72.19 -47.19 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.752 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.519 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 0.8 OUTLIER -76.7 -6.95 54.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 109.808 179.512 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.1 OUTLIER 71.08 62.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.682 179.695 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' LEU . 15.1 m-20 -126.67 165.75 18.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.599 179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.532 ' C ' ' CE2' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -135.14 -37.6 0.79 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.068 -1.02 . . . . 0.0 110.536 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -145.15 143.28 30.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.136 -0.977 . . . . 0.0 110.515 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 52' ' ' ILE . 42.7 t -48.73 123.25 6.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.796 179.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -84.04 1.22 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.472 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.3 mm -88.76 -40.83 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 110.244 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.637 ' SG ' HG23 ' A' ' 55' ' ' VAL . 30.5 p -115.28 -17.5 11.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.207 -0.933 . . . . 0.0 110.261 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.51 29.61 13.66 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.992 -1.099 . . . . 0.0 110.404 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.637 HG23 ' SG ' ' A' ' 53' ' ' CYS . 96.2 t -103.17 144.37 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.914 -1.345 . . . . 0.0 110.089 179.52 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.532 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 21.8 t -86.73 148.07 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 0.0 110.478 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.904 ' CD2' HD22 ' A' ' 42' ' ' LEU . 13.7 m-85 -65.24 -46.06 82.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 110.129 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 47.71 78.72 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.505 -0.747 . . . . 0.0 110.399 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.612 HG22 ' CE1' ' A' ' 21' ' ' PHE . 30.7 p -106.0 117.63 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.239 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.272 0.558 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -91.39 153.14 20.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 110.075 179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -50.36 168.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.192 -0.942 . . . . 0.0 110.381 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -43.85 154.34 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.863 . . . . 0.0 110.171 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.28 177.25 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.712 HG12 ' HG2' ' A' ' 15' ' ' GLU . 10.4 t -121.89 110.28 33.34 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.878 . . . . 0.0 110.114 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.567 ' HB2' ' CB ' ' A' ' 32' ' ' ASN . 47.7 Cg_endo -71.66 162.42 42.18 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.959 1.505 . . . . 0.0 110.291 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 14' ' ' GLU . 2.5 t -121.74 139.26 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.895 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 16' ' ' LEU . 7.8 t -69.02 118.91 12.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 109.814 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.588 ' CZ2' HG12 ' A' ' 11' ' ' ILE . 67.2 p-90 -60.92 -18.31 55.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.519 -0.738 . . . . 0.0 111.473 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.588 HG12 ' CZ2' ' A' ' 10' ' ' TRP . 10.8 mt -75.57 -57.23 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.976 -1.078 . . . . 0.0 111.318 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 24.8 p -102.22 3.66 38.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.021 -1.049 . . . . 0.0 110.854 -179.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 55.77 53.83 8.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.984 . . . . 0.0 110.037 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.579 ' C ' HG13 ' A' ' 8' ' ' VAL . 34.8 tt0 -140.76 137.56 33.49 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 110.03 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.712 ' HG2' HG12 ' A' ' 6' ' ' VAL . 7.4 mt-10 -56.91 140.49 48.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 0.0 109.81 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -118.96 5.5 11.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.194 -0.941 . . . . 0.0 110.745 -179.316 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.589 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 67.99 13.23 63.92 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 6.7 t30 80.41 53.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.67 -0.9 . . . . 0.0 109.171 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.64 ' H ' HD12 ' A' ' 16' ' ' LEU . 1.1 tm-20 -58.53 105.24 0.28 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.745 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 mtt-85 -58.94 96.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.071 -178.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.826 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -148.95 101.6 3.19 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 57' ' ' TYR . 9.3 mmt180 -72.6 101.88 3.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 0.0 110.062 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.826 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -120.69 2.42 10.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.464 -0.772 . . . . 0.0 110.524 -179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 50' ' ' CYS . 0.4 OUTLIER 177.72 -156.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 110.651 -179.783 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' CYS . . . -162.18 24.18 0.22 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 72.3 m -53.51 -166.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 110.345 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -128.59 29.21 5.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.151 -0.968 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -152.81 -125.18 1.08 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.895 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 21.7 pt-20 -65.7 -42.62 90.96 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.377 -1.072 . . . . 0.0 111.373 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -54.59 -16.06 2.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 110.879 -178.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -61.54 -60.01 4.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.017 -1.052 . . . . 0.0 109.953 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.567 ' CB ' ' HB2' ' A' ' 7' ' ' PRO . 28.7 m-20 -95.56 124.93 39.82 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.057 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -147.95 143.24 19.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.986 -1.071 . . . . 0.0 111.458 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.599 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 1.9 m80 -65.76 122.0 16.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.712 -0.618 . . . . 0.0 110.259 179.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.546 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -65.57 -15.26 62.54 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.03 -1.044 . . . . 0.0 109.609 179.209 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.489 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 36.7 p -77.61 -61.75 1.89 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.535 -0.728 . . . . 0.0 111.265 -179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 2.2 p -75.6 -21.32 57.9 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.97 -1.081 . . . . 0.0 111.144 -179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 33' ' ' VAL . 5.2 tp -80.51 -59.86 2.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.732 -1.23 . . . . 0.0 109.855 179.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.908 ' HA ' HD21 ' A' ' 42' ' ' LEU . 8.5 t -50.36 -33.08 19.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -0.862 . . . . 0.0 109.809 179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.627 ' O ' HD12 ' A' ' 44' ' ' ILE . 38.0 p -84.18 -44.02 14.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.568 ' CZ2' ' ND2' ' A' ' 47' ' ' ASN . 23.2 t90 -54.34 -57.64 10.48 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.372 -0.83 . . . . 0.0 109.746 179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.908 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.2 pp -55.1 -30.26 59.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.177 -0.952 . . . . 0.0 109.752 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.637 ' N ' HD12 ' A' ' 42' ' ' LEU . 42.1 m -72.74 -43.16 63.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 109.681 179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 40' ' ' THR . 5.9 mt -73.11 -43.54 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.284 -0.885 . . . . 0.0 109.597 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -85.68 0.36 52.93 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.383 -0.823 . . . . 0.0 109.86 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 11.5 ttt180 53.93 72.37 0.45 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.355 -0.84 . . . . 0.0 110.616 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.762 ' C ' HG23 ' A' ' 48' ' ' THR . 30.1 m-20 -110.81 -60.07 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.973 . . . . 0.0 109.863 179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.762 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.3 -33.61 0.24 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.9 -0.5 . . . . 0.0 111.097 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -151.13 140.78 21.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.691 -1.256 . . . . 0.0 110.697 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.536 ' CB ' ' SG ' ' A' ' 24' ' ' CYS . 8.3 t -59.85 152.7 22.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.584 -0.698 . . . . 0.0 110.236 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -97.76 -26.78 14.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.323 -0.861 . . . . 0.0 110.373 -179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 19.1 mm -52.39 -48.81 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 0.0 110.413 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.55 ' SG ' HG23 ' A' ' 55' ' ' VAL . 7.7 p -121.17 -17.91 7.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.107 -0.996 . . . . 0.0 110.6 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.13 37.35 7.21 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.884 -1.15 . . . . 0.0 110.786 179.141 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.9 t -103.93 127.63 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.962 -1.316 . . . . 0.0 109.697 179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 21.9 t -65.82 152.15 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.866 -179.389 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 52.6 m-85 -73.79 -51.53 16.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 110.223 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.486 ' CB ' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER 67.56 111.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.256 -0.903 . . . . 0.0 110.428 179.741 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.2 p -135.2 118.21 16.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 110.082 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.14 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.256 0.551 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -121.4 -49.86 2.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.183 -0.948 . . . . 0.0 110.342 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 4' ' ' GLU . 8.6 t0 -102.37 -56.33 2.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 0.0 110.405 -179.762 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 3' ' ' ASP . 4.7 pt-20 -37.0 138.56 0.26 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.268 0.556 . . . . 0.0 110.832 179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 4' ' ' GLU . 30.0 t70 54.52 168.04 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.32 -0.862 . . . . 0.0 110.479 179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 ' CG1' ' HG2' ' A' ' 15' ' ' GLU . 99.2 t -127.36 109.26 21.2 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.222 -0.924 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.606 ' CB ' ' ND2' ' A' ' 32' ' ' ASN . 48.6 Cg_endo -72.55 162.02 42.51 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.08 1.568 . . . . 0.0 110.871 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.1 t -121.06 144.81 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.653 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' HG23 ' A' ' 33' ' ' VAL . 11.7 t -65.73 119.07 10.54 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.283 -0.885 . . . . 0.0 109.658 179.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CE2' ' CG1' ' A' ' 11' ' ' ILE . 60.0 p-90 -59.9 -18.11 42.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.397 -0.815 . . . . 0.0 111.672 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.62 ' CG1' ' CE2' ' A' ' 10' ' ' TRP . 10.0 mt -79.86 -57.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 120.918 -1.114 . . . . 0.0 111.892 -178.76 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.4 p -102.72 3.68 37.25 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.031 -1.043 . . . . 0.0 110.788 -179.185 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 27.9 m120 57.91 48.24 13.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.273 -0.892 . . . . 0.0 110.539 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.614 ' C ' HG13 ' A' ' 8' ' ' VAL . 3.8 tt0 -124.78 134.36 52.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.28 -0.887 . . . . 0.0 110.151 179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.565 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.4 OUTLIER -61.67 136.31 57.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.033 -1.042 . . . . 0.0 110.253 -179.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -111.76 -29.62 7.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.032 -1.042 . . . . 0.0 109.068 178.899 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 81.43 -30.56 2.76 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.494 177.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.56 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 4.7 t30 165.09 72.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.201 -1.176 . . . . 0.0 110.049 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 106.11 18.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.89 -1.132 . . . . 0.0 109.326 179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.45 94.82 0.06 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.98 -1.075 . . . . 0.0 109.563 -179.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.795 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.5 t80 -151.18 98.45 2.56 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.523 -0.735 . . . . 0.0 110.261 -179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 8.8 mtm-85 -75.06 92.06 2.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.577 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -112.16 -14.53 13.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.177 -0.952 . . . . 0.0 110.535 -179.38 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.564 ' HA ' ' CG1' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -175.23 166.97 3.44 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.968 -1.083 . . . . 0.0 110.355 -179.916 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.507 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.6 49.33 0.89 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -80.4 -172.67 3.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -1.095 . . . . 0.0 109.839 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 27' ' ' THR . 7.2 t -128.49 28.78 5.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.247 -0.908 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -145.46 -136.73 3.01 Favored Glycine 0 N--CA 1.488 2.139 0 C-N-CA 119.619 -1.277 . . . . 0.0 109.928 -179.788 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 10' ' ' TRP . 24.4 pt-20 -59.76 -37.07 77.98 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -1.032 . . . . 0.0 110.86 -179.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.585 HD22 ' CD2' ' A' ' 10' ' ' TRP . 0.1 OUTLIER -61.76 -12.88 19.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.193 -0.942 . . . . 0.0 111.307 -179.05 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -69.83 -35.51 74.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.825 -1.172 . . . . 0.0 110.268 -179.936 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.866 ' HB3' HD11 ' A' ' 16' ' ' LEU . 40.6 m-80 -122.65 121.83 37.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.996 . . . . 0.0 110.248 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.616 HG23 ' SG ' ' A' ' 9' ' ' CYS . 2.3 p -150.29 141.85 16.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.175 -0.953 . . . . 0.0 110.996 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CD2' ' HB3' ' A' ' 16' ' ' LEU . 49.7 m80 -65.44 125.28 24.63 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.701 178.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.562 ' HA ' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -61.95 -15.01 40.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.995 -1.066 . . . . 0.0 109.326 179.004 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.596 ' O ' HG22 ' A' ' 40' ' ' THR . 1.2 t -71.6 -57.31 4.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.534 -0.729 . . . . 0.0 111.269 -179.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 19.6 p -78.68 -28.62 45.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.777 -1.202 . . . . 0.0 111.197 -179.135 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.795 HD23 ' CE2' ' A' ' 21' ' ' PHE . 5.5 tp -76.92 -60.1 2.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.781 -1.2 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.874 ' HA ' HD21 ' A' ' 42' ' ' LEU . 3.9 t -49.84 -34.49 19.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -0.943 . . . . 0.0 110.19 179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 36' ' ' SER . 15.2 t -85.41 -39.25 17.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.915 179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.521 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 22.8 t90 -58.82 -56.99 15.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.819 179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.874 HD21 ' HA ' ' A' ' 39' ' ' SER . 1.9 pp -51.39 -32.01 24.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.037 -1.04 . . . . 0.0 109.955 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 ' N ' HD12 ' A' ' 42' ' ' LEU . 18.7 m -67.36 -49.83 62.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.03 -1.044 . . . . 0.0 109.716 179.507 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mt -65.3 -50.64 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' ARG . 48.2 t -74.74 -4.75 39.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.955 179.486 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 45' ' ' SER . 0.0 OUTLIER 65.23 66.19 0.55 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.345 -0.847 . . . . 0.0 110.868 179.771 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 85.9 m-20 -130.85 149.37 52.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.574 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 82.6 p -131.16 -11.41 3.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.023 -1.048 . . . . 0.0 110.923 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' C ' ' CZ ' ' A' ' 57' ' ' TYR . . . -152.2 146.54 25.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.924 -1.11 . . . . 0.0 110.563 179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.582 ' N ' ' CE1' ' A' ' 57' ' ' TYR . 43.0 t -61.37 132.49 53.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.375 -0.828 . . . . 0.0 109.936 179.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -85.61 -9.89 56.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.097 -1.002 . . . . 0.0 110.708 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 24.0 mm -70.53 -50.95 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.06 -1.025 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.766 ' SG ' HG23 ' A' ' 55' ' ' VAL . 22.0 p -115.32 -17.11 11.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.224 -0.922 . . . . 0.0 110.012 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.62 46.41 3.73 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.016 -1.088 . . . . 0.0 110.444 179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.766 HG23 ' SG ' ' A' ' 53' ' ' CYS . 58.0 t -114.1 136.19 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.053 -1.263 . . . . 0.0 109.739 179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' ALA . 4.0 t -71.49 148.32 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.945 . . . . 0.0 111.038 -179.383 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.582 ' CE1' ' N ' ' A' ' 50' ' ' CYS . 17.8 m-85 -73.94 68.54 1.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.42 -0.8 . . . . 0.0 110.209 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -49.5 114.23 1.0 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -0.843 . . . . 0.0 110.501 179.94 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.1 p -111.83 140.44 46.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.314 -0.866 . . . . 0.0 110.052 179.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.27 -179.95 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 mtm . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.208 0.528 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -97.67 -144.21 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.193 -0.942 . . . . 0.0 110.482 -179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -64.21 167.87 6.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 110.252 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -111.98 -86.5 0.56 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.93 . . . . 0.0 110.208 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.83 128.31 49.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.174 -179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.22 113.6 65.8 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.309 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.581 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 54.2 Cg_endo -74.42 162.98 37.22 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.924 1.486 . . . . 0.0 110.194 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.842 HG22 ' HG3' ' A' ' 15' ' ' GLU . 2.3 t -127.18 148.87 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.339 -0.851 . . . . 0.0 110.821 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.504 ' N ' HD22 ' A' ' 16' ' ' LEU . 5.3 t -80.01 120.12 23.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 0.0 109.826 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.511 ' CE2' HG12 ' A' ' 11' ' ' ILE . 59.5 p-90 -65.4 -17.15 64.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.483 -0.761 . . . . 0.0 111.624 -179.123 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.767 HD11 HD13 ' A' ' 38' ' ' LEU . 6.1 mt -77.55 -55.78 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.85 -1.156 . . . . 0.0 111.165 -179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.79 1.87 37.72 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.054 -1.029 . . . . 0.0 110.868 -179.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.55 62.4 2.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.103 -0.998 . . . . 0.0 110.234 179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 8' ' ' VAL . 33.7 tt0 -150.92 135.9 17.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 110.342 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.842 ' HG3' HG22 ' A' ' 8' ' ' VAL . 1.0 OUTLIER -58.45 137.02 57.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.84 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -117.66 -8.62 10.88 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.416 -0.803 . . . . 0.0 109.68 179.91 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.71 ' O ' ' CB ' ' A' ' 18' ' ' ASN . . . 86.22 -29.88 4.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 179.075 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.71 ' CB ' ' O ' ' A' ' 17' ' ' GLY . 10.2 t-20 127.93 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.61 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' H ' HD12 ' A' ' 16' ' ' LEU . 27.7 tp10 -58.67 119.67 7.51 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.229 -0.92 . . . . 0.0 109.413 -179.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.98 95.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 109.84 -179.399 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.839 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -149.4 98.0 2.73 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.626 -0.671 . . . . 0.0 109.402 179.62 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -77.18 94.91 4.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 110.006 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . . . -108.8 1.47 21.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.354 -0.841 . . . . 0.0 110.602 -179.696 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER 171.87 167.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.096 -1.002 . . . . 0.0 109.968 -179.911 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -124.07 52.36 0.79 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -78.99 -165.86 0.82 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.133 . . . . 0.0 109.978 179.951 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 m -127.85 26.74 5.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.307 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 31' ' ' GLU . . . -147.24 -153.73 6.01 Favored Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.294 -179.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 22.0 pt-20 -42.59 -41.49 3.06 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.496 -1.002 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -49.94 -20.02 0.83 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.027 -1.045 . . . . 0.0 111.036 -178.761 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -60.32 -49.1 78.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 109.892 179.629 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 7' ' ' PRO . 75.6 m-20 -106.03 122.86 47.02 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.21 -0.931 . . . . 0.0 109.656 179.577 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.06 HG21 HD22 ' A' ' 38' ' ' LEU . 3.9 p -147.58 141.32 19.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.022 -1.048 . . . . 0.0 111.191 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.605 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 2.3 m170 -64.73 119.89 11.42 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.66 -0.65 . . . . 0.0 110.228 179.305 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.532 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.1 OUTLIER -64.36 -16.01 61.47 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.012 -1.055 . . . . 0.0 109.502 179.229 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 37' ' ' CYS . 8.8 p -75.38 -61.5 1.88 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.565 -0.71 . . . . 0.0 111.181 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 4.6 p -76.8 -22.34 53.82 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.908 -1.12 . . . . 0.0 110.916 -179.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.06 HD22 HG21 ' A' ' 33' ' ' VAL . 7.6 tp -78.67 -59.61 2.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.846 -1.159 . . . . 0.0 109.9 179.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.876 ' HA ' HD21 ' A' ' 42' ' ' LEU . 21.6 t -52.9 -36.13 59.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.862 . . . . 0.0 110.223 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.5 HG23 ' N ' ' A' ' 41' ' ' TRP . 11.4 t -81.27 -38.04 27.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.304 -0.873 . . . . 0.0 109.936 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.527 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 30.4 t90 -61.02 -57.24 13.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.22 -0.925 . . . . 0.0 109.756 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.0 pp -55.27 -26.91 43.01 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 0.0 110.126 179.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 ' N ' HD12 ' A' ' 42' ' ' LEU . 5.1 m -68.27 -39.0 82.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.951 . . . . 0.0 109.468 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mt -78.96 -38.69 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.339 -0.851 . . . . 0.0 109.339 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 46' ' ' ARG . 11.0 t -80.81 -13.75 58.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.858 179.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . 1.1 ttt85 62.18 65.15 0.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.446 -0.783 . . . . 0.0 110.526 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.76 ' C ' HG23 ' A' ' 48' ' ' THR . 6.5 m-20 -117.53 -61.05 1.75 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.143 -0.973 . . . . 0.0 109.647 179.515 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.76 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.2 p 70.59 -6.73 1.15 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.857 -0.527 . . . . 0.0 111.237 179.484 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 56' ' ' VAL . . . -153.11 137.71 16.87 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.647 -1.283 . . . . 0.0 110.804 179.82 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 24' ' ' CYS . 42.6 t -56.33 135.53 53.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.645 179.462 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -89.73 -8.19 52.82 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.127 -0.983 . . . . 0.0 110.875 -179.263 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 50' ' ' CYS . 13.1 mm -76.16 -49.23 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.022 -1.049 . . . . 0.0 110.516 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.723 ' SG ' HG23 ' A' ' 55' ' ' VAL . 24.4 p -112.71 -17.55 12.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.074 -1.017 . . . . 0.0 110.52 -179.76 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.05 50.17 3.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 179.635 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.723 HG23 ' SG ' ' A' ' 53' ' ' CYS . 47.5 t -121.03 131.43 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.058 -1.26 . . . . 0.0 109.897 179.424 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 58' ' ' ASN . 66.0 t -64.59 143.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 110.479 -179.771 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.616 ' CD2' HD22 ' A' ' 42' ' ' LEU . 28.0 m-85 -68.4 -33.57 74.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.255 -0.903 . . . . 0.0 110.103 179.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.569 ' H ' HG12 ' A' ' 56' ' ' VAL . 6.6 t-20 50.48 65.89 1.32 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.827 . . . . 0.0 110.624 179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 p -79.27 117.27 20.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.729 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.266 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG2' ' O ' ' A' ' 1' ' ' MET . 4.3 ttp . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.283 0.563 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.08 -15.27 8.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 110.171 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 4' ' ' GLU . 17.8 t0 -101.31 -20.73 15.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.329 -0.857 . . . . 0.0 109.934 179.92 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 55.8 mt-10 42.65 -121.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.959 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 1.8 t0 69.81 143.82 0.05 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.738 -1.226 . . . . 0.0 110.377 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 31.9 t -122.01 130.77 24.59 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 0.0 109.922 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.44 ' HB3' ' ND2' ' A' ' 32' ' ' ASN . 49.8 Cg_endo -72.83 160.9 45.09 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.874 1.46 . . . . 0.0 110.585 -179.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.682 HG13 ' C ' ' A' ' 14' ' ' GLU . 3.7 t -128.12 150.36 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.402 -0.811 . . . . 0.0 110.4 -179.893 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB ' ' A' ' 11' ' ' ILE . 15.4 t -70.29 113.42 7.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.716 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.565 ' CE2' HG12 ' A' ' 11' ' ' ILE . 64.3 p-90 -55.17 -14.34 1.63 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 111.463 -179.293 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 10' ' ' TRP . 6.1 mt -82.76 -57.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.858 -1.151 . . . . 0.0 111.594 -179.119 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 14' ' ' GLU . 30.0 p -102.85 2.5 35.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.867 -1.145 . . . . 0.0 110.596 -179.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 1.6 m120 60.62 43.06 13.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.227 -0.921 . . . . 0.0 110.386 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.682 ' C ' HG13 ' A' ' 8' ' ' VAL . 1.7 tp10 -121.01 130.89 53.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.239 -0.913 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' N ' HG13 ' A' ' 8' ' ' VAL . 0.2 OUTLIER -58.93 137.98 57.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.888 . . . . 0.0 110.738 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.767 ' N ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -118.09 -34.72 4.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 108.81 178.656 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 18' ' ' ASN . . . 75.01 -30.11 1.1 Allowed Glycine 0 N--CA 1.494 2.546 0 O-C-N 121.46 -0.775 . . . . 0.0 112.72 177.3 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' GLY . 2.6 t-20 -179.54 44.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.235 -1.744 . . . . 0.0 111.995 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.5 102.82 3.32 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.613 -1.304 . . . . 0.0 108.906 178.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.78 96.98 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.044 -1.035 . . . . 0.0 109.561 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.722 ' CE2' HD23 ' A' ' 38' ' ' LEU . 1.8 t80 -149.06 98.6 2.85 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.343 -0.848 . . . . 0.0 110.62 -179.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -74.2 95.28 2.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.207 -0.933 . . . . 0.0 109.934 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 57' ' ' TYR . . . -128.73 -12.07 4.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.987 -1.071 . . . . 0.0 110.873 -179.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.821 ' SG ' HD12 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -179.2 168.63 1.53 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.161 -0.962 . . . . 0.0 109.961 -179.729 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -149.75 50.24 0.55 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.0 m -60.24 -108.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -1.227 . . . . 0.0 110.316 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 -15.23 5.1 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 111.021 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' CA ' ' HB2' ' A' ' 31' ' ' GLU . . . 170.2 -65.67 0.16 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.506 ' HG3' ' HB3' ' A' ' 10' ' ' TRP . 12.7 tt0 -42.41 -61.39 1.21 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -1.129 . . . . 0.0 110.064 179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.821 HD12 ' SG ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -74.91 -22.62 58.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 110.38 -179.68 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.525 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -51.56 -44.14 62.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.141 -0.974 . . . . 0.0 110.109 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.614 ' HB3' HD11 ' A' ' 16' ' ' LEU . 15.3 m-80 -108.37 121.13 44.29 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.154 -0.966 . . . . 0.0 109.576 179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.003 HG21 HD22 ' A' ' 38' ' ' LEU . 2.6 p -150.05 139.04 15.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.003 -1.061 . . . . 0.0 111.616 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.607 ' HB2' ' SG ' ' A' ' 37' ' ' CYS . 9.2 m170 -65.6 123.95 21.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.645 -0.659 . . . . 0.0 110.038 178.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.614 ' HG3' ' CG ' ' A' ' 21' ' ' PHE . 4.8 tmm_? -65.56 -14.46 61.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.208 -0.932 . . . . 0.0 110.076 179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 40' ' ' THR . 32.2 t -77.47 -61.54 1.96 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.215 -0.928 . . . . 0.0 111.267 -179.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.607 ' SG ' ' HB2' ' A' ' 34' ' ' HIS . 3.6 p -75.25 -25.08 57.77 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.91 -1.118 . . . . 0.0 111.364 -178.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.003 HD22 HG21 ' A' ' 33' ' ' VAL . 3.7 tp -77.22 -56.02 4.92 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.523 -1.361 . . . . 0.0 109.692 179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.928 ' HA ' HD21 ' A' ' 42' ' ' LEU . 26.7 p -54.68 -39.29 67.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.878 . . . . 0.0 110.016 179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 36' ' ' SER . 15.3 t -78.13 -31.85 50.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 110.008 179.81 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.505 ' HE3' HD12 ' A' ' 38' ' ' LEU . 12.0 t90 -68.38 -55.86 10.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.213 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 39' ' ' SER . 3.5 pp -57.06 -22.91 42.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.179 -0.951 . . . . 0.0 109.633 179.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.505 ' N ' HD12 ' A' ' 42' ' ' LEU . 31.3 m -66.75 -46.51 75.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 0.0 109.287 179.232 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 mt -73.07 -39.17 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.378 -0.826 . . . . 0.0 109.4 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.7 t -81.84 -12.59 58.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.688 179.476 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER 48.39 77.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.754 . . . . 0.0 110.507 179.834 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.781 ' C ' HG23 ' A' ' 48' ' ' THR . 4.5 m-20 -114.07 -39.7 3.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.647 179.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 47' ' ' ASN . 1.3 p 75.83 -31.69 0.2 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.864 -0.523 . . . . 0.0 111.448 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 56' ' ' VAL . . . -152.66 154.52 35.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.629 -1.294 . . . . 0.0 110.762 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.527 ' SG ' HD12 ' A' ' 52' ' ' ILE . 48.5 t -65.13 118.06 8.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.329 -0.857 . . . . 0.0 109.863 179.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.88 -2.56 30.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.527 HD12 ' SG ' ' A' ' 50' ' ' CYS . 30.3 mt -84.15 -42.51 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 110.297 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.61 ' SG ' HG23 ' A' ' 55' ' ' VAL . 29.7 p -115.03 -17.36 11.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.245 -0.91 . . . . 0.0 110.364 -179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.98 23.79 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 53' ' ' CYS . 93.3 t -101.72 143.81 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.085 -1.244 . . . . 0.0 110.152 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 49' ' ' ALA . 53.4 t -80.23 147.88 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.26 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 27.7 m-85 -70.28 -37.52 74.86 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.271 -0.893 . . . . 0.0 110.802 -179.629 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.425 ' H ' HG12 ' A' ' 56' ' ' VAL . 0.6 OUTLIER 43.57 77.18 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 0.0 109.983 -179.766 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 60' ' ' ARG . 17.9 p -92.9 140.08 29.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.9 . . . . 0.0 110.554 -179.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 59' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 118.11 -0.948 . . . . 0.0 110.312 179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A 1061 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A 1062 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_